DGFT Committee Minutes
Recovered from broken page tree (FzErrorArgument: code=4: Attempt to use Leptonica from 2 threads at once!)
,1
: : : :
:
|
.
:
; coe . a
. Office of Directorate General of Foreign Trade New Delhi -0
.
7
Para 4,07 Decision
—
Minutes of the Norms ‘Committee — 3 Meeting No. NC/3/MEET/Jun/202122/2 dated 02.07.2021 (Online Meeting) for considering the cases/issues under Duty Exemption Scheme (Chapter-4) of Foreign Trade Policy, 2015-20 pertaining to Chemical and Allied products falling under Chapter 29 and 30, held under the Chairmanship of Shri Vijay Kumar, Addl. DGFT
==> picture [1 x 1] intentionally omitted <==
----- Start of picture text -----<br> |<br>----- End of picture text -----<br>
Following members were present in the Meeting: .
,
==> picture [453 x 52] intentionally omitted <==
----- Start of picture text -----<br> [Si“*" [Name& Designation TDepariment<br>‘1_____| Sbri Shaish Kumar, Technical-1 |Consultant<br>----- End of picture text -----<br>
- The Norms Committee has taken decision only with respect to technical aspect/ wastage norms. While redeeming the application, RAs should check that the applicant has fulfilled all requirements as prescribed in policy/procedure including those in policy circulars issued from time to time or any other provisions under FTP/HBP for issuance of Advance Authorization and regularization of the case. . a
_ The committee went through the minutes of earlier mecting No. NC/3/MEET/Jan/202021/4 dated 12.02.2021 (actually held on.26.02.2021, 12.03.2021 and 12.05.2021). _
,
2
,
.
|
ONLINE CASES
==> picture [507 x 468] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|iMeeting|No:|.|
|re|||
|FRA|File Number:}039404000466AMI16,|
|[License|Number:|[0310811611|}|a|
|||Authorisation|03-03-2017|
|i Issued:|
|| Office|of|||
|0306019787.|||a|
|fice:|Issue:|Office of the Additional Director General|of Foreign Trade, Mumbai|.|Pe|
|iName:|~~|~«{CROPNOSYS|(INDIA) PRIVATE LIMITED|~|
|‘Address:|B1-104C|BOOMERANG,ANDHERI-EAST|MUMBAI,400072.|ae~|
|||PIN:|~~|(400072|
|[Type of License:|{Advance Licence with AU Condition|||
|VApplication|Export Order|i”|
|Status|{Manufacturer|Exporter|
|omepofexporter: Type:||)Private Limitedneni||
|Export|Product|||Chemical|and|Allied|Products|:|
|| Group:|_|.|
|Cie|Value of the|17|843200|||
|TPOB|Value:|185816000||||.|
|[Foe FCC:|{1360000|_|)|,|a|
|Decision:|The Committee|considered|the|case|as|per agenda|in|the|presence|of technical|experts|and|it was|observed}|
|that|the|norms|for|the:|subject|Advance|Authorization|have|already|been|ratified|by|NC-3|in|its|Meeting|No,|
|/82-ALC4/2018|dated 25.07.2018.|
|_|In view of above, the Committee|decided|to withdraw the case.|
----- End of picture text -----<br>
==> picture [2 x 5] intentionally omitted <==
----- Start of picture text -----<br> J<br>----- End of picture text -----<br>
3
|
| i
,
.
:
|
|
‘
| Meeting<br>No: | ||
|---|---|---|
| ee<br>Authorisation<br>02-07-2020<br>.<br>Issued:<br>;<br>Officeofthe Additional Director General ofForeignTrade,Mumbai | . | ; |
| Basis: | ||
| ofExporter: | ||
| cmrocjsease | ||
| Decision:<br>TheCommittee considered the case asperagenda inthepresence oftechnical experts and itwas observed<br>that the norms for the subject Advance Authorization have already been ratified by NC-3 in its Meeting No,<br>3/82-ALC4/2020dated07.08.2020. |
b
Sen
|
|
|
|
,
| Meeting<br>No: | |
|---|---|
| acmefem<br>Authorisation<br>Issued:<br>. | fem<br>[31-03-2021 |
| Basis: | |
| ofExporter: |
|
|
<!-- page 5 skipped: FzErrorArgument: code=4: Attempt to use Leptonica from 2 threads at once! -->
6
—~
,
|
||Meeting<br>No:||
|---|---|---|
|_|cmonfromm<br>Authorisation<br>31-03-2021<br>[|Issued:<br>:||
||PosOSS||
||Basis:||
||ofExporter:||
||jrFcG.(25000|(25000|
||roprcc:|(ps7s0|
7
.
;
| Meeting<br>No: |
|---|
| peefee<br>Authorisation<br>31-03-2021<br>Issued: |
| pusiS |
| Basis: |
| ofExporter:<br>: |
| FOBVahe:[ris0961_SSS<br>roproc:_fyssea_SSC |
| |
8
;
|
,
|
==> picture [447 x 378] intentionally omitted <==
----- Start of picture text -----<br>
|||
|---|---|
|Meeting|No:|
|Authorisation|31-03-2021|
|Issued:|.|
|cm|fem|
|Basis:|
|ofExporter:|
|CS|
|rosroo.psse9SOSOSSSCSCSCSCSSCSCSSCSSCSS|
----- End of picture text -----<br>
|
|
‘
9
_
|
|
o
||Meeting<br>No:|||
|---|---|---|---|
||imefem<br>Authorisation<br>31-03-2021<br>Issued:<br>= eee<br>ae<br>:<br>.|||
||PN ps<br>OSOCSCSSOSCOCSCSCSC“CNSCNSC‘“#NNNNNY|||
||Basis:|||
||ofExporter:|||
||jarroc.|pias|SSS“|
||||||
10
. ;
==> picture [2 x 8] intentionally omitted <==
----- Start of picture text -----<br> .<br>----- End of picture text -----<br>
||MeetingNo:<br>NC/3/MEET/Jun/202122/2|Date: 02/07/2021<br>oweonwnmeat|Date: 02/07/2021<br>oweonwnmeat||CaseNo:<br>9/NC/3/MEET/Jun/202122/2|CaseNo:<br>9/NC/3/MEET/Jun/202122/2|CaseNo:<br>9/NC/3/MEET/Jun/202122/2|CaseNo:<br>9/NC/3/MEET/Jun/202122/2|CaseNo:<br>9/NC/3/MEET/Jun/202122/2||
|---|---|---|---|---|---|---|---|---|---|---|
||HQ FileNumber:| HQRNORMAPPLY00117698AM21||||||||||
||RA FileNumber:]03A4A04033579AM21||||||||||
||0311000962||||||||||
||Date of||||||||||
||Authorisation<br>31-03-2021||||||||||
||Issued:|||||,|||||
||Office ofIssue:<br>|Office ofthe Additional Director||General ofForeignTrade, Mumbai||||||||
||RALCPOOOM||||||||||
||PIRAMALPHARMALIMITED||||||||||
||PIRAMAL ANANTA, PIRAMAL AGASTYA PARK,KURLA, MUMBAI,400070.||||||||||
|_||Type ofLicense: |Advance Licence|withAU Condition|||||||||
||Application<br>Export Order||||||||||
||Basis:||||||||||
||Status<br>Manufacturer Exporter||||||||||
||ofExporter:||||||||||
||ExporterType:<br>|Public Limited||||||||||
||Chemical and Allied Products||||||||||
||Group:||||||||||
||CIFValue ofthe 682455424<br>License:<br>:||||||||:||
||CIF FCC:<br>9304095||||||||||
||FOB Value:<br>944853588||||||||||
||Decision:<br>|TheCommitteeconsideredtherequestofthe|||firmanditwasdecidedtoratify|||adhocnormsunder|||Paral|
||4.07 ofHBP vol. I asperdetails givenbelow|below oras appliedby the firm, whichever is||||less:|||||
||SL<br>ExportProduct|Qty.|Sl.|| Importitems|||Qty.||||
||No.<br>1<br>Atorvastatin Calcium|131960430|No.<br>1|Atorvastatin||Calcium | 1483.37kg|||||
||TabletsUSP 10mg (Pack<br>Size90 tabs)((Net wt. of<br>Import Sr.No. 1 is<br>.<br>1454.24kgs, Sr. No. 2 is<br>054 6ke,<br>Sr.<br>No.3<br>i<br>8094.6kg,<br>Sr.<br>No. 8<br>2287.27kg, St. No. 4 is|Numbers|2<br>4|Propylene<br>Glycol<br>Solvate<br>USP<br>:<br>Microcrystallin<br>Cellulose 8054.60kg<br>(MCC)NF(AvicelPH 102)<br>:<br>2287.27 kg<br>Plastic Bottles 75CC white | Relevant<br>as<br>HDPERound38mm<br>per<br>packing)||||||~|
||1466227 Nos., Sr. No, 8||||||policy||||
||is 1466227 Nos., Sr.No.<br>12 is 1466227Nos))||5|CR38400APIT865<br>BLUE| Relevant<br>as<br>PP465<br>1400<br>(Plastics |per<br>packing<br>Caps/ClosuresPP38MM- 400| policy|||||||
|||||BlueCR)|||||||
|||||Strippax Sorbent 50 C & 50 <br>SG 2gm 1480889 (Silica Gel|||| Relevant<br>as<br> |per<br>packing||||
|||||Dessicants)}|||policy||||
: cain i , : }
11
—
. - , .
==> picture [380 x 680] intentionally omitted <==
----- Start of picture text -----<br> Atorvastatin Calcium | 169663000 1 Atorvastatin Calctum | 1907.18 kg<br>Tablets USP 10mg | Numbers Propylene Glycol Solvate USP<br>(Pack Size 1000<br>tabs)((Net wt. of Import 2 Microcrystalline Cellulose | 10355.89 kg<br>Sr, No. 1 is 1869.86kgs, (MCC) NF (Avicel PH 102)<br>Sr. No. 2 is 10355.89kg,<br>Sr. No. 5 is 169663<br>Nos., Sr. No.9 is 169663 4 250cc Rnd White 53/400 | Relevant as<br>Nos., Sr. No. 12 is Hdpe Sclair 58a (Plastic | per packing<br>169663 Nos)) Bottles 250CC white HDPE ! policy<br>Round 38mm)<br>5 Blue 53mm Pp Cap Lp-E & | Relevant as<br>Triseal F217hy (Plastics | per _ packing<br>Caps/Closures PP 53MM-| policy<br>400 BhiePP)<br>Strippax Sorbent 50 C & 50 | Relevant as<br>SG 2gm (Silica Gel | per packing<br>Dessicants) policy<br>Atorvastatin Calcium | 13663350 1 Atorvastatin Calcium | 307.19 kg<br>Tablets USP 20mg (Pack | Numbers Propylene Glycol Solvate<br>Size 90 tabs)((Net wt. of USP<br>Import Sr. No. 1 is 2 Microcrystallin Cellulosg 1673.87 kg<br>301.17kgs, Sr. No. 2 is (MCC) NF (Avicel PH 102)<br>1673.87kg, Sr. No. 3 is<br>151815 Nos., Sr. No. 8 is<br>151815 Nos., Sr. No. 12 4 Plastic Bottles 75CC white | Relevant as<br>is 151815 Nos)) HDPE Round 38mm per packing<br>polic<br>5 CR38400APJT865 BLUE | Relevant as<br>PP465 1400 (Plastics | per _packing<br>Caps/Closures PP 383MM- 400 | policy<br>Blue CR)<br>Strippax Sorbent 50 C & 50 | Relevant as<br>SG 2gm 1480889 (Silica Gel | per packing<br>Dessicants) policy<br>Atorvastatin Calcium | 183801960 | 1 Atorvastatin. Calcium | 8264.66 kg<br>Tablets USP 40mg (Pack | Numbers Propylene Glycol<br>Size 90 tabs)((Net wt. of Solvate USP<br>Import Sr. No. 1 is<br>8102.73kgs, Sr. No, 2 is 2 Microcrystailin Cellulosd 44878.92 kg<br>44878,92kg, Sr, No. 3 is (MCC) NF (Avicel PH 102)<br>12744,09kg, Sr. No. 4 .<br>8 is 2042244 Nos., Sr.<br>No. 12 is 2042244 Nos)) 4 Plastic Bottles 75CC white} Relevant as<br>HDPE Round 38mm per packing<br>policy<br>5 | CR38400APJT865 BLUE | Relevant as<br>PP465 1400 (Plastics | per packing<br>Caps/Closures PP 383MM- 400 | policy<br>Blue CR)<br>Strippax Sorbent 50 C & 50] Relevant as<br>SG 2gm 1480889 (Silica Gel | per packing<br>Dessicants) policy<br>----- End of picture text -----<br>
12
:
:
a
==> picture [404 x 449] intentionally omitted <==
----- Start of picture text -----<br> 5 Atorvastatin Calcium | 37702980 1 Atorvastatin Calcium | 3390.67 kg<br>Tablets USP 80mg (Pack | Numbers Propylene Glycol ‘<br>Size 90 tabs)((Net wt. of Solvate USP<br>Import Sr. No. 1 is<br>- 3324.20kgs, Sr. No. 2 is Microcrystallin Cellulose<br>18500.44kg, Sr. No. 3 is (MCC) NF (Avicel PH 102}<br>5249.65kg, Sr. No. 6 is<br>418922 Nos., Sr. No. 11<br>is 418922 Nos)) 4 Plastic Bottles 75CC white | Relevant as<br>HDPE Round38mm per packing<br>polic<br>5 CR38400APJT865 BLUE| Relevant as<br>PP465 1400 (Plastics | per packing<br>Caps/Closures PP 38MM- 400 | policy<br>Blue CR). _<br>Strippax Sorbent 50 C & 50 | Relevant as<br>SG 2gm 1480889 (Silica Gel |] per packing<br>Dessicants) policy<br>6 Atorvastatin Calcium | 43594000 1 Atorvastatin Calcium | 3920.45 kg<br>Tablets USP 80mg | Numbers Propylene Glycol Solvate ;<br>(Pack Size 1000 USP<br>tabs)((Net wt. of Import<br>Sr. No. 1 is 3843.60kgs, Microcrystallin Cellulose<br>Sr. No. 2 is 21391.10kg, (MCC) NF (Avicel PH 102)<br>Sr. No. 3 is 6069.90kg,<br>Sr. No. 10 is 43594<br>Nos., Sr. No. 11 is 43594 4 Plastic Bottles 75CC white | Relevant as<br>Nos)) HDPE Round 38mm per packing<br>policy<br>5 CR38400APIT865 BLUE| Relevant as<br>PP465 1400 (Plastics | per packing<br>Caps/Closures PP 38MM- 400 | policy<br>Blue CR)<br>6 Strippax Sorbent 50 C & 50 | Relevant as<br>SG 2gm 1480889 (Silica Gel | per packing<br>Dessicants) policy<br>----- End of picture text -----<br>
RA concerned may take further necessary action as per above decision of NC.
13
. : : ;
==> picture [464 x 507] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Meeting|No:|Case|No:|
|NC/3/MEET/Jun/202122/2|Date:|02/07/2021|LO/NC/3/MEET/Jun/202122/2|
|HQ|File|Number:]|HRRNORMAPPLY00117718AM21|
|RA|File|Number:|]34AA04003342AM21|
|3411000346|
|Date|of|
|Authorisation|31-03-2021|
|____[Issued:|
|Office|of Issue:||Office|of the|Joint|Director|General|of Foreign Trade,|Vadodara|
|3405008237|
|RENOWN|PHARMACEUTICALS|PRIVATE|LIMITED|
|SURVEY NO|.143,|A VILLAGE|RANU,,|VADODARA,391445.|
|59185|
|Type|of License:|||[Advance]|[Licence]|[with]|[AU]|[Condition]|
|Application|Export|Order|
|Basis:|
|Status|Manufacturer|Exporter|
|ofExporter:|
|Group:|id|Chemical and Allied Products|
|CIF Value|of|the|10049318|
|License:|
|CIF|FCC:|137005|
|FOB|Value:|56605551|‘|
|FOB|FCC:|790580|
|Decision:|©The|Committee|considered|the|case|as|per|online|agenda|in|the|presence|of technical|experts|and|it|was|
|decided|to|call|for following|information|from the|firm:|
|(i)|Export|product|description|is|not|complete|and|is|not|matching|with|DML|furnished,|
|Each|export|product|may|be|separately|described|as|per|DML|alongwith|number|o|
|‘|capsules|to|be|exported.|
|(ii)|Copy|of|Master-Batch|Formula|for|each|export|product|duly|authenticated|by|Q.C.|
|Incharge|indicating|net|content|of each|input|both|for|shell and|medicament.|
|(iii)|Net weight|of Soft Gelatine|Capsules|shell|and|medicament|for|each|export product.|
|(iv)|Copy|of Batch-Log|Sheet|for|latest|three|consecutive|batches.|
|(v)|Technical|catalogue|for|Encapsulation|machine|with Guaranteed|Wastage|norms.|
|(vi)|Detailed working|for|calculation|of import|requirement and|norms|applied.|
----- End of picture text -----<br>
|
14
,
| ssofom<br>Authorisation<br>Issued: | fom<br>01-04-2021 |
|---|---|
| Basis: | |
| ofExporter: |
|
;
|
,
==> picture [466 x 292] intentionally omitted <==
----- Start of picture text -----<br>
|||
|---|---|
|Authorisation|01-04-2021|
|Issued:|
|[l|
|Basis:|
|ofExporter:|
|CS|a|
|roprec: owe)|
----- End of picture text -----<br>
|
16
| Sreepe<br>Authorisation<br>01-04-2021<br>Issued: | Sreepe<br>Authorisation<br>01-04-2021<br>Issued: |
|---|---|
| Basis: | |
| ofExporter: |
17
.
==> picture [449 x 310] intentionally omitted <==
----- Start of picture text -----<br>
|||||||
|---|---|---|---|---|---|
|Authorisation|05-04-2021|
|Issued:|
|ln|
|Basis:|
|ofExporter:|
|SSS|
|roprcc:|pose|
|for|in|this|Advance Authorization|by the|firm.|
----- End of picture text -----<br>
18
:
;
| oo<br>Authorisation<br>Issued: | 05-04-2021 | . |
|---|---|---|
| Basis: | ||
| ofExporter: |
|
19
:
,
==> picture [459 x 319] intentionally omitted <==
----- Start of picture text -----<br>
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Authorisation|05-04-2021|
|Issued:|
|!|
|el|
|PR|feesMAHARASHTRA,421103.|
|Basis:|
|ofExporter:|
|CS|S20|
|Decision;|The|Committee|considered|the|case|as|per|agenda|and|it was|decided|to|ratify|adhoc norms|as|applied|
|for|in|this|Advance|Authorization by the|firm.|
----- End of picture text -----<br>
20
|
—_
|
:
==> picture [447 x 344] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Authorisation.|05-04-2021|
|Issued:|
|ee|fee|
|(East),|MUMBAI,400022.|
|Basis:|
|ofExporter:|
|Decision:|The Committee|considered|the|case|as|per|agenda and|it|was|decided|to|call|for|following|information|
|from|the|firm:|
|@|Production|Consumption|data|duly|certified|by GST.|
----- End of picture text -----<br>
21
|
==> picture [447 x 174] intentionally omitted <==
----- Start of picture text -----<br>
|||
|---|---|
|Authorisation|05-04-2021|
|Issued:|.|
|fete|em|
|Basis:|
|ofExporter:|
----- End of picture text -----<br>
,
|
==> picture [447 x 127] intentionally omitted <==
----- Start of picture text -----<br>
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Decision:|| The|Committee|considered|the request|of the|firm|and|it|was|decided|to|ratify|adhoc|norms|under|Paral|
|4.07 of|HBP|vol.|I|as per details|given below|or|as|applied by the|firm,|whichever|is|less:|
|~_||No,|
|-|,|
|MG(DICLOXACILLIN|CAPSULES|||Numbers|SODIUM|
|500 MG BP/EP/USP/IP|
|1500.00 KG)|
|RA|concerned|may take further necessary|action|as|per above|decision of NC.|
----- End of picture text -----<br>
22
; ,
==> picture [450 x 311] intentionally omitted <==
----- Start of picture text -----<br>
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Authorisation|95-04-2021|||
|Issued:|
|fe|foo|
|mecasa|
|SSCS|
|pm|pees|
|Basis:|
|ofExporter:|;|
|License:|
|fee|fmer|
|cirroc[imassa—SSSSCSCSCSSSCSCSCSSSSOOC|
|Fosrec[aauaOSSSCSCSSCSSSOSOSCCCCC—~*”|
|Decision:|The|Committee|considered|the|request|of the|firm|and|it|was|decided|to|ratify|adhoc norms|under|Para|
|4.07|of|HBP|vol.|I|as per|details|given below|or|as|applied by the|firm,|whichever|is|less:|
----- End of picture text -----<br>
No.
RA concerned may take further necessary action as per above decision of NC,
|.
; °
}
==> picture [443 x 27] intentionally omitted <==
----- Start of picture text -----<br>
| eeting | No: | ae. | iCase | No: |
| [NC/BIMEE'T/Junv/202122/2 | j | Date: 02/07/2021 | 120/NC/3/MEET/Jun/202 | 122/2 |
----- End of picture text -----<br>
==> picture [500 x 611] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|[HQ FileNumber:||HQRNORMAPPLY00003606AM22,_...2~«~«~2~2~2~”C~COCOCS™|
|[RA|File Number:|03AA04000129AM22|
|i|License Number:|[0311003034|
|[Date of|
|| Authorisation|105-04-202]|
|| Office|of Issue:|||Office|of|the|Additional|Director|General|of Foreign|Trade,|Mumbai|
|HEC:|[0388014482|
|j Name:|IGLENMARK PHARMACEUTICALS|LTD|_|
|jAddress:|1B/2 MAHALAXMI|CHAMBERS,MUMBAI,400026.|
|HPIN:|||[400026]|||
|||Type|of|License:|||Advance|Licence|with|AU|Condition|||
|Application||ixport|Order|
|iStatus||Merchant Cum|Manufacturer|Exporter|i|
|pofExporter:|ae|_|
|Type:|Public|Limited|||
|xn|a|7|
|Export|Product|fChemical|and|Allied|Products|
|PGroup:|||||
|{CIF|Value|of|the|17645065|||
|i|License:|i|
|CIF|FCC:|§|104227|
|FOB|Value:|1443132400|
|FOB|FCC:|16189000|||
|Decision:|The|Committee|considered|the|request|of the|firm|and|it|was|decided|to|ratify|adhoc|norms|under|Para,|
|1.07|of HBP|vol.|I|as|per|details|given|below|or|as|applied|by|the|firm,|whichever|is|Jess:|
|i|fl|
|ce|cee|eee|_.|E|
|||Export|Product|Qty.|Import|items|Qty.|
|F|No.|
|FLUOCINOLONE|ACE|EAR|DROPS|||500000|||FLUOCINOLONE|1020|gram|
|0.01|pereent|20ML|~~|(Fluocinolone|| Numbers|ACETONIDE|BP|
|Acetonide|Oil|0.0lpercent)((|Net|Wt.|of|
|j|| FLUOCINOLONE|ACETONIDE|BP|
|in|L100Gms.)|ee|ee|
|B|| FLUOCINOLONE -ACE|SCALP|OIL|500000|||FLUOCINOLONE|6018|gram|||
|||0.01 percent|!I8SML|~~|(Fluocinolone|Numbers|-|ACETONIDE|BP|
|i|Acctonide|0.0lpercent|‘Topical|Oil)((Net|
|i|||Wt.|of FLUOCINOLONE|ACETONIDE|||
|,|||BP in 6490 Gms jy|||||
|p|| FLUOCINOLONE|ACE|BODY|OIL|200000|i|FLUOCINOLONE|2407.20|gram|
|:|||0.0lpercent|118ML|>|~—|(Fluocinolone|Numbers|ACETONIDE BP|
|i|||Acetonide|0.0lpercent|Topical|Oil((|Net|
|i|||Wt.|of FLUOCINOLONE|ACETONIDE|
|RA|concerned|may|take|further|necessary|action|as|per|above|decision|of NC.|
----- End of picture text -----<br>
==> picture [1 x 16] intentionally omitted <==
----- Start of picture text -----<br> ,<br>----- End of picture text -----<br>
:
24
:
==> picture [487 x 435] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||
|---|---|---|---|---|---|---|---|
|—_|)|
|ig Tie NumberHGRNORMAPPLYOOSOSIANGR)|||
|||
|TRA|File Number:]039404000229AM2)|
|[License Number:|[031|1002737|
|||Authorisation|(05-04-2021|
|iIssued:|a|;|a|
|||
|HEC:(Name:|~~|[AARTI0388189151DRUGS|LTD|||||||
|||dares:|)|striae,| Mahendra|Industrial|Estate, Ground Tne Floor, Ploteos FINOIIE No.109/D, RoadRENO No.29, Sem Sion|—_|i|
|)|
|Type|of License:|[Advance Licence with AU Condition|
|Application|[Export Order|
|eaeBasis:|7|iMerchant Cum Manufacturer|Exporter|||
|off:xporter:|
|[exporter Type:|[Public Limited|
|een Product|||cremical and Allied Products|
|[cr Fcc:|[590075|||]|a|a||a|
|a|_|—||||
|[FOB|Value:|150127525|
|Fonroc. (605250|
|from|the|firm:|
|Pane|The Committee considered the case as per agenda and|it was decided to call for following information|
|(i)|Production Consumption|data|duly|certified|by GST.|
----- End of picture text -----<br>
25
, -
:
:
NC/3/MEET/Jun/202122/2Meeting No: Date:; 02/07/2021 22/NC/3/MEET/Jun/202122/2Case No: HQ File Number:|HQRNORMAPPLY00003719AM22 RA File Number: |26AA04002622AM21 Date of Authorisation 05-04-2021 Issued: Office of Issue: |Office of the Joint Director General of Foreign Trade,’ Visakhapatnam —_ 0915028258 INNOVARE LABS PRIVATE LIMITED PLOT NO. 64, Ist FLOOR, ROAD NO.5,,GAJULARAMARAM,500090. Type of License: |[Advance][Licence][with][ AU][Condition] Application Export Order Basis: Status Manufacturer Exporter ofExporter: _ [Export Product Chemical and Allied Products Group: - License:CIF Value ofthe 86781751 CIF FCC: 1183118 FOB Value: 302400000
==> picture [447 x 164] intentionally omitted <==
----- Start of picture text -----<br> Decision: The Committee considered the request of the firm and it was decided to ratify adhoc norms under Para<br>4.07 ofHBP vol. I as per details given below or as applied by the firm, whichever is less:<br>; No.<br>Oseltamivir Phosphate or ethyl | 3000kg | 1 (3R,48,5R)- 3,4,5- 4980 kg<br>(3R4R,5S)- 5-amino-4- acetamido-3- trinydroxycyclo hex- 1-ene-1-<br>(pentan-3-yloxy)- cyclohex-1-ene- carboxylic acid or Shikimic acid<br>1-carboxylate Triethyl orthoformate 13350 kg<br>; Methanesulfonyl chloride 4380 kg<br>Triethysilane 2700 kg<br>5 Di isopropyl ether or Isopropy! | 33000 kg<br>. Ether<br>6 Dimethyl Sulphoxide or 15000 kg<br>Methylsulfinyl methane<br>----- End of picture text -----<br>
==> picture [293 x 11] intentionally omitted <==
----- Start of picture text -----<br> RA concerned may take further necessary action as per above decision of NC.<br>----- End of picture text -----<br>
26
| Authorisation | [05-04-2021 |
|---|---|
| Issued: | |
| Basis: | |
| ofExporter: |
,
Decision: | The Committee considered the request of the firm and it was decided to ratify adhoc norms under Paral 4.07 of HBP vol. I as per details given below or as applied by the firm, whichever is less: .
|
|
27
;
—_
;
;
co,
|
NC/3/MEET/Jun/202122/2Meeting No: Date:. 02/07/2021 24/NC/3/MEET/Jun/202122/2Case No:
|
==> picture [449 x 349] intentionally omitted <==
----- Start of picture text -----<br>
||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|HQ|File|Number:||HQRNORMAPPLY00003034AM22|
|RA|File|Number:|]03AA04026534AM21|
|0311002354|
|Date|of|
|Authorisation|05-04-2021|
|Issued:|
|Office|of Issue:|[Office|of the Additional|Director|General|of Foreign Trade,|Mumbai|
|[ea|CD|
|AMOLI|ORGANICS|PRIVATE|LIMITED|
|PLOT NO.|322/4 B|G.L.D.C.,GUJARAT,396195.|
|COSC|
|POSS|
|Type|of License:|||[Advance]|[Licence]|[with]|[AU]|[Condition]|
|Application|Export|Order|
|Basis:|
|Status|Merchant Cum|Manufacturer|Exporter|
|ofExporter:|
|Export Product|Chemical|and Allied Products|
|Group:|
|CIF Value ofthe|15026267|
|License:|
|FOB|Value:|90462960|
|FOBRCC:|[1263449CS|
|Decision:|| The Committee|considered|the request of the|firm|and|it was|decided|to|ratify|adhoc norms|under|Paral|
|4.07 ofHBP|vol.|I|as per|details|given|below|or|as|applied by the firm,|whichever|is|less:|
----- End of picture text -----<br>
==> picture [404 x 102] intentionally omitted <==
----- Start of picture text -----<br> No.<br>Oxcarbazepine USP / BP / EP 11966 kg 1 10-Methoxy 13162.60 kg<br>Iminostilbene<br>11966.00_kg<br>3 Methylene 15196.80 kg<br>Chloride ;<br>3230.80 kg<br>RA concerned may take further necessary action as per above decision of NC.<br>----- End of picture text -----<br>
28
==> picture [411 x 24] intentionally omitted <==
----- Start of picture text -----<br> Meeting No: . Case No:<br>NC/3/MEBT/Jun/202122/2 Date: 02/07/2021 25/NC/3/MEET/Jun/202122/2<br>----- End of picture text -----<br>
==> picture [448 x 473] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|HQ|File Number:||HQRNORMAPPLY00003040AM22|
|RA|File|Number:|]03AA040265354M21|
|0311002358|
|Date|of|
|Authorisation|05-04-2021|
|Lssued:|
|Office|of Issue:||Office|of the|Additional|Director|General|of Foreign|Trade,|Mumbai|
|psor1450i|
|AMOLI|ORGANICS|PRIVATE|LIMITED|
|PLOT|NO,|322/4|B|G.LD.C.,GUIARAT,396195.|
|386195|
|Type|of License:|}|[Advance]|[Licence]|[with][ AU]|[Condition]|
|Application|Export|Order|
|Basis:|
|Status|Merchant|Cum|Manufacturer|Exporter|
|ofExporter:|
|Export Product|Chemical|and Allied|Products|
|Group:|
|CIF Value of the|75026267|
|License:|
|CIF|FCC:|1022852|
|FOB|Value:|90462960|
|FOB|FCC:|1263449|
|Decision:|The|Committee|considered|the|request|of the|firm|and|it|was|decided|to|ratify|adhoc|norms|under|Para|
|4.07 of|HBP|vol.|I|as|per|details|given below|or|as|applied|by|the|firm,|whichever|is|less:|
|No.|
|Oxcarbazepine USP|/ BP|/ EP|11966 kg|1|10-Methoxy|13162.60 kg|
|Iminostilbene|
|11966.00|kg|
|3|Methylene|15196.80 kg|
|Chloride|
|3230.80|kg|
|RA|concerned|may take|further|necessary action|as per|above|decision of NC,|
----- End of picture text -----<br>
29
:
.
|
==> picture [451 x 275] intentionally omitted <==
----- Start of picture text -----<br>
|||
|---|---|
|Authorisation|06-04-2021|
|Issued:|
|ee|
|Basis:|
|ofExporter:|
|—SSCSCSCSSCSSCSCSCSSCSSCSCSCSCSS|
|FOB Voke|[meas|
----- End of picture text -----<br>
Decision: | The Committee considered the case as per agenda and it was decided to ratify adhoc norms as applied for in this Advance Authorization by the firm,
30
, .
Authorisation 06-04-2021 aIssued: Basis: ofExporter: CS —SSSSSOSSSSOSCSSS rosroo: [595500 Decision: | The Committee considered the request of the firm and it was decided to ratify adhoc norms under Para 4.07 of HBP vol. I as per details given below or as applied by the firm, whichever is less:
|ACURATE<br>TABLETS((Paracetamol | 29820kg<br>450mg+Doxylamine<br>Succinate<br>5meg+Caffeine<br>30mg+Codeine<br>Phosphate 10mg+Colour<br>Quinoline<br>300:000+Calsine 1800.0004Codcine-|No.<br>;<br>USP /Ph. EurGrade<br>2<br>CAFFEINEANHYDROUS<br>io|No.<br>;<br>USP /Ph. EurGrade<br>2<br>CAFFEINEANHYDROUS<br>io|1836ke<br>eee|
|---|---|---|---|
||YELLOW<br>Cl|47005||
||(SPECTRACOL)|||
RA concerned may take further necessary action as per above decision ofNC.
:
31
,
| [Date of | , | |
|---|---|---|
| Issued: | ||
| PIN | po | |
| Basis: | ||
| ofExporter: | ||
| ourec: | ft2sss6TT | O™~—™OCOCOCSCSCSC(‘S™SN |
32
;
:
==> picture [461 x 395] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Authorisation|08-04-2021|
|Issued:|
|WEST,400601.|
|Basis:|
|ofExporter:|
|—OOS—SSSS—S—COOCCCCTCTTCCCC—Sd|
|\aerca|sme|
|Decision:|The|Committee|considered|the|request|of the|firm|and|it|was|decided|to|ratify|adhoc|norms|under|Para||
|4.07 of|HBP|vol.|I|as per details|given below|or|as|applied|by the|firm,|whichever|is|less:|
|No.|
|2-|METHYL|PROPARNE)(ISO|
|BUTYL|BROMIDE|(i-BROMO|-2-|
|METHYL PROPARNE))|
----- End of picture text -----<br>
33
| |
:
LicenseNumber:f0s11002135_—————S Authorisation 08-04-2021 Issued: eee fee pies fuss Basis: ofExporter: : License: a Pom Vater [p159192 Fonroc [ams Decision: The Committee considered the request of the firm and it was decided to ratify adhoc norms under Para| 4.07 of HBP vol. I as per details given below or as applied by the firm, whichever is less: No. mg & 50mg)(Each Film coated Tablet contains: Diosmin USP 450 mg, Hesperidin 50 mg.) RA concerned may take further necessary action as per above decision of NC,
34
==> picture [448 x 334] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||
|---|---|---|---|---|---|---|---|---|---|
|Authorisation|09-04-2021|
|Issued:|
|ee|re|
|Basis:|
|ofExporter:|
|Exporter|type|SSCSPableLinied|
|SSS|
|arrec|se|
|ronrcc.|aosSSS|
|for|in this|Advance Authorization by|the|firm.|
|RA|concerned may|take|further necessary|action|as|per|above|decision of|NC.|
----- End of picture text -----<br>
35
| ,
|
==> picture [450 x 261] intentionally omitted <==
----- Start of picture text -----<br>
|||
|---|---|
|Authorisation|09-04-2021|
|Issued:|
|foie|frm|
|403, 4THFLOORTITANIUMSQUARENRTHALTEJCROSSROAD,AHMEDABAD,380054.|
|Basis:|
|ofExporter:|
|License:|
|eal|
----- End of picture text -----<br>
,
36
|
==> picture [461 x 310] intentionally omitted <==
----- Start of picture text -----<br>
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Authorisation|09-04-2021|
|Issued:|
|mm|Powe|
|Basis:|
|ofExporter:|
|jarroc|ps0|SSCS|
|—SSOSSOSOSCSCSSSSSSSOSCOOOOCCC|
|||posto|[ans|
|Decision:|The|Committee|considered|the|request|of the|firm|and|it|was|decided|to|ratify|adhoc norms|under|Para|
|4.07|of|HBP|vol.|I|as|per details|given below|or|as|applied by the|firm,|whichever|is|less:|:|
----- End of picture text -----<br>
==> picture [355 x 57] intentionally omitted <==
----- Start of picture text -----<br>
||||
|---|---|---|
|;|No.|‘|
|120mg Hard Capsules|Numbers|
|Capsules|Numbers|
----- End of picture text -----<br>
RA concerned may take further necessary action as per above decision ofNC.
37
,
==> picture [459 x 252] intentionally omitted <==
----- Start of picture text -----<br>
|||
|---|---|
|Authorisation|09-04-2021|
|Issued:|
|,|
|Se|fe|
|Basis:|
|ofExporter:|
|License:|
|fees PMH|
----- End of picture text -----<br>
:
38
;
~ : .
.
.
==> picture [219 x 51] intentionally omitted <==
----- Start of picture text -----<br> Meeting No:<br>NC/3/MEET/Jun/202122/2 Date: 02/07/2021 02/07/2021<br>HQ File Number:| HQRNORMAPPLY00008718AM22<br>----- End of picture text -----<br>
==> picture [262 x 26] intentionally omitted <==
----- Start of picture text -----<br> Case No:<br>Date: 02/07/2021 02/07/2021 35/NC/3/MEET/Jun/202122/2<br>----- End of picture text -----<br>
|HQ File Number:|Number:||HQRNORMAPPLY00008718AM22|
|---|---|
|RA FileNumber:|/074A04011194AM21|
||0711000869|
|Date of||
|Authorisation|09-04-2021|
|Issued:<br>OfficeofIssue:|;<br>|Office oftheAdditional Director General ofForeignTrade, Bengaluru|
||0799007803|
||MAIVAPHARMA PRIVATE LIMITED|
||688, Ground Floor, 6thMain,,BANGALORE,560097.|
||560097|
|Type ofLicense:||Advance Licence withAU Condition|
|Application|Export Order|
|Basis:||
|Status|ManufacturerExporter|
|ofExporter:||
|ExporterType:|[Private Limited|
|E|Chemical andAlliedProducts|
|Group:||
|CIFValue ofthe <br>License:|6638762|
|CIF FCC:|90508|
|FOBValue:|44801856|
==> picture [447 x 245] intentionally omitted <==
----- Start of picture text -----<br> Decision: The Committee considered the request of the firm and it was decided to ratify adhoc norms under Para<br>4.07 of HBP vol. I as per details given below or as applied by the firm, whichever is less:<br>No,<br>Bumetanide Injection USP 0.25mg per mL, 4mL fill | 259600 ] V-35 4416/50 GRY SIL 3 Relevant as<br>in SmL Vial,(4m fill in SmL Vial - filled with Img | Numbers Westar RS/SP02 (13mm| per packing<br>of Bumetanide as bulk drug mixed in water for ‘RFS Gray Silicon Westar policy<br>injection and filled for 4mL in SmL Vial and capped Rubber Stopper 3)<br>with 13mm RFS Gray Silicon Westar Rubber<br>Stopper)<br>Bumetanide Injection USP 0.25mg per mL, 10mL j 189200 1 V-35 4416/50 GRY SIL 3 Relevant as<br>Vial.(10ml. Vial -filled with 2.50mg of Bumetanide | Numbers Westar RS/SP02 (13mm | Pet packing<br>as bulk drug mixed in water for injection and filled RFS Gray Silicon Westar policy<br>in 10mL Vial and capped with 13mm RFS Gray Rubber Stopper 3)<br>Silicon Westar Rubber Stopper)<br>Famotidine Injection USP 10mg per mL, 2mL | 748000 V-35 4416/50 GRY SIL 3 Relevant as<br>Vial.(2mL Vial - filled with 20mg of Famotidine as | Numbers Westar RS/SP02 (13mm | Pet packing<br>bulk drug mixed in water for injection and filled in RFS Gray Silicon Westar policy<br>2mL Vial and capped with 13mm RFS Gray Silicon Rubber Stopper 3)<br>Westar Rubber Stopper)<br>RA concerned may take further necessary action as per above decision of NC.<br>----- End of picture text -----<br>
39
:
| |
a
==> picture [448 x 437] intentionally omitted <==
----- Start of picture text -----<br>
||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Authorisation|10-04-2021|
|Issued:|
|ee|
|236,,AHMEDABAD,382481.|
|Basis:|
|ofExporter:|
|Exporier|Types|[PublioLimied|
|Group:|
|jomrocfnas3|
|FOR Vaiue fries|
|Decision:|| The Committee|considered|the|request|of the|firm|and|it was|decided|to|ratify|adhoc norms|under|Paral|
|4.07|of|HBP|vol.|I as per details|given below|or as applied by the firm,|whichever|is|less:|
|No.|
|MG((ACTIVE|INGREDIENT:|
|MESALAMINE|USP|-|NET|WT.|
|864.000|KGS.))|
|RA|concerned may take further necessary|action|as|per above|decision of|NC.|
----- End of picture text -----<br>
40
.
ce oe
Meeting No: . Case No: NC/3/MEET/Jun/202122/2 Date: 02/07/2021 37/NC/3/MBET/Jun/202122/2
==> picture [452 x 459] intentionally omitted <==
----- Start of picture text -----<br>
||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|-|HQ|File Number:||HQRNORMAPPLY00018647AM22|
|RA|File Number:]31A404007645AM21|
|Date|of|
|Authorisation|15-04-2021|
|Issued:|
|Office|of Issue:|| Office|of the|Joint|Director|General|of Foreign Trade,|Pune|
|(307052001|
|DEEPAK NOVOCHEM TECHNOLOGIES|LIMITED|
|OFFICE|NO.515,|5th FLOOR,CITY|POINT,PUNE,411001,|
|PNRSSSOSOSCSSCCC|
|Type of License:|||[Advance]|[Licence]|[with][ AU]|[Condition]|
|Application|Export|Order|3|
|Basis:|
|Status|Manufacturer|Exporter|
|ofExporter:|
|Exporter Type:|{Public|Limited|
|Chemical|and|Allied|Products|:|
|Group:|
|CIF Value|of|[the]|[263539200]|
|License:|
|CIF|FCC:|3592899|
|FOB|FCC:|6000000|
|Decision:|| The|Committee|considered|the|case|as|per|agenda|and|taking|cue|from|earlier|decision|for|same|expo|
|product|in|Meeting|No.|07/82-ALC4/2019|dated|24.12.2020|against|advance|authorization|No.|3110067177|dt.|
|26.09.2018,|it|was|decided to|ratify norms|under|Para|4.07|of HBP|Vol.|I|as|per|details|given below|or|as|applied|by|
|the|firm,|whichever|is|less:|
|No.|
|DNOVO BP818|(Tetra Methyl Bisphenol|F)|||1kg|2,6|xylenol|1.06 kg|
|Paraformaldehyde|0.130 kg|
|0.100|kg|
|RA may|take|appropriate|action|as|per the|decision of Norms|Committee.|
----- End of picture text -----<br>
41
- ; :
: : :
|
.
==> picture [459 x 646] intentionally omitted <==
----- Start of picture text -----<br>
||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Meeting|No:|;|Case No:|
|NC/3/MEET/Jun/202122/2|Date:|02/07/2021|38/NC/3/MEET/Jun/202122/2|
|HQ|File|Number:||HQRNORMAPPLY00018662A M22|
|RA|File Number:|]03A404000558AM22|
|LicenseNumberfosii003135_——————SSS:|
|Date|of|
|||Authorisation|15-04-2021|:|Ten|Tes|
|Issued:|
|Office of Issue:|jOffice|of the Additional|Director General|of Foreign Trade,|Mumbai|
|038014483|
|GLENMARK|PHARMACEUTICALS|LTD|
|PIN|B/2 MAHALAXMI CHAMBERS,MUMBAI,400026.|
|Type|of License:[00026|Advance|Licence|with AU|Condition|,|
|Application|Export|Order|
|Basis:|
|Status|Merchant Cum Manufacturer Exporter|‘|
|ofExporter:|
|Exporter Type:||Public|Limited|
|Export Product|Chemical|and Allied Products|
|Group:|
|CIF|Value|of the|
|License:|
|POBRCC:|[3253710|OC™O—OCOCSCSCSC‘S|
|Decision:|||The Committee|considered|the request|of the|firm|and|it|was|decided|to|ratify adhoc norms|under|Para|
|4.07 ofHBP|vol.|I|as per details|given below or as applied by the|firm,|whichever|is|less:|
|Sl.|Export Product|Qty.|
|No.|
|1|Mometasone|Furoate|Ointment|0.10|Percent|(Pack|10gms)|(Net|Wt.|of|| 20000 Numbers|
|2|Mometasone Furoate Micronized 0.200 Kgs.)|
|Mometasone|Furoate|Ointment|0.10|Percent|(Pack|15gms)|(Net|Wt.|of|| 20000 Numbers|
|3|Mometasone Furoate Micronized0.300 Kgs.)|
|Mometasone|Furoate|Ointment|0.10|Percent /Momate|Ointment|0.10|Percent|| 20000 Numbers|
|4|(Pack 20gms)((Net Wt. of|Mometasone Furoate Micronized|0.400 Kgs.))|
|Mometasone|Furoate|Ointment|0.10|Percent|(Pack|30gms)|(Net|Wt.|of|||100000 Numbers|
|Mometasone Furoate Micronized3,000 Kgs.)|
|5|Mometasone|Furoate|Ointment|0.10|Percent|(pack|45gms)|(Net|Wt.|of|||100000 Numbers|
|Mometasone Furoate|Micronized4.050|Kgs.)|
|Mometasone|FuroateOintment|0.10|Percent|(Pack|50gms)|(Net|Wt.|of|| 20000 Numbers|
|Mometasone|Furoate Micronized1.00|Kgs.)|
|7|Mometasone Furoate Ointment 0.10|Percent (pack 60gms)|(Net|Wt.|of|30000 Numbers|
|Mometasone Furoate|Micronized|1.800 Kgs.)|
|Mometasone|FuroateOintment|0.10|Percent|(pack|100gms)|(Net|Wt.|of | 20000 Numbers|
|Mometasone Furoate Micronized2.000|Kgs.)|
|9|Mometasone|Furoate|Tropical|Solution|USP|0.1|Percent|(Lotion)|(Pack|||30000 Numbers|
|30ml)((NetWt. of|Mometasone Furoate Micronized 0.900 Kgs.) __|||;|
----- End of picture text -----<br>
42
.
;
| 60ml)((NetWt. ofMometasoneFuroateMicronized 1.800 Kgs.) | 60ml)((NetWt. ofMometasoneFuroateMicronized 1.800 Kgs.) | , | |||
|---|---|---|---|---|---|
| MometasoneFuroateMicronized 0.300 Kgs.) | |||||
| MometasoneFuroateMicronized 1.050 Kgs.) | |||||
| MometasoneFuroate Micronized 1.00 Kgs.) | |||||
| (Pack30gms)((NetWt. ofMometasone FuroateMicronized 2.40 Kgs.) | |||||
| Mometasone Furoate Micronized 1.800 Kgs.) | |||||
| Mometasone Furoate Micronized 3.000 Kgs.) | |||||
| MometasoneFuroate Micronized4,800Kgs.) | ; | _ | . | a | |
| MometasoneFuroateMicronized28.700Kgs.) |
43
,
:
==> picture [457 x 402] intentionally omitted <==
----- Start of picture text -----<br>
||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|[citineammae|—|reoimams|ESC|Srnacman|||
|Authorisation|15-04-2021|
|Issued:|
|ee|em|
|Basis:|
|ofExporter:|
|erroc se|
|FoR Value|senateSSS|
|Decision:|The|Committee|considered|the|case|as per agenda|and|it was decided|to|call|for following|information|
|from the|firm:|
----- End of picture text -----<br>
<!-- page 44 skipped: FzErrorArgument: code=4: Attempt to use Leptonica from 2 threads at once! -->
45
| . | ||
|---|---|---|
| Try | ||
| Authorisation | 15-04-2021 | |
| Issued: | ||
| PIN, | e005SSS | |
| Basis: | ||
| fstioces<br>ofExporter: | ||
| ~ | frosroc | fers<br>S |
46
|
|
|
|iefem<br>Authorisation<br>16-04-2021<br>Issued:|
|---|
|PN; ps<br>SOSSCSCSSSSCSCSC‘“SC‘“‘~‘;‘;<C;C|
|Basis:|
|ofExporter:|
|crrcc.|iamo_SSCSCSCSCSC—C—CS‘“‘—sCSs‘“‘“‘“‘“<“<CSC|
|Fonroc<br>prss00_SCS|
.
47
|
:
| TieenseNumber:[0511002233<br>_———SSCSCSCSCSCSCSSCSS<br>a<br>Authorisation<br>19-04-2021<br>Issued: |
|---|
| pin<br>os |
| Basis: |
| ofExporter: |
| a<br>License:<br>lomrcc pies<br>SOSOSOSOSSOSCOCSSCS |
| roprcc:fiaes<br>SSSCSOSCSCSCSCSCSCSSSSCSS |
48
:
==> picture [410 x 27] intentionally omitted <==
----- Start of picture text -----<br> Meeting No: ; Case No:<br>NC/3/MEET/Jun/202122/2 Date: 02/07/2021 44/NC/3/MEET/Tisn/202122/2<br>----- End of picture text -----<br>
==> picture [219 x 11] intentionally omitted <==
----- Start of picture text -----<br> HQ File Number:|HQRNORMAPPLY00021972AM22<br>----- End of picture text -----<br>
||RA File Number:|]334404000403AM22||
|---|---|---|---|
|||3311000189||
||Date of||,|
||Authorisation|19-04-2021||
||Issued:|||
||Office ofIssue: <br>mc||Office oftheJoint Director General ofForeignTrade, Panipat<br>.<br>.<br>psrorss<br>SCSCSCSCSCSCSCSC‘“‘;<C;<;‘CS<br>COMBITIC GLOBAL CAPLET PRIVATE LIMITED||
||M-15,D-2&D-3,INDUSTRIALAREA,,SONIPAT,131001.<br>PNoor<br>Type ofLicense: |Advance Licence withAU Condition<br>,|||
|;|Application|Export Order||
||Basis:|||
|||Merchant Cum Manufacturer Exporter||
||ofExporter:|||
||ExportProduct<br>Group:|Chemical andAlliedProducts||
||CIFValue ofthe <br>License:|15040000||
:
:
==> picture [447 x 224] intentionally omitted <==
----- Start of picture text -----<br> Decision: The Committee considered the request of the firm and it was decided to ratify adhoc norms under Para<br>4.07 ofHBP vol. I as per details given below or as applied by the firm, whichever is less:<br>No.<br>CIPROFLOXACIN TABLETS TP/BP/USP | 9522700 1 CIPROFLOXACIN 5285.10 kg<br>500MG,((Each Film Coated Tablet Contains | Numbers HYDROCHLORIDE IP<br>Ciprofloxacin Hcl IP/BP/USP 580mg. Equivalent<br>Ciprofloxacin 500mg.))<br>Ciprofloxacin Tablets IP/BP/USP 250 MG.((Each } 2000000 1 CIPROFLOXACIN 555.00 kg<br>Film Coated Tablet Contains Ciprofloxacin Hel | Numbers HYDROCHLORIDEIP<br>IP/BP/USP 290mg. Equivalent Ciprofloxacin<br>250mg.))<br>Ciprofloxacin Hydrochloride Tablets IP/BP/USP 2000000 1 CIPROFLOXACIN 1665.00 kg<br>750 MG.((Each Film Coated Tablet Contains | Numbers HYDROCHLORIDE<br>Ciprofloxacin Hel IP/BP/USP , IP<br>870mg, Equivalent Ciprofloxacin .<br>750mg.))}<br>RA concerned may take further necessary action as per above decision ofNC.<br>----- End of picture text -----<br>
49
~ .
:
,
Authorisation 20-04-2021 , Issued: ee feces a Basis: ofExporter: jarroo aes SSS ronrec. sss Decision: | The Committee considered the request of the firm and it was decided to ratify adhoc norms under Para 4.07 ofHBP vol. I as per details given below or as applied by the firm, whichever is less: : No. EP fluorophenyl)- 6-isopropyl- 2-(Nmethylmethylsulfonamido)pyrimidin5- ylvinyl)-2,2-di
50
,
==> picture [479 x 351] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|SSS|
|Ticense Number|0311009171|
|Authorisation|20-04-2021|
|(|e|eeIssued:|
|Basis:|
|ofExporter:|
|CS|
|SSS|
|Foprec.[aeag|
|Decision:|| The|Committee|considered|the|case|as|per|agenda|and|it|was|decided|to|call|for|following|information|
|from the|firm:|
|(i)|DML|showing Approved|Composition.|
----- End of picture text -----<br>
31
:
a
==> picture [447 x 279] intentionally omitted <==
----- Start of picture text -----<br>
||||
|---|---|---|
|Authorisation|20-04-2021|
|Issued:|
|ee|
|Neme:___ | SAMRUDH|PHARMACEUTICALS|PRIVATE LATED|
|Basis:|
|ofExporter:|
|Group:|
|License:|
|a|
|FOR|Vanes [26003600|
----- End of picture text -----<br>
Decision: | The Committee considered the request of the firm and it was decided to ratify adhoc norms under Para 4.07 ofHBP vol. Las per details given below or as applied by the firm, whichever is less:
No.
==> picture [301 x 84] intentionally omitted <==
----- Start of picture text -----<br>
|||||||
|---|---|---|---|---|---|
|750mg(Each|vial|contain|Numbers|Sterile USP|
|Cefuroxime|Sodium USP|Eg,|to|
|Cefuroxime|750mg Nett wt.|of|
|RM|in RP|is|
|1115kg)|
|RA|concerned may také further necessary action|as|pet above decision|of|NC.|
----- End of picture text -----<br>
52
|
|
|
==> picture [449 x 332] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Authorisation|[21-04-2021|
|Issued:|
|ee|fem|
|Basis:|
|ofExporter:|
|CS|
|—SSOSOSOSSSSCSCSCSCSCSSSSSSCCSYC|
|Fonroc:|[mesos|
|Decision:|The|Committee|considered|the case|as|per agenda and|it|was|decided|to|call|for following|information||
|from|the|firm:|
|r())|Percentage|purity|of export.|;|
----- End of picture text -----<br>
53
os
.
oo
:
==> picture [455 x 292] intentionally omitted <==
----- Start of picture text -----<br>
|||
|---|---|
|Authorisation|21-04-2021|
|Issued:|
|fe|a|
|Basis:|
|ofExporter:|
|a|
|rosrec [zeae|
----- End of picture text -----<br>
54
|
:
==> picture [448 x 391] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Authorisation|21-04-2021|
|Issued:|
|ee|am|
|Basis:|
|ofExporter:|
|ronroc:|~~|[ugss——SSSCSCSCSCSSSSC“CSC—CSsC‘CSCSCSSSSSSSSCSY|
|Decision:||The|Committee|considered|the|request|of the|firm|and|it|was|decided|to|ratify|adhoc|norms|under|Para|
|4.07 of|HBP|vol.|I|as per|details|given below|or|as|applied by|the firm,|whichever|is|less:|
|No.|
|AMANTADINE|2273080|1|AMANTADINE|231.85|kg|
|HYDROCHLORIDE|100 MG|Numbers|HYDROCHLORIDE|
|Someone[See|[Petes [I|
----- End of picture text -----<br>
,
55
|
;
:
| a<br>Authorisation<br>21-04-2021<br>Issued: |
|---|
| Basis: |
| ofExporter: |
| el tc<br>License:<br>CSSES<br>FoRVee iano<br>SCOSCSSCSCSCSCSCSCSSSS<br>romrec:[i009<br>S<br>S |
56
7
tin, :
Ca :
TGicense Number:[031003273 Authorisation 22-04-2021 Issued: mm femme
Basis:
ofExporter:
SSCS FOB Vane [ons
Decision: | The Committee considered the request of the firm and it was decided to ratify adhoc norms under Para| 4.07 of HBP vol. I as per details given below or as applied by the firm, whichever is less:
No. AZELAIC ACID 300000 1 Azelaic Acid 2295.00 kg GEL 15 percent Numbers (Pack Size 50 Grams) (Net Wt. of Azelaic Acid is 2250.00 Kgs.)(AZELAIC ACID GEL 15 percent (Pack Size 50 Grams) (Net Wt. of Azelaic Acid is RA concerned may take further necessary action as per above decision of NC.
:
_
37
:
:
|
,
| omfee<br>Authorisation<br>{22-04-2021<br>Issued: | omfee<br>Authorisation<br>{22-04-2021<br>Issued: |
|---|---|
| Type ofieense: | [Advance Licence withAUCondition<br>SY |
| Basis: | |
| ofExporter: | |
| aa<br>License:<br>carrer<br>OOOO | |
| romrec | fiaasOSC |
58
.
,
C5
| a<br>Authorisation<br>Issued: | 23-04-2021 |
|---|---|
| Basis: | |
| ofExporter: | . |
| cirroa <br>FOBVanes | paseSSCS<br>pa29sses)<br>SS |
:
59
,
==> picture [447 x 343] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Authorisation|23-04-2021|
|Issued:|
|a|
|Basis:|
|ofExporter:|
|CS 1|
|Pom Vatu|[130330|
|Fosrcc:|isi)|
|Decision:|The|Comunittee|considered|the|case|as|per agenda and|it was|decided|to|call|for following|information|
|from the|firm:|
|(ii)|Master Batch|Formula.|
----- End of picture text -----<br>
60
.
m
|
==> picture [450 x 333] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Authorisation|
|Issued:|
|eecae|
|Basis:|
|ofExporter:|
|Force,|[wissSCS|
|Decision:|The Committee|considered|the|case|as per|agenda|and|it|was|decided|to|call|for|following|information|
|from the|firm:|
|@|COA|of imported|leaves|from|foreign|supplier.|
----- End of picture text -----<br>
61
_.
:
:
,
==> picture [448 x 599] intentionally omitted <==
----- Start of picture text -----<br>
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|NC/3/MBET/Jun/202122/2Meeting|No:|Date:;|02/07/2021|57/NC/3/MBET/Jun/202122/2Case|No:|
|HQ|File Number:]|HQRNORMAPPLY00025300AM22|
|RA|File|Number:107AA04000759AM22|
|0711000943|
|AuthorisationDate|of|;|23-04-2021|.|
|Issued:|
|Office|of Issue:|||Office|ofthe|Additional|Director|General|of Foreign|Trade,|Bengaluru]|
|GLOBAL|CALCIUM|PVT|LTD|
|[a|125 & 126 SIPCOT INDUSTRIAL COMPLEX,HOSUR,635126.|
|Type|of License:|2Advance|Licence|with AU|Condition|
|Application|Export|Order|
|Basis:|.|
|Status|Manufacturer Exporter|
|ofExporter:|
|Export Product|Chemical|and Allied Products|.|
|Group:|
|License:CIF Value|ofthe|56954442|
|FOB|Value:|70623508|
|FOB|FCC:|948603|
|Decision:|The Committee|considered|the|case|as|per|agenda|and|taking|cue|from|earlier|decision|for same|export|
|product in Meeting No. 07/AM21|dated|24.12.2020|against advance authorization|No. 0710110528 dated|19.10.2016,|
|it|was|decided|to|ratify norms|under|Para|4.07|of HBP|Vol.|I|as_|per. details|given|below|or|as|applied|by|the|firm,|
|whichever|is|less:|
|Sl.|||EXPORT PRODUCT|IMPORT ITEMS|QTY.|
|No,|No,|
|1.|||CALCIUM LACTOBIONATE|||1|kg|CALCIUM CARBONATE|0,172 kg|
|2.|LACTOSE|1.16 kg|
|||CALCIUM|1kg|CALCIUM CARBONATE|0.360 kg|
|BROMOLACTOBIONATE||2,|[LACTOSE|||1.02 kg|
|3.|HYDROBROMIC|ACID|0.510kg|
|| CALCIUM GLUBIONATE|Lkg|CALCIUM CARBONATE|0.140 kg|
|LACTOSE|0.829|kg|
|3.|CALCIUM|GLUCONATE|-||0,42k¢|
|ORAL|GRADE|
|4.|LACTOBIONIC ACID|lig|i|CALCIUM CARBONATE|0,234 kg|
|LACTOSE|1.58|kg|
|RA may|take|appropriate|action|as|per the|decision|of Norms|Committee.|
----- End of picture text -----<br>
,
62
|
:
,
,
|
| Authorisation | 26-04-2021 |
|---|---|
| Issued: | |
| Basis: | |
| ofExporter: | |
| jarrca_saisSSCS |
63
| |
7
,
,
==> picture [452 x 310] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Authorisation|26-04-2021|
|Issued:|
|fie|fe|
|LS|
|Basis:|
|ofExporter:|
|jorroc|ps0|ses|
|rosrec:feasaig|
|Decision:|| The|Committee|considered|the|case|as|per agenda|and|it was|decided|to|ratify|adhoc norms|as|applied|
|for|in|this Advance Authorization|by the|firm.|
----- End of picture text -----<br>
64
==> picture [448 x 51] intentionally omitted <==
----- Start of picture text -----<br>
|||
|---|---|
|Authorisation|27-04-2021|
|Issued:|
|pcm fom|
----- End of picture text -----<br>
.
Basis: ofExporter:
|
Decision: | The Committee considered the case as per agenda and taking cue from earlier decision for same export product in Meeting No, 2/82-ALC4/2018 dated 16.05.2018 against advance authorization No, 0710111738 dated 12.06.2017, it was decided to ratify norms under Para 4.07 of HBP Vol. I as per details given below or as applied by| the firm, whichever is less:
No.
RA may take appropriate action as per the decision of Norms Committee.
65
- |
!
|Meeting No:<br>:<br>NC/3/MEET/Jun/202122/2<br>Date: 02/07/2021|Meeting No:<br>:<br>NC/3/MEET/Jun/202122/2<br>Date: 02/07/2021|CaseNo:<br>61/NC/3/MEET/Jun/202122/2|||
|---|---|---|---|---|
|HQ FileNumber:| HQRNORMAPPLY00027755A<br>M22||.||,|
|RA File Number: /07AA04002423AM22|||||
|0711000987|||||
|Date of|||||
|Authorisation<br>27-04-2021|||||
|Issued:<br>;|||||
|OfficeofIssue: |OfficeoftheAdditional Director|GeneralofForeignTrade, Bengaluru||||
|(788016849|||||
|GLOBAL CALCIUM PVT LTD|||||
|125&126SIPCOTINDUSTRIAL COMPLEX,HOSUR,635126.<br>PIN<br>fesseSS<br>Type ofLicense: |Advance Licence withAU Condition|||||
|Application<br>Export Order|||||
||Basis:|||||
|Status<br>ManufacturerExporter|||||
|ofExporter:|||||
|ExportProduct<br>Chemical andAlliedProducts<br>Group:|||.||
|CIFValue of the §8325000<br>License:|||||
|FOB Value:<br>70708434|||||
|FOB FCC:<br>949743|||||
|Decision:<br>—TheCommittee considered the case as peragenda andtakingcue from earlier decision for same expor'<br>product in Meeting No. NC/3/MEET/Jan/202021/4 12.02.2021 against advance authorization No. 0710116038<br>\dated 17.01.2020, it was decided to ratify norms under Para 4.07 ofHBP Vol. I as per details given below or as<br>appliedbythefirm,whicheverisless:|||||
==> picture [424 x 168] intentionally omitted <==
----- Start of picture text -----<br> SL | Export product Qty. | Sl | Import items Qty.<br>No. No.<br>[ |CALCIUM LACTATE GLUCONATE] 1 kg LACTIC ACID - ANY GRADE 0,560 kg<br>CALCIUM GLUCONATE 0.686 kg<br>FERROUS CALCIUM CARBONATE 0.310 kg<br> LACTATE LACTIC ACID - ANY GRADE 1.028 kg<br>4 MAGNESIUM LACTATE LACTIC ACID - ANY GRADE 1.19 kg<br>5 |ZINCLACTATE kg [1 | LACTICACID- ANY GRADE | 0.990 kg<br>{MAGNESIUM LACTATE Lkg 1 LACTIC ACID - ANY GRADE 0,390 kg<br>LUCONATE 4 GLUCONO DELTA LACTONE 0.617 kg<br>CALCIUM LACTATE lkg LACTIC ACID — ANY GRADE 0.922 kg<br>CALCIUM CARBONATE 0.50 kg<br>RA may take appropriate action as per the decision of Norms Committee,<br>----- End of picture text -----<br>
66
;
| en<br>Authorisation<br>Issued: | en<br>Authorisation<br>Issued: | 27-04-2021 |
|---|---|---|
| PN | jess<br>SSOS—SSCSC“CSCSC‘“C‘“‘SS | |
| Basis: | ||
| ofExporter: |
,
67
,
_
| cepee<br>Authorisation<br>[27-04-2021<br>Issued: | cepee<br>Authorisation<br>[27-04-2021<br>Issued: |
|---|---|
| Basis: | |
| ofExporter: | |
| a<br>License:<br>CSS | |
| FoBRCG | Yes |
68
|
| enfm<br>Authorisation<br>27-04-2021<br>.<br>Issued: |
|---|
| Basis: |
| ofExporter: |
| eesare<br>License:<br>arroofemSCSSSCOSCSCSCSSCSSCSSSSSCSSSSS<br>FORVa feset—SCSCSCSC—“S*s‘“‘“‘“C<br>Foro.pi)<br>—SSSCSCSs—“‘s“‘“‘“‘C |
69
3
.
a
| Authorisation | 27-04-2021 |
|---|---|
| Issued: | |
| Basis: | |
| ofExporter: |
ewroca
==> picture [470 x 176] intentionally omitted <==
----- Start of picture text -----<br> Decision: | The Committee considered the request of the firm and it was decided to ratify adhoc norms under Para<br>4.07 of HBP vol. I as per details given below or as applied by the firm, whichever is less:<br>: No.<br>VicksGMJARS(2) 10 GMVaporub (5) FLATS100in GMPacks(3) JARS(Vicks Vaporub 25GM((1) 5GM. JARSFLATS (4)50 | 548760 kg 25 |SotaEucalyptus Oil 5863.30 ke |<br>in Packs ((1) 5GM. FLATS (2) 10 GM<br>FLATS (3) 25GM JARS (4)50 GM JARS (5)<br>. RA concerned may take further necessary action as per above decision ofNC. ‘<br>----- End of picture text -----<br>
70
_ : . .
Meeting No: Case No: NC/3/MEET/Tun/202122/2 Date: 02/07/2021 66/NC/3/MEET/Iun/202122/2
==> picture [463 x 603] intentionally omitted <==
----- Start of picture text -----<br> HQ File Number:] HQRNORMAPPLY00027982AM22<br>RA File Number: |564A04000294AM22<br>Date of<br>Authorisation 27-04-2021<br>Issued: ;<br>Office of Issue: | Office of the Deputy Director General of Foreign Trade, Indore<br>[103005158<br>MAKSON HEALTH CARE PRIVATE LIMITED<br>PLOT NO 6A SECTOR D INDUSTRIAL AREA,MANDIDEEP, 462046.<br>162046<br>Type of License: | [Advance] [Licence] [with][ AU] [Condition]<br>Application Export Order<br>Basis:<br>Status Manufacturer Exporter<br>ofExporter:<br>Exporter Type:<br>Group: i Chemical and Allied Products<br>CIF Value ofthe [48567531]<br>License:<br>Decision: The Committee considered the case as per agenda and it was decided to ratify adhoc norms under Para<br>. |4.07 ofHBP vol. 1 as per details given below or as applied by the firm, whichever is less:<br>No.<br>Vicks Vaporub in Packs (1) 50 GM | 57312 kg Eucalyptus Oil 777.73 kg<br>JARS (2) 80 GM TUBES (3) 100<br>50 GM JARS 80 GM TUBES (3) 3 | Turpentine Oil 2736.10 kg<br>100 GM JARS)<br>5 White Petrolatum [47168.00 kg<br>poet(White50 gms Labelssoft Paraffin)eeRelevant as per packing<br>100 gms Labels ‘<br>/e policy<br>80 gms Tube & cap<br>RA concerned may take further necessary action as per above decision ofNC.<br>----- End of picture text -----<br>
71
|2
|
|
,
==> picture [450 x 338] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Authorisation|[27-04-2021|
|Issued:|
|pm|daseSSS|
|Basis:|
|ofExporter:|
|License:|
|a|
|CS|
|Decision:|The|Committee|considered|the|case|as|per|agenda|and|it|was|decided|to|call|for|following|information|
|from the firm:|
|(ii)|COA of export|item.|
|(ii)|Process|and wastage.|
----- End of picture text -----<br>
==> picture [2 x 11] intentionally omitted <==
----- Start of picture text -----<br> ,<br>----- End of picture text -----<br>
72
- .
:
==> picture [448 x 579] intentionally omitted <==
----- Start of picture text -----<br> Meeting No: ; Case No:<br>NC/3/MBET/Jun/202122/2 Date: 02/07/2021 68/NC/3/MBET/Tun/202122/2<br>HQ File Number:|HQRNORMAPPLY00028172AM22<br>RA File Number:]03AA04007088AM22<br>SSCS<br>[iconse Number fosni00s372.<br>Date of<br>Authorisation 28-04-2021<br>Issued:<br>Office of Issue: |Office of the Additional Director General of Foreign Trade, Mumbai<br>isc: __ | AAACZS2128 — 2<br>GLENMARK LIFE SCIENCES LIMITED<br>Plot 170-172, Chandramouli,Solapur,413213.<br>PISS<br>Type of License: | [Advance] [Licence] [with][ AU] [Condition]<br>Application Export Order<br>Basis:<br>Status Merchant Cum Manufacturer Exporter<br>ofExporter: ;<br>Exporter Type: |Public Limited<br>Export Product Chemical and Allied Products<br>Group:<br>CIE Value of the 13657293<br>License:<br>FOB Value: 44075889<br>Decision: | The Committee considered the case as per agenda and it was decided to ratify adhoc norms under Para<br>4.07 of HBP vol. I as per details given below or as applied by the firm, whichever is less: :<br>No,<br>TOFACITINIB CITRATE 30 kg 1 (3R,4R)-1- BENZYL- N,4- {78.00 kg<br>DIMETHYLPIPERIDIN- 3-AMINE<br>DIHYDROCHLORIDE<br>2 2,4- DICHLORO- 7H- PYRROLO- |46,2 kg<br>[2,3-D]- PYRIMIDINE<br>3 METHYLENE CHLORIDE (MDC) 336.00 kg<br>4 ACETONITRILE 139.20 kg<br>TETRA HYDRO FURAN (THF) 120.00 kg<br>METHANOL 205.20 kg<br>DIMETHYL FORMAMIDE (DMF) }135.00 kg<br>----- End of picture text -----<br>
: “ iH
73
|
- ;
oe
; : . :
;
NC/3/MEET/Jun/202122/2Meeting No: Date:. 02/07/2021 69/NC/3/MEET/Jun/202122/2Case No:
==> picture [464 x 370] intentionally omitted <==
----- Start of picture text -----<br>
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|HQ|File|Number:||HORNORMAPPLY00028425AM22|
|RA|File|Number:|/08AA04001824AM22|
|0811001359|
|:|Date|of|
|Authorisation|—|}28-04-2021|eile|
|Tssued:|
|Office of Issue:|| Office|of the Additional|Director|General|of Foreign Trade, Ahmedabad|
|0395001721|
|CADILA HEALTHCARE|LIMITED|
|Address:|ZYDUS|CORPORATE PARK,|SCHEME NO.|63,|SURVEY NO.|
|536,,|AHMEDABAD,382481.|
|382481|
|Type|of License:|||[Advance]|[Licence]|[with][ AU]|[Condition]|
|Application|Export|Order|
|Basis:|
|Status|Merchant Cum|Manufacturer|Exporter|
|ofExporter:|
|Exporter|Type:|{Public|Limited|
|Export Product|Chemical and Allied|Products|
|Group:|
|CIF|Value|of|the|119548566|
|License:|
|CIF|FCC:|1569908|
|FOB|Value:|138852544|
|FOB|FCC:|1865044|
|Decision:|The|Committee|considered|the|request|of the|firm|and|it|was|decided|to|ratify|adhoc norms|under|Para|
|4.07|of|HBP|vol.|I|as per details|given below|or|as|applied by the firm,|whichever|is|less:|
----- End of picture text -----<br>
==> picture [371 x 177] intentionally omitted <==
----- Start of picture text -----<br> SL Export Product Qty. SL. Import items Qty.<br>No. No.<br>1 BUSPIRONE 131960430 1 BUSPIRONE 23.454 kg<br>HYDROCHLORIDE Numbers HYDROCHLORIDE USP<br>TABLETS USP 3 2 LACTOSE 224.573 kg<br>MG(ACTIVE MONOHYDRATE NF/PH<br>INGREDIENT : _EUR<br>BUSPIRONEHYDROCHLORIDE 3 MICRO CRYSTALLINE 76.65 kg<br> USP CELLULOSE<br>- NET WT. 22.994 KGS.)) NEF/IP/BP/PH EUR<br>AVICEL PH102<br>4 SODIUM STARCH 13.80 kg<br>GLYCOLATE NF<br>5 COLLOIDAL SILICON 3.449 kg<br>DIOXIDE NF<br>MAGNESIUM STEARATE | 3.449 kg<br>PH EUR/NF/JP<br>----- End of picture text -----<br>
74
:
.
“=
;
.
==> picture [436 x 658] intentionally omitted <==
----- Start of picture text -----<br> HYDROCHLORIDE Numbers HYDROCHLORIDE USP :<br>MG((ACTIVE MONOHYDRATE NF/PH<br>; INGREDIENT : EUR<br>BUSPIRONE 3 MICRO CRYSTALLINE 804.98 kg<br>HYDROCHLORIDE USP CELLULOSE<br>- NET WT. 241.494 NE/IP/BP/PH EUR<br>KGS.)) AVICEL PH102<br>eeGLYCOLATE NF<br>DIOXIDE NF<br>aPH EUR/NF/JP<br>3 BUSPIRONE 13663350 211.095 kg<br>. ___.|. HYDROCHLORIDE Numbers HYDROCHLORIDE.USP ; .<br>TABLETS USP 10 2 LACTOSE 2021.277 kg<br>: MG((ACTIVE MONOHYDRATE NF/PH<br>INGREDIENT : EUR<br>BUSPIRONE 3 MICRO CRYSTALLINE 699.784 kg<br>HYDROCHLORIDE USP CELLULOSE<br>- NET WT. 206,956 NF/IP/BP/PH EUR<br>KGS.) AVICEL PH102)<br>GLYCOLATE NF<br>DIOXIDE NF .<br>PH EUR/NF/JP<br>HYDROCHLORIDE Numbers HYDROCHLORIDE USP<br>MG((ACTIVE MONOHYDRATE NF/PH<br>INGREDIENT : EUR<br>BUSPIRONE 3 MICRO CRYSTALLINE 3334.61 ke<br>HYDROCHLORIDE USP CELLULOSE<br>- NET WT. 1000.383 NF/IP/BP/PH EUR<br>KGS.)) AVICEL PH102)<br>GLYCOLATE NF<br>DIOXIDE NF<br>aPH EUR/NF/JP<br>5 BUSPIRONE 37702980 1 BUSPIRONE 668.50 kg<br>TABLETS USP 30<br>MG((ACTIVE 2 LACTOSE<br>INGREDIENT : MONOHYDRATE NF/PH<br>BUSPIRONE EUR<br>HYDROCHLORIDE USP 3 MICRO CRYSTALLINE 2184.65 kg<br>- NET WT. 655.394 CELLULOSE<br>KGS.)) NF/IP/BP/PH EUR<br>(AVICEL PH102)<br>GLYCOLATE NF<br>DIOXIDE NF<br>PH EUR/NEF/JP<br>RA concerned may take further necessary action as per above decision of NC.<br>----- End of picture text -----<br>
75
.
|
|
==> picture [224 x 41] intentionally omitted <==
----- Start of picture text -----<br> e<br>----- End of picture text -----<br>
Authorisation 28-04-2021 Issued: OCOSCSCSOSSCOCOCSCSCSS PIN, poo Basis:
ofExporter:
:
Decision: The Committee considered the case as per agenda and it was decided to ratify adhoc norms under Para 4.07 of HBP vol. I as per details given below or as applied by the firm, whichever is less:
} No. ; Suspension, 0.1 Percent w/v Numbers NEPALACT Sterile Eye Drops, : Sml) (PRANAYAM) ((Each ml contains Nepafenac 1.0 mg (Equivalent to 147.5Gram of Bulk Drug))
:
76
.
;
,
|
|
| elee<br>Authorisation<br>28-04-2021<br>Issued: | elee<br>Authorisation<br>28-04-2021<br>Issued: |
|---|---|
| Basis: | |
| ofExporter: | ‘ |
|
77
a
|
==> picture [450 x 398] intentionally omitted <==
----- Start of picture text -----<br>
||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Meeting|No:|Cc|:|
|Authorisation|28-04-2021|,|
|Issued:|
|fie poo|
|Basis:|
|ofExporter:|
|Group:|
|Decision:|The|Committee|considered|the|case|as|per|agenda|and|it|was|decided|to|ratify|adhoc|norms|under|Para|
|4.07|of|HBP|vol.|J|as|per details|given|below|or|as|applied by|the|firm,|whichever|is|less:|
----- End of picture text -----<br>
:
No, |: VORICONAZOLE 300 kg Yl1 ivronevenaone6-ETHYL-5FLUORO-4[|990,00 kg SULPHONIC ACID MDC) (THF)
78
|
| eea<br>Authorisation<br>29-04-2021<br>Issued: | eea<br>Authorisation<br>29-04-2021<br>Issued: |
|---|---|
| Basis: | |
| ofExporter: |
79
| i
7
:
.
| a<br>Authorisation<br>Issued:<br>- | 30-04-2021 |
|---|---|
| Basis: | |
| ofExporter: |
FOB Vaher 5650758 rosrce: fs Decision: | The Committee considered the case as per agenda and it was decided to ratify adhoc norms under Para 4.07 of HBP vol. L as per details given below or as applied by the firm, whichever is less:
; No. RA concerned may take further necessary action as per above decision of NC,
;
,
80
~~
==> picture [448 x 662] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Meeting|No:|Case|No:|
|Date|of|.|
|Authorisation|30-04-2021|
|SSSSCSCSCSOSC‘“‘“‘C—id|
|PN|os|
|Basis:|
|ofExporter:|
|Group:|.|
|CcLicense:|
|Decision:||The|Committee|considered|the|request|of the|firm|and|it|was|decided|to|ratify|adhoc|norms|under|Paral|
|4.07 of|HBP|vol.|I|as per details|given|below|or|as applied by the firm,|whichever|is|less:|
|No.|
|1|TYLOSIN|TARTRATE|POWDER|100PCT-100GM|SACHET(TYLOSIN ||150kg|
|TARTRATE|POWDER|100PCT-100GM|SACHET|(EACH|GRAM|CONTAINS|
|TYLOSIN|TARTRATE|100PCT)|(nett|content|of exempt|material|is|150|kgs)|(1500|
|TARTRATE|POWDER|100PCT-500GM|SACHET|(EACH|GRAM|CONTAINS|
|TYLOSIN|TARTRATE|100PCT)|(nett|content|of|exempt|material|is|150|kgs)|(300|
|NOS))|
|3|TYLOSIN|TARTRATE|POWDER|100PCT|-IKG|JAR(TYLOSIN|TARTRATE|||150kg|
|POWDER|100PCT|-1KG|JAR|(EACH|GRAM|CONTAINS|TYLOSIN|TARTRATE|
|4|TYLOSIN.|TARTRATE|POWDER|99PCT-100GM|SACHET(TYLOSI|N|||148kg|
|TARTRATE|POWDER|99PCT-100GM|SACHET|(EACH|GRAM|CONTAINS|
|TYLOSIN|TARTRATE|99PCT)|(nett|content|of exempt|material|is|148.5|kgs)|(1500|
|"|e|eck)|
|5|TYLOSIN|TARTRATE|POWDER|99PCT|-500GM|SACHET(TYLOSIN ||148 kg|
|NOS|
|"|[eateTARTRATE POWDER meeeat 99PCT -500GMaes SACHET (EACHtecaree| GRAM|CONTAINS|
----- End of picture text -----<br>
|
, _ . -
:
==> picture [496 x 572] intentionally omitted <==
----- Start of picture text -----<br> ; 81<br>| TYLOSIN TARTRATE POWDER 99PCT -IKG JAR(TYLOSIN TARTRATE | 148 kg<br>: POWDER 99PCT -IKG JAR (EACH GRAM CONTAINS TYLOSIN TARTRATE<br>99PCT) (nett content of exempt material is 148.5kgs) (150 NOS))<br>7 TYLOSIN TARTRATE POWDER 20PCT - SGM(TYLOSIN TARTRATE POWDER| 5 kg<br>.<br>20PCT -SGM (EACH GRAM CONTAINS TYLOSIN TARTRATE EQ. TO<br>| TYLOSIN 20PCT) (nett content ofexempt material is 5 kgs) (5000 NOS)) ©<br>TYLOSIN TARTRATE POWDER 20PCT - 100GM(TYLOSIN TARTRATE | 100 kg<br>POWDER 20PCT -100GM (EACH GRAM CONTAINS TYLOSIN TARTRATE EQ.<br>TO TYLOSIN 20PCT) (nett content of exempt material is 100 kgs) (5000 NOS))<br>TYLOSIN TARTRATE POWDER 20PCT- 500GM(TYLOSIN TARTRATE | 200 kg<br>POWDER 20PCT-500GM (EACH GRAM CONTAINS TYLOSIN TARTRATE EQ.<br>10 TO TYLOSIN 20PCT) (nett content of exempt material is 200 kgs) (2000 NOS))<br>TYLOSIN TARTRATE POWDER 20PCT -1KG JAR(TYLOSIN TARTRATE| 400 kg<br>POWDER 20PCT -1KG JAR (EACH GRAM CONTAINS TYLOSIN TARTRATE<br>1 EQ. TO TYLOSIN 20PCT) (nett content of exempt materialis 400 kgs) (2000 NOs)) |<br>TYLOSIN BOLUS 200MG( TYLOSIN BOLUS 200MG (EACH BOLUS | 20kg<br>CONTAINS TYLOSIN 200MG) (nett content of exempt material is 20 kgs) (100000<br>NOS))<br>| 12 TYLOSIN INJECTION 5PCT-30 ML(TYLOSIN INJECTION 5PCT-30 ML (EACH | 112 kg<br>ML CONTAINS TYLOSIN TARTRATE EQ, TO TYLOSIN BASE 50MG) (nett<br>content of exempt material is 112.5 kgs) (75000 NOS))<br>13 TYLOSIN INJECTION 5PCT-50 ML(TYLOSIN INJECTION 5PCT-50 ML (EACH | 125 kg<br>ML CONTAINS TYLOSIN TARTRATE EQ. TO TYLOSIN BASE 50MG) (nett<br>content of exempt material is 125 kgs) (50000 NOS))<br>14 TYLOSIN INJECTION 5PCT-100 ML(TYLOSIN INJECTION 5PCT-100 ML | 50kg<br>(EACH ML CONTAINS TYLOSIN TARTRATE EQ. TO TYLOSIN BASE 50MG)<br>15 {nett content of exempt material is 50kgs) (10000 NOS))<br>TYLOSIN TARTRATE INJECTION 20PCT-30 ML(TYLOSIN TARTRATE | 60 kg<br>INJECTION 20PCT-30 ML (EACH ML CONTAINS TYLOSIN TARTRATE EQ. TO<br>TYLOSIN 200MG) (nett content of exempt material is 60 kgs) (10000 NOS))<br>16 TYLOSIN TARTRATE INJECTION 20PCT-50 MI{TYLOSIN TARTRATE | 250 kg<br>INJECTION 20PCT-50 ML (EACH ML CONTAINS TYLOSIN TARTRATE EQ. TO<br>TYLOSIN 200MG) (nett content of exempt material is 250 kgs) (25000 NOS))<br>17 TYLOSIN TARTRATE INJECTION 20PCT-100 ML(TYLOSIN TARTRATE | 298 kg<br>INJECTION 20PCT-100 ML (EACH ML CONTAINS TYLOSIN TARTRATE EQ.<br>TO TYLOSIN 200MG) (nett content of exempt material is 298 kgs) (14900 NOS)) _<br>No, (for total exports)<br>TYLOSIN TARTRATE<br>RA concerned may take further necessary action as per above decision of NC.<br>----- End of picture text -----<br>
82
| ee<br>Authorisation<br>30-04-2021<br>Issued: | ee<br>Authorisation<br>30-04-2021<br>Issued: |
|---|---|
| Basis: | |
| ofExporter: | . |
| CCC<br>FOBVane <br>Foproc. <br>Decision: | peasy’SSS<br> wie<br>O<br>TheCommittee consideredthe case as peragenda and itwas decided to call for following information |
| fromthe firm: | |
| (i)<br>DML.<br>© | |
| ; | (ii)<br>MasterBatchFormula.<br>: |
|
|
;
.
,
:
==> picture [470 x 352] intentionally omitted <==
----- Start of picture text -----<br>
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|Authorisation|30-04-2021|
|Issued:|
|ee|
|Basis:|
|ofExporter:|
|CRRCC:|[110905|
|—|FOB|Valve|fiesi9|
|[Roprec|TT|fiseat|
|Decision:|The Committee|considered the|case|as per agenda|and|it was|decided|to|call|for foliowing information||
|from the|firm:|
|(ii)|DML.|:|
|(iii)|Master Batch|Formula.|
----- End of picture text -----<br>
84
oN
,
==> picture [1 x 1] intentionally omitted <==
----- Start of picture text -----<br> ee<br>----- End of picture text -----<br>
| Authorisation | 30-04-2021 |
|---|---|
| Issued: | |
| PN | nome<br>SSOSSSSCSC‘“‘CSCSCSCSCSCSC |
| Basis: | |
| ofExporter: |
Decision: The Committee considered the case as per agenda and taking cue from earlier decision for same export product in Meeting No. NC/3/MEET/J an/202021/4 dt. 12.02.2021 against advance authorization No. 0510413195 dated 03.01.2020, it was decided to ratify norms under Para 4,07 of HBP Vol. I as per details given below or as applied by the firm, whichever is less: FSCEARKOLIDE ——[Tme_[ 1No.| SoLaREOL as
RA may take appropriate action as per the decision ofNorms Committee.
:
85
i
;
~
.
==> picture [447 x 173] intentionally omitted <==
----- Start of picture text -----<br>
|||
|---|---|
|Authorisation|30-04-2021|
|Issued:|
|eeee|
|Basis:|
|ofExporter:|
----- End of picture text -----<br>
==> picture [447 x 82] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Decision:|| The|Committee|considered|the|case|as|per|agenda|and|it|was|decided|to|ratify|adhoc norms|under|Paral|
|4.07|of|HBP|vol.|I|as per details given below|or as|applied|by the firm,|whichever|is|less:|
|No.|
|SODIUM PHOSPHATE|EPOXIDE (8DM)|
----- End of picture text -----<br>
86
a
| ee fom<br>Authorisation<br>03-05-2021<br>Issued:<br>Tec<br>(AAGOKSSMSOSCSCSCSC“‘“SCSCSCSCSCS |
|---|
| PN<br>pad<br>COSCSCSCSCSCSCSCSCSC“CSC“CNSNNNC_CO |
| Basis: |
| ofExporter:<br>; |
| arrest<br>—SO—CSCSCSSCSCSCSCSSCiCSSS<br>FOBVane<br>fissools<br>SS<br>S<br>FopFo®:_po7oaSCS |
,
87
:
|
| peepe<br>Authorisation<br>03-05-2021<br>Issued: | peepe<br>Authorisation<br>03-05-2021<br>Issued: | |
|---|---|---|
| . | Basis: | |
| ofExporter: | ||
| CS | ||
| roprcG | fliesSSS |
88
.
==> picture [449 x 278] intentionally omitted <==
----- Start of picture text -----<br>
|||
|---|---|
|SSS|
|Triesnse Number|[0311003517|
|Authorisation|03-05-2021|
|eeIssued:|
|Basis:|
|ofExporter:|
|[cirrcc,fmsa775|
----- End of picture text -----<br>
89
fe
.
.
_
==> picture [452 x 277] intentionally omitted <==
----- Start of picture text -----<br>
||||
|---|---|---|
|Authorisation|03-05-2021|
|Issued:|
||pee)|
|Basis:|
|ofExporter:|
|ROB Value:|[27741334|OCOC~™SOSOSOSCSCSS|
----- End of picture text -----<br>
Decision: The Committee considered the case as per agenda and it was decided to ratify adhoc norms as applied for fin this Advance Authorization by the firm.
90
|
|
==> picture [453 x 462] intentionally omitted <==
----- Start of picture text -----<br>
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Eine|ee|Eien|
|Authorisation|04-05-2021|
|Issued:|
|im|few|
|PR|paseCSCC|
|Basis:|
|ofExporter:|
|CN|
|Forroc,|[wesSSCS|
|Decision:|The|Committee|considered|the|case|as|per|agenda|and|it was|decided|to|cal!|for|following|information|
|from the|firm:|
|(i)|%|content of active|ingredient|(a.i.)|in import and|export|item.|
|(ii)|COAof|import items from|foreign|supplier.|
|(iii)|Complete|technical|details|as per Appendix|4E.|
----- End of picture text -----<br>
==> picture [1 x 2] intentionally omitted <==
----- Start of picture text -----<br> dC<br>----- End of picture text -----<br>
|
91
:
7
| feefem<br>Authorisation<br>Issued: | fem<br>04-05-2021 | fem<br>04-05-2021 |
|---|---|---|
| PIN,<br>peo | ||
| Basis: | ||
| ofExporter: | ||
| emrce | [isa | SOS |
92
;
|
| fgmee <br>Authorisation<br>Issued: | fem<br>04-05-2021 |
|---|---|
| Basis: | |
| ofExporter: | |
| ere<br>License: | fies |
|
93
;
==> picture [454 x 556] intentionally omitted <==
----- Start of picture text -----<br> Meeting No:<br>NC/3/MEET/Jun/202122/2 . Case No:<br>Date: 02/07/2021 87/NC/3/MEET/Jun/202122/2<br>HQ File Number:| HQRNORMAPPLY00033817AM22 <br>RA File Number: /03AA04007113AM22<br>[License Number:[051100359 SS<br>Date of<br>Authorisation<br>Issued:<br>Office of Issue: | Office of the Additional Director General of Foreign Trade, Mumbai<br>fee fanaczene<br>GLENMARK LIFE SCIENCES LIMITED<br>Plot 170-172, Chandramouli,Solapur,4<br>PINSfas13213.<br>Type of License: | [Advance] [Licence] [with][ AU] [Condition]<br>Application Export Order<br>Basis:<br>Status Merchant Cum Manufacturer Exporter<br>ofExporter:<br>Exporter Type: |Public Limited<br>Export Product Chemical and Allied Products<br>Group:<br>CIF Value of the<br>License:<br>CIF FCC: 430009<br>FOB Value: 45898425<br>roproc:— eies0<br>Decision: The Committee considered the request of the firm and it was decided to ratify adhoc norms under Par<br>4.07 ofHBP vol, I as per details given below or as applied by the firm, whichever is less:<br>Export Product Import items<br>; No.<br>ROSUVASTATIN CALCIUM 500kg |i | ACETONITRILE ————| -33700ke<br>[2 [METHANOL<br>[386.00] [kg]<br>“3 [[TOLUENE]] 1 937.00 g<br>4 Tert- Butyl(E)-(6-(2-(4-(4- 650.00 kg<br>fluorophenyl)- 6-Isopropyl-<br>2-(Methyl(Methyl<br>Sulfonyl)Amino Pyrimidin-5-<br>yl)Vinyl)(4R,6 — 2,2-Dimethyl<br>(1,3) Dioxane-4-yl) Acetate<br>RA concerned may take further necessary action as per above decision of NC. ,<br>----- End of picture text -----<br>
94
|
ao ,
oe
==> picture [454 x 312] intentionally omitted <==
----- Start of picture text -----<br>
||||||||
|---|---|---|---|---|---|---|
||Authorisation|05-05-2021|.|co|.|.|.|
|Issued:|
|_ee|ce|
|Basis:|
|ofExporter:|
|for|in this|Advance Authorization by|the|firm.|
----- End of picture text -----<br>
"RA concerned may take further necessary action as per above decision of NC.
95
;
:
| Authorisation | 05-05-2021 | ||
|---|---|---|---|
| Issued: | ; | ||
| Basis: | |||
| ofExporter: | |||
| a<br>License: | |||
| Fosroc: Jea9 | |||
| forin this Adance Authorizationbythe firm. | ; |
96
wy
|
:
|Authorisation|05-05-2021|
|---|---|
|Issued:||
|PN|osSSS|
|Basis:||
|ofExporter:||
|jarroc|faOO|
|roprcc:||s0—SOSCSCSCSC—C“—sSC—‘“‘“‘<;CO|
97
|
. -
.
;
==> picture [102 x 24] intentionally omitted <==
----- Start of picture text -----<br> NC/3/MEET/Jun/202122/2Meeting No:<br>----- End of picture text -----<br>
==> picture [261 x 21] intentionally omitted <==
----- Start of picture text -----<br> Date:. 02/07/2021 91/NC/3/MEET/Tun/202122/2Case No:<br>----- End of picture text -----<br>
==> picture [462 x 539] intentionally omitted <==
----- Start of picture text -----<br> HQ File Number:} HQRNORMAPPLY00033259AM22<br>RA File Number:]094.A04006937AM21<br>0911000776<br>Date of<br>Authorisation 05-05-2021<br>Issued:<br>Office of Issue: |Office of the Additional Director General of Foreign Trade, Hyderabad .<br>0905004500<br>VANDANA LIFE SCIENCES PRIVATE LIMITED<br>CY PLOT NO 3,4,5, IST CROSS, ANRICH,BOLLARAM,502325.<br>Type of License: | [Advance] [Licence] [with][ AU] [Condition]<br>Application Export Order<br>Basis:<br>Status Manufacturer Exporter<br>ofExporter:<br>Export Product Chemical and Allied Products<br>Group:<br>CIF Value of the<br>License:<br>CIF FCC: 834292<br>FOB Value: 79998680<br>FOB FCC: 1074528 .<br>Decision: The Committee considered the request of the firm and it was decided to ratify adhoc norms under Para<br>4.07 of HBP vol. I as per details given below or as applied by the firm, whichever is less:<br>Lamivudine : No. :<br>(SVM) I 20000 kg 1 GLYOXYLIC ACID 50 17020 kg<br>|23 [|][LC)MENTHOL] percent | 14720 kg<br>2,5 DI HYDROXY 1,4 7600 kg<br>DITHIANE (DIOL)<br>CYTOSINE 9560 kg ;<br>5 HEXAMETHYL 11800 kg<br>DISILAZANE (HMDS)<br>6 METHYLENE 60000 kg<br>| DICHLORIDE<br>'8 | SODIUMBOROHYDRIDE | 4493 00 k eg<br>RA concerned may take further necessary action as per above decision ofNC.<br>----- End of picture text -----<br>
.
98
o—~\
7
| ace <br>Authorisation<br>Issued: | fom<br>05-05-2021 |
|---|---|
| Basis: | |
| ofExporter: | |
| jarreG | [ails<br>SSOSCSCS—SSCSCSCSCSC‘“s‘“‘ |
99
of
,|
| feefe<br>Authorisation<br>05-05-2021<br>Issued:<br>. | feefe<br>Authorisation<br>05-05-2021<br>Issued:<br>. | feefe<br>Authorisation<br>05-05-2021<br>Issued:<br>. | feefe<br>Authorisation<br>05-05-2021<br>Issued:<br>. |
|---|---|---|---|
| Name | [SkPuiMITeD | SS | OOSOSSCSCSCSCSCTTCOC |
| pe | fos | OSSOSCSCSCSSCSCSST | |
| Basis: | |||
| ofExporter: | |||
| al<br>License: |
,
100
;
|
==> picture [447 x 175] intentionally omitted <==
----- Start of picture text -----<br>
|||
|---|---|
|Authorisation|05-05-2021|
|beIssued:|
|Basis:|
|ofExporter:|
----- End of picture text -----<br>
|
101
iQ File Number [HQRNORMAPPLYOOIS3ES¥AMED Authorisation — |96-05-2021 Issued: ela pi, osn - Basis: ofExporter: License: teow PH fronroc: p20360 Decision: The Committee considered the case as per agenda and it was decided to call for following information from the firm: : (ii) Master Batch Formula.
102
|
| sone pom<br>Authorisation<br>06-05-2021<br>Issued: |
|---|
| Basis:. |
| ofExporier: |
| emesis<br>License:<br>CSCC |
,
103
.
.
,
7
==> picture [467 x 341] intentionally omitted <==
----- Start of picture text -----<br>
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Authorisation|06-05-2021|
|Issued:|
|ae|
|Basis:|
|ofExporter:|
|||
|Fom|Value fess|
|romroc:|essa)|
|Decision:|||The|Committee|considered|the case|as|per agenda|and|it|was|decided|to|call|for|following|information!|
|from|the|firm:|
|(ii)|COA of export|item.|-|
----- End of picture text -----<br>
104
of
,
|fmm <br>Authorisation<br>Issued:|fee<br>06-05-2021<br>.|
|---|---|
|Basis:||
|ofExporter:||
|a<br>License: <br>Froprcc,|pesos<br>|ians0SSCS|
for in this Advance Authorization by the firm.
RA concemed may take further necessary action as per above decision of, NC.
: 105 , Authorisation 07-05-2021 Issued: fae pe Basis: ofExporter: . .
106
==> picture [450 x 537] intentionally omitted <==
----- Start of picture text -----<br>
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|ing|No:|:|.|
|Authorisation|07-05-2021|
|Issued:|
|fmm|
|Ce|
|Basis:|;|
|ofExporter:|
|License:|
|cee|loam|
|CSc|
|roarce;|[sien—SCOSCSOSCSSSCSCSCSCSCCCCCCSC*”|
|Decision:|The|Committee|considered|the|request|of the|firm|and|it|was|decided|to|ratify|adhoc norms|under|Para|
|4.07 of|HBP|vol.|I|as per|details given below|or|as|applied by the|firm, whichever|is|less:|
|:|No.|;|
|Enoxaparin|Sodium|Injection|USP 40mg|Numbers|
|in|0.4ml|Pre-filled|Syringe(Composition|
|per|syringe,|Enoxaparin|Sodium|USP|
|40mg,|Water|for|Injection|USP|qs.|to|
|0.4m!)|Shielding|
|System|
|RA concerned may take further necessary|action|as per above|decision of|NC.|
----- End of picture text -----<br>
107
3
Ce
| faefe<br>Authorisation<br>08-05-2021<br>Issued: | faefe<br>Authorisation<br>08-05-2021<br>Issued: |
|---|---|
| Basis: | |
| ofExporter: |
Decision: | The Committee considered the request of the firm and it was decided to ratify adhoc norms under Para 4.07 ofHBP vol. I as per details given below or as applied by the firm, whichever is less: DENTAL GRADE)(SODIUM SACCHARIN SACCHARIN (PURE DENTAL GRADE))
108
™
7
.
:
==> picture [448 x 403] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Authorisation|08-05-2021|
|Issued:|
|ee fee|
|—idosaoaisesSSSCSCSCSCSCSCSCSC“S~S~*sCSC*|
|ec|
|ISSCC‘|
|PN|
|Basis:|
|ofExporter:|
|CS|
|Decision:|The|Committee|considered|the|request|of the|firm|and|it|was|decided|to|ratify|adhoc|norms|under|Para|
|4.07|ofHBP|vol,|I|as per|details|given below|or|as|applied|by|the firm,|whichever|is|less:|
|No.|
|Vial(Kombinil-|DUO|Eye/Ear|Drops|Sml|||vials|EUR USP JP|
|Vial)|
|RA|concerned|may take further necessary|action|as|per|above|decision|of NC.|
----- End of picture text -----<br>
109
-
- . , : .
;
.
:
==> picture [447 x 486] intentionally omitted <==
----- Start of picture text -----<br>
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Meeting|No:|;|Case|No:|
|NC/3/MEET/Jun/202122/2|Date:|02/07/2021|103/NC/3/MEET/Jun/202122/2|
|HQ|File Number:]|HQRNORMAPPLY00036028AM22|
|RA|File|Number:|]05AA04006619AM22|
|0511002498|
|Date|of|
|Authorisation|08-05-2021|
|Issued:|;|
|Office|of Issue:|{Office|of the|Additional|Director|General|of Foreign|Trade, CLA|Delhi|
|7995002926|
|SWATI MENTHOL AND|ALLIED|CHEMICALS|LIMITED|
|OPPOSITE AKASWANI|,MORADABAD,|244901.|
|244901|
|Type of License:|||[Advance]|[Licence]|[with][ AU]|[Condition]|
|Application|Export|Order|
|Basis:|
|Status|Manufacturer Exporter|
|ofExporter:|
|Exporter|Type:|{Public|Limited|
|Export Product|Chemical|and Allied Products|
|Group:|
|License:CIF Value|ofthe|158392000|
|CIF|FCC:|2079999|
|FOB|Value:|178084400|
|FOB|FCC:|2392000|
|Decision:|||The|Committee|considered|the request|of the|firm|and|it|was|decided|to|ratify|adhoc norms|under|Para|
|4.07 ofHBP|vol,|I|as per details|given below|or|as|applied|by|the|firm,|whichever|is|less:|
|-|||No.|
|TRANS|ANETHOLE|DOUBLE|155200 kg|||1|ANETHOLE CONTAINING|||156782 kg|
|DISTILLED|99.6|PERCENT|TO|TRANS ANETHOLE|99|
|99.8|PERCENT(TRANS|PERCENT|
|ANETHOLE|DOUBLE|DISTILLED|
|99.6 PERCENT TO|99,8|PERCENT)|
----- End of picture text -----<br>
110
==> picture [448 x 52] intentionally omitted <==
----- Start of picture text -----<br>
|||
|---|---|
|Authorisation|08-05-2021|
|Issued:|
|im few|
----- End of picture text -----<br>
Basis: ofExporter: CS —OSSSSSCSCSSCSCSCSCSCSCSCSCSSSSSSSSCSSSSCS FoR Vane [osnas Fonrcc:[iam_——SSOSCSSCSSCSCSCSCSCSCSCSSCSSCSCSSCSSSCSCSCSC*d Decision: | The Committee considered the request of the firm and it was decided to ratify adhoc norms under Paral 4.07 of HBP vol, 1 as per details given below or as applied by the firm, whichever is less:
==> picture [331 x 58] intentionally omitted <==
----- Start of picture text -----<br> No.<br>Cineole 99 Percent)<br>RA concerned may take further necessary action as per above decision ofNC.<br>----- End of picture text -----<br>
:
111
, 7
|
| Authorisation | 09-05-2021 |
|---|---|
| Issued: | |
| poo | |
| Basis: | |
| ofExporter: | |
| Ce |
112
oy
:
==> picture [451 x 333] intentionally omitted <==
----- Start of picture text -----<br>
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|Authorisation|10-05-2021|
|Issued:|
|Se fem|
|pe|soosSSS|
|Basis:|
|ofExporter:|
|License:|
|fd|
|arrca|assSSCS|
|Decision:|The Committee considered|the|case|as per agenda|and|it was|decided|to|cali|for following information|
|from the|firm:|
|(i)|Complete technical|details|as per Appendix|4E.|
----- End of picture text -----<br>
113
==> picture [448 x 310] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Authorisation|10-05-2021|
|Issued:|
|fm|fem|
|Basis:|
|ofExporter:|
|License:|
|a|
|Fopree,|353953|
|Decision:|| The|Committee|considered|the|request|of the|firm|and|it was|decided|to|ratify|adhoc norms|under|Paral|
|(4.07|of|HBP|vol.|I as per details|given below|or|as applied by the firm,|whichever|is|less:|
----- End of picture text -----<br>
.
==> picture [315 x 67] intentionally omitted <==
----- Start of picture text -----<br> No, :<br>Numbers<br>RA concerned may take further necessary action as per above decision of NC.<br>----- End of picture text -----<br>
114
==> picture [477 x 445] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Authorisation|
|Issued:|
|fee|
|Basis:|
|ofExporter:|
|License:|
|[alCn|
|||FOB Var fiosnisas0|
|Fosroc|[assoSOCSSCSCSSSS—SSSS—SSCC|
|Decision:|The|Committee|considered|the request|of the|firm|and|it|was|decided|to|ratify|adhoc|norms|under Para|
|4.07 of|HBP|vol.|I|as per details|given below|or as|applied by the firm, whichever|is|less:|
|No.|
|IBUPROFEN|USP|(SODIUM||100000 kg|.|
|METAL ||ann|anes”|2|[sopiommetat|21900 kg|
|PRODUCTS)|
|SODIUM DICHROMATE|
|RA concerned may take further necessary action|as per above|decision|ofNC.|
----- End of picture text -----<br>
|
115
:
,
|
OO
:
|
==> picture [452 x 452] intentionally omitted <==
----- Start of picture text -----<br> Authorisation 11-05-2021<br>Issued:<br>omepe<br>Basis:<br>ofExporter:<br>License:<br>a<br>FoR Valve fiosnia350—<br>Decision: The Committee considered the request of the firm and it was decided to ratify adhoc norms under Paral<br>4.07 of HBP vol. I as per details given below or as applied by the firm, whichever is less:<br>No.<br>IBUPROFEN USP (SODIUM METAL | 100000 kg<br>ROUTE)(CHEMICAL AND ALLIED 21,900 kg<br>PRODUCTS) 3 MONOCHLORO ACETIC 91,900 kg<br>Tiggesea<br>RA concerned may take further necessary action as per above decision of NC,<br>----- End of picture text -----<br>
,
!
:
116
;
==> picture [463 x 335] intentionally omitted <==
----- Start of picture text -----<br>
||||||
|---|---|---|---|---|
|11-05-2021|
|Issued:|
|Authorisation|pv|
|icc,atoms|
|Basis:|
|ofExporter:|
|Sma|
|||
|for in|this|Advance|Authorization by the|firm.|
|RA concerned may take|further necessary|action as per above decision of|NC.|
----- End of picture text -----<br>
;
117
—
==> picture [2 x 2] intentionally omitted <==
----- Start of picture text -----<br> ,<br>----- End of picture text -----<br>
| pgfen<br>Authorisation<br>11-05-2021<br>Issued: |
|---|
| pre<br>es |
| Basis: |
| ofExporter:ewe<br>License: |
roprec: —fnaay
Decision: | The Committee considered the request of the firm and it was decided to ratify adhoc norms under Para 4.07 of HBP vol, I as per details given below or as applied by the firm, whichever is less:
|;|‘||No.||:|
|---|---|---|---|---|
|CHLORIDEHYDROCHLORIDE-<br>65 percent SOLUTIONINWATER|||PROPANE||
|DMPC-65percent|||||
118
,
,
,
==> picture [449 x 343] intentionally omitted <==
----- Start of picture text -----<br>
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Authorisation|12-05-2021|
|Issued:|
|ae femme|
|Basis:|
|ofExporter:|
|arrest SCS|
|SSCS|
|rosrce.|foun|
|Decision:|The|Committee|considered|the|case|as|per|agenda|and|it was|decided|to|call|for|following|information|
|from the|firm:|
|{i)|DML.|
|(ii)|Complete|technical details|as|per Appendix|4E.|
----- End of picture text -----<br>
:
119
==> picture [451 x 344] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|Authorisation|12-05-2021|
|Issued:|
|ee|
|PIN|fioSOS|
|Basis:|
|ofExporter:|
|[Exporter Type: [PartnershipCSC~C“‘“S*S*s*~‘“s“s‘“sCtCtSY|
|License:|
|fee fH|
|CC|(22|
|Decision:|The|Committee considered the case|as|per agenda and|it|was|decided|to|call|for following|information|
|from the firm:|
|;|(ii)|Complete|technical|details|as per Appendix|4E.|;|
----- End of picture text -----<br>
120
; :
ee
||||||||
|---|---|---|---|---|
|MeetingNo:<br>.<br>NC/3/MEET/Jun/202122/2<br>Date:02/07/2021||Case No:<br>~<br>L14/NC/3/MBET/un/202122/2|||
|HQ FileNumber:||HQRNORMAPPL Y00039153AM22||||
|RA FileNumber:|]034A04003451AM22|.|||
||a31003785||||
|Date of|||||
|Authorisation|||||
|Issued:|||||
|OfficeofIssue: |OfficeoftheAdditional DirectorGeneral ofForeignTrade,<br>isc; ____Josow012563<br>BELCHEMINDUSTRIES INDIAPVT LTD||Trade,Mumbai||,|
|69A,NETIVALIVILLAGE,CHAKKINAKA,,THANE,421306,<br>PNas<br>Type ofLicense: |Advance Licence withAU Condition|||||
|Application|Export Order||||
|Basis:|||||
|Status|Manufacturer Exporter||||
|ofExporter:|||||
|Export Product|Chemical andAlliedProducts||||
|Group:|||||
|CIFValue ofthe <br>License:|3750000<br>.||||
Decision: The Committee considered the case as per agenda and taking cue from earlier decision for. same expor' product in Meeting No, 6/82-ALC4/2018 dt. 26.07.2018 against advance authorization No. 0310814264 dated 27.06.2017, it was decided to ratify norms under Para 4.07 of HBP Vol. Las per details given below or as applied by the firm, whichever is less:
Export Product Qty Sl. | Import Items Qty No. 1,3DIMETHYLOL§,5-| Lkg | 1. 5,5 DIMETHYL HYDANTOIN ASSAY 99 | 0.382 kg DIMETHYL HYDANTOIN Percentage MIN COLOUR PURE WHITE (DMDM HYDANTOIN ; 52Percentage55Percentage) ASSAY 55Percentage MAX BELGUARD DMDMH
RA may take appropriate action as per the decision of Norms Committee.
.
|
||121|
|---|---|
|esefm<br>Authorisation<br>{12-05-2021<br>.<br>Issued:||
||||
|Basis:|-|
|ofExporter:|,|
|
==> picture [42 x 27] intentionally omitted <==
----- Start of picture text -----<br> CS<br>----- End of picture text -----<br>
|
:
==> picture [447 x 125] intentionally omitted <==
----- Start of picture text -----<br> Decision: | The Committee considered the case as per agenda and taking cue from earlier decision for same export<br>product in Meeting No. 1/82-ALC4/2018 dt. 01.05.2018 against advance authorization No. 0310813901 dated<br>12.06.2017, it was decided to ratify norms under Para 4.07 of HBP Vol. 1 as per details given below or as applied b<br>he firm, whichever is less:<br>No.<br>SODIUM STEARYL LACTYLATE Lkg<br> Ponenseanveracniare [ue [Ere ae<br>RA may take appropriate action as per the decision of Norms Committee.<br>----- End of picture text -----<br>
122
a
oO
|
i : oO: Ticonse Number[551000732 Authorisation 13-05-2021 _[[Issued:] Sie fm [A 01 Basis: ofExporter:
arrocassisSSCSCSSCSCSCSCSSCSCSCSCSSCSCSSSS
Decision: |The Committee considered the request of the firm and it was decided to ratify adhoc norms under Para 4.07 of HBP vol. I as per details given below or as applied by the firm, whichever is less:
No. Tablets 100 mg ( Each Capsule/Tablet | Numbers Hydrochloride contains Minocycline 100mg. (Equivalent to Minocycline Hydrochloride 107.97mg.) Pharmaceutical Formulations / Standard. Grade) (Equivalent to 583.038Kg of bulk drug)) RA concerned may take further necessary action as per above decision of NC.
123
==> picture [7 x 1] intentionally omitted <==
----- Start of picture text -----<br> 7<br>----- End of picture text -----<br>
|Meeting No:<br>.<br>NC/3/MEET/Jun/202122/2<br>Date: 02/07/2021|Meeting No:<br>.<br>NC/3/MEET/Jun/202122/2<br>Date: 02/07/2021|Case No:<br>117/NC/3/MEET/Jun/202122/2|
|---|---|---|
|HQ FileNumber:| HQRNORMAPPLY00040838AM22|||
|RA File Number: }08AA04012847AM21|||
||0817001489||
|Date of|||
|Authorisation|14-05-2021||
|Issued:|||
|OfficeofIssue:|4OfficeoftheAdditional DirectorGeneral ofForeignTrade,|Trade,Ahmedabad|
||oso000s240||
||ASCENT FINECHEM PRIVATE LIMITED||
||i1,GROUND FLOOR,SURYARATH,,AHMEDABAD.,380006.||
||380006||
|Type ofLicense:||Advance Licence withAU Condition||
|Application|Export Order||
|Basis:|||
|Status<br>ofExporter:|MerchantCum Manufacturer Exporter||
|Group:|Chemical andAlliedProducts||
|CIFValue ofthe <br>License:|52506792||
|FOB Value:|65745000||
|FOB FCC:|900000||
|Decision:<br>| The Committee considered the case as per agenda and taking cue from earlier decision forsame export<br>product in Meeting No. 4/82-ALC4/2019 dt. 19.07.2019 against advance authorization No, 0810142416 dated|||
|18.04.2018, itwas decided to ratifynorms underPara4.07 of HBPVol. I as per details givenbelow or as applied by|<br>thefirm,whicheverisless:|||
|Exportproduct|Sl.|||Import items||
|---|---|---|---|---|
||No,||||
|N-(@-AMINOPROPYL) IMIDAZOLE| 1 kg|||IMIDAZOLE<br>0.68kg<br>SODIUMMETHOXIDEPOWDER | 1.00kg||
||||ACRYLONITRILE|0.466kg|
RA may take appropriate action as per the decision of Norms Committee.
124
| en<br>Authorisation<br>Issued: | en<br>Authorisation<br>Issued: | 17-05-2021 | 17-05-2021 | 17-05-2021 |
|---|---|---|---|---|
| Basis: | ||||
| ofExporter: | ; | |||
| Decision: | The | Committee considered the case as per agenda and itwas decided to call for following information | ||
| from the firm: | ||||
| (i) | DML. | |||
| (ii) | © | Working. |
|
125
.
|
==> picture [452 x 306] intentionally omitted <==
----- Start of picture text -----<br>
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|Authorisation|
|Issued:|
|sim|fe|
|Nane(RAIBEVMUKUE|
|PIN|nos|
|Basis:|
|ofExporter:|
|License:|
|A|
|Decision:|The Committee|considered|the case|as per agenda|and|it was decided|to|call|for following|information||
|from the firm:|
----- End of picture text -----<br>
126
==> picture [503 x 356] intentionally omitted <==
----- Start of picture text -----<br>
|||||||
|---|---|---|---|---|---|
|Authorisation,|
|Pe|freIssued:|
|PN|pensOSS|
|Basis:|
|ofExporter:|
|||
|License:|
|a|Cc|
|arrce.[pin—SSCSCSCSCSCSCSSSSSSS|
|Decision:|The Committee considered the case as per agenda and|it was|decided to|call for following information|
|from the|firm:|
|(i)|°%|content|of active ingredient|(a.i.)|in import and export item.|
|(ii)|COA of import|items from foreign|supplier.|
|(iii)|Complete technical|details|as|per Appendix 4E.|
----- End of picture text -----<br>
:
127
|
—
| soefer<br>Authorisation<br>17-05-2021<br>Issued: | soefer<br>Authorisation<br>17-05-2021<br>Issued: |
|---|---|
| Basis: | |
| ofExporter: | |
| lowmrrecs | aisese<br>OCS |
| (Ropree: | YatesSS |
128
,
|
| few <br>Authorisation<br>Issued: | few<br>18-05-2021 |
|---|---|
| PIN;pos | |
| Basis: | |
| ofExporter: |
|
;
Decision: The Committee considered the request of the firm and it was decided to ratify adhoc norms under Paral 4.07 of HBP vol. I as per details given below or as applied by the firm, whichever is less:
No. Enoxaparin Sodium Injection USP, Numbers 40mg in 0.4ml — Pre-filled Syringe(Composition per syringe, Enoxaparin Sodium USP 40mg, Water for Injection USP Shielding System q.s. to 0.41} RA concerned may take further necessary action as per above decision ofNC.
129
7
:
|
==> picture [450 x 391] intentionally omitted <==
----- Start of picture text -----<br>
||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Authorisation|18-05-2021|
|Issued:|
|fie|fee|
|Basis:|
|ofExporter:|
|License:|
|a|
|jour roc|a9|sess|
|Fowrcc, pass|
|Decision:||§ The Committee|considered|the|request|of the|firm|and|it was|decided to|ratify|adhoc norms under|Paral|
|4.07 ofHBP|vol.|I as|per details given below or|as|applied by the|firm,|whichever|is|less:|
|:|No.|
|Prednisolone|IP/BP/EP/USP|=|50|
|kgs)(Prednisolone|Acetate|(Net|Content|
|Prednisolone IP/BP/EP/USP =|50|kgs))|
----- End of picture text -----<br>
RA concerned may take further necessary action as per above decision ofNC.
130
==> picture [449 x 335] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||
|---|---|---|---|---|---|---|---|---|---|
|Authorisation|18-05-2021|
|aIssued:|a|
|Rane|EMESAURAV|CHEMICALS|
|Pa|OSC‘CC|
|Basis:|
|ofExporter:|
|Decision:|The Committee|considered|the case|as per agenda and|it was|decided|to|call|for following information||
|from the|firm:|
|(id|Complete technical|details|as|per Appendix 4E.|
----- End of picture text -----<br>
131
Authorisation 18-05-2021 , Issued: Se a Basis: ofExporter: fexponer Type; [PubliobinfedSSS Cc robree:_faises—SSSSCSSSOCC Decision; The Committee considered the case as per agenda and taking cue from earlier decision for same expo ( product in Meeting No. NC/3/MEET/Jan/202021/4 dt. 12.02.2021 against advance authorization No. 0310827769 dated 18.03.2019, it was decided to ratify norms under Para 4.07 of HBP Vol. I as_per details given below or as applied by the firm, whichever is less:
No.
RA may take appropriate action as per the decision of Norms Committee.
132
|
|1||Tr:|
|---|---|---|
||.||
|enCoe<br>Authorisation<br>18-05-2021<br>Issued:|||
|pi;|psan0SSSSSCSCSCSSCOSSCOCCCCCS||
|Basis:|;||
|ofExporter:|||
|aepare<br>License:<br>CC|pare||
|Fonrce <br>Decision:|psaSOS<br>The Committee considered the request ofthe firm and it was decided to ratify adhoc norms under Para||
|4.07 ofHBP|vol. I asperdetails given below oras appliedbythe|firm, whichever is less:|
||No.|;|
|mg<br>(1091<br>KGS)<br>(Diosmin<br>and | Tablets||HESPERIDIN (9:1)|
|Hesperidin<br>Tablets<br>500 mg<br>(1091|||
|KGS))|||
|
133
:
a Authorisation 18-05-2021 Issued: a pe oon Basis: ofExporter: jarroo fis) Decision: | The Committee considered the case as per agenda and taking cue from earlier decision for same export product in Meeting No. 7/AM21 dt. 24.12.2020 against advance authorization No. 3110067177 dated 26.09.2018, it was decided to ratify norms under Para 4.07 of HBP Vol. I as per details given below or as applied by| the firm, whichever is less: | DNOVO BP818 (Tetra Methyl Bisphenol F) | Tkg [1No. [26xylenoi ——~S=«diCO kg RA may take appropriate action as per the decision ofNorms Committee,
134
:
:
|
==> picture [448 x 345] intentionally omitted <==
----- Start of picture text -----<br>
|||||
|---|---|---|---|
|Authorisation|
|Issued:|
|re|ee|
|PeasMAHARASHTRA,421COCOOSCSCSCSSS103.|
|Basis:|
|ofExporter:|
|for in|this Advance Authorization by the|firm.|
|RA concerned may take|further necessary action|as per above decision of|NC.|
----- End of picture text -----<br>
.
|
135
:
:
==> picture [449 x 341] intentionally omitted <==
----- Start of picture text -----<br>
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|Authorisation|19-05-2021|
|Issued:|
|som|oem|
|Basis:|
|ofEx|porter:|
|roves;|[ipa|
|froproc:|fiesting|SSS|
|Decision:|
|from|the|firm:The|Committee considered|the case|as per agenda and|it was|decided to|call|for|following information|
|(ii)|COA|of export|item.|
----- End of picture text -----<br>
136
;
:
Authorisation 19-05-2021 Issued: ae fo
Basis: ofExporter: Cr Decision: |The Committee considered the case as per agenda and taking cue from earlier decision for same export product in Meeting No. 6/82-ALC4/2020 dated 13.11.2020 against advance authorization No, 0310831560 dt 16.09.2019, it was decided to ratify norms under Para 4.07 of HBP Vol. 1 as per details given below or as applied by the firm, whichever is less:
No. PHOSPHITE (DPDP) RA may take appropriate action as per the decision of Norms Committee.
137
.
,
==> picture [452 x 310] intentionally omitted <==
----- Start of picture text -----<br>
||||
|---|---|---|
|Authorisation|19-05-2021|
|||Issued:|
|own|fe|
|Basis:|
|ofExporter:|
|CS|
|Fonroc|[iisSCOOT|
|for in this|Advance|Authorization by the firm.|
----- End of picture text -----<br>
138
==> picture [1 x 12] intentionally omitted <==
----- Start of picture text -----<br> |<br>----- End of picture text -----<br>
==> picture [1 x 1] intentionally omitted <==
----- Start of picture text -----<br> |<br>----- End of picture text -----<br>
==> picture [449 x 419] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|HQRNORMAPPLY00046025AM22|;|
|34AA04001602AM22|
|Authorisation|19-05-2021|
|Issued:|
|ie|fromm|
|Basis:|
|ofExporter:|
|FOB|Vane [pois]|
|ronroc:[ai00SSSSSSCSSCSCSCSCSCSCSSSSSSSSSSSSSCSOSCCC*|
|Decision:|The|Committee|considered|the|request|of the|firm|and|it|was|decided|to|ratify|adhoc|norms|under|Para|
|4.07 of|HBP|vol.|J|as per details|given below|or|as|applied by the firm,|whichever|is|less:|
|No.|
|RA|concerned|may take|further necessary|action|as|per above|decision|ofNC.|
----- End of picture text -----<br>
:
139 ©
;
|
==> picture [453 x 263] intentionally omitted <==
----- Start of picture text -----<br>
|||
|---|---|
|Authorisation|19-05-2021|
|Issued:|
|eeae|
|fee|seo|
|PNpes|
|Basis:|
|ofExporter:|
|CSS|
----- End of picture text -----<br>
==> picture [447 x 116] intentionally omitted <==
----- Start of picture text -----<br> Decision: | The Committee considered the request of the firm and it was decided to ratify adhoc norms under Para<br>4.07 of HBP vol. | as per details given below or as applied by the firm, whichever is less:<br>. No. .<br>AZODICARBONAMIDE BLOWING | 200000kg | 1 AZODICARBONAMIDE 201000 kg<br>AGENT), PURITY MINIMUM 99.50 CRUDE PURITY<br>PERCENT, PARTICLE SIZE 4.5 TO MINIMUM 97 PERCENT<br>PERCENT MICRON<br>----- End of picture text -----<br>
140
in
|
|Authorisation|20-05-2021|
|---|---|
|Issued:||
|Basis:||
|ofExporter:||
|eeeaes<br>License:||
|Foproc, <br>Decision:||1os8)SCC<br>The Committee considered the case as per agenda and it was decided to call for following information||
|from the firm:||
||(i)<br>DML.|
141
|
:
==> picture [452 x 306] intentionally omitted <==
----- Start of picture text -----<br>
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Authorisation|20-05-2021|
|Issued:|
|ee|em|
|pre fs|
|Basis:|
|ofExporter:|
|CSS|
|Decision:|| The|Comimittee|considered|the|case|as per|agenda|and|it|was|decided|to|call|for|following|information|
|from the|firm:|
----- End of picture text -----<br>
142
.
oO
|
Authorisation ‘[Issued: em femme PNses Basis: ofExporter: cieroc, psoas? Fonrcc. [iaiT00Cd Decision: The Committee considered the request of the firm and it was decided to ratify adhoc norms under Para 4.07 of HBP vol. las per details given below or as applied by the firm, whichever is less:
==> picture [405 x 113] intentionally omitted <==
----- Start of picture text -----<br> No. ;<br>Enoxaparin Sodium Injection USP Numbers<br>dome in O4mlPredfiled<br>Syringe(Composition per syringe,<br>Enoxaparin Sodium USP 40mg, Water<br>for Injection USP q.s. to 0.4ml) Shielding System<br>RA concerned may take further necessary action as per above decision of NC.<br>----- End of picture text -----<br>
143
| peefe<br>Authorisation<br>20-05-2021<br>Issued: | peefe<br>Authorisation<br>20-05-2021<br>Issued: |
|---|---|
| PINT | sons<br>OSCSCSCSCSSSCSCSNST |
| Basis: | |
| ofExporter: |
144
ee
| per<br>Authorisation<br>20-05-2021<br>_[Issued: |
|---|
| PN<br>pose<br>SSOSOSCSSCSCSCSC‘CSCSC~S |
| Basis: |
| ofExporter: |
| arrec[oamomSSCS |
Decision: | The Committee considered the request of the firm and it was decided to ratify adhoc norms under Paral 4.07 of HBP vol. I as per details given below or as applied by the firm, whichever is less:
; No. ; Enoxaparin Sodium Injection USP Numbers cng in Om Prevfilled Syringe(Composition per syringe, Enoxaparin Sodium USP 80mg, Water for Injection USP q.s. to 0.8ml) Shielding System RA concerned may take further necessary action as pet above decision of NC.
‘
145
7
|
Authorisation Issued: a Basis: ofExporter:
row rec: fasss6i9 Decision: | The Committee considered the request of the firm and it was decided to ratify adhoc norms under Para 4.07 of HBP vol. I as per details given below or as applied by the firm, whichever is less:
==> picture [440 x 95] intentionally omitted <==
----- Start of picture text -----<br> Export Product Import items<br>. . No, ;<br>(1S, 4R)-4-Amino-2- cyclopentene-1- | 25000 ke 2-Azabicylo [2.2.1] hept-<br>methanol D{-) tartarate (AAT) 5-en-3-one (Vince lactam)<br>SS<br>RA concerned may take further necessary action as per above decision ofNC.<br>----- End of picture text -----<br>
146
;
|
:
7
|
—
==> picture [451 x 335] intentionally omitted <==
----- Start of picture text -----<br>
||||||||
|---|---|---|---|---|---|---|
|Authorisation|
|Issued:|
|eee pm|
|mc|oneneOSOS—SSCSC“‘“‘CS3MW|
|CS|EC|
|Basis:|
|ofExporter:|
|License:|
|pews|
|arrca|fianSO|
|op|Vane pai|
|troprec,|pisCCOC—CSSSSSSCSCSSSSOCCCCC|
|Decision:|The Committee considered the case|as per agenda and|it was|decided to|call|for following information|
|from the|firm:|
|(i)|DML|for each export product showing Approved Composition.|
----- End of picture text -----<br>
1 j
!
147
,
| LicenseNumber[oriwooiIs2<br>ee<br>Authorisation<br>Issued: |
|---|
| PINs<br>[500075 |
| Basis: |
| ofExporter: |
| rosRCo!952760] |
148
;
==> picture [450 x 279] intentionally omitted <==
----- Start of picture text -----<br>
|||
|---|---|
|Authorisation|
|Issued:|
|ee fee|
|PN|pesoOSOSOSSSSC‘“‘“‘;SS|
|Basis:|
|ofExporter:|:|
|Top Vane|ps7sss00—SOSSCSC“s*‘“‘“‘<;2C2SCSSS|
----- End of picture text -----<br>
149
|
|
|Authorisation|21-05-2021|
|---|---|
|Issued:||
|pI|(sas<br>OSCSCSCSCSCSC“SSCS~‘S|
|Basis:||
|ofExporter:<br>fExponerType:_[Publistimied —————S—S—SCSCSCSCSCCCTCCSCSCSCSCSCSSC~*r||
|roprce|iessms<br>SS<br>SSSCSCSCSSCSOSCSCSCSCSCSCSC“‘“‘SCSSSSCSCS||
150
| -
|
|
,
==> picture [448 x 362] intentionally omitted <==
----- Start of picture text -----<br>
||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|SC|
|icons|Numberfosiio277;|
|Authorisation|©|[21-05-2021|
|Issued:|
|femme|
|(East)|MUMBAI,400022.|
|Basis:|
|ofExporter:|
|Decision:|The|Committee|considered|the|case|as per agenda|and|it was|decided|to|call|for following information|
|from the|firm:|
|~|Production|Consumption|data duly|certified|by GST.|~|
----- End of picture text -----<br>
151
,
Authorisation 21-05-2021 Issued: Basis: ofExporter:
Decision; The Committee considered the request of the firm and it was decided to ratify adhoc norms under Paral 4.07 of HBP vol. I as per details given below or as applied by the firm, whichever is less: No. ; Enoxaparin Sodium Injection USP | Numbers 40mg in 0.4ml Pre-filled Syringe(Composition per __syringe, for Injection USP q.s. to 0.4ml) Shielding System ===) aS RA concerned may take further necessary action as per above decision of NC.
152
—_
;
.
| |
|
|
.
| Siemfee<br>Authorisation<br>23-05-2021<br>Issued: | Siemfee<br>Authorisation<br>23-05-2021<br>Issued: |
|---|---|
| Basis: | |
| ofExporter: |
,
|
|
153
e ,
a
Authorisation 24-05-2021 Issued: fe a
Basis:
ofExporter:
|
Decision: The Committee considered the request of the firm and it was decided to ratify adhoc norms under Para| 4.07 ofHBP vol, | as per details given below or as applied by the firm, whichever is less: 28,00,000 Enoxaparin Sodium Injection USP | Numbers 60mg in 0.6ml Pre-filled Syringe(Composition per syringe, Enoxaparinfor Injection Sodium USP q.s. USPto 0.6ml) 60mg, Water SeeShielding System ae
154
os
; ,
==> picture [448 x 387] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Meeting|No:|Case No:|
|NC/3/MEET/Jun/202122/2|Date:|02/07/2021|148/NC/3/MEET/Jun/202122/2|
|HQ|File|Number:}||HQRNORMAPPLY00049790AM22|
|RA|File|Number:|}094AA04005477AM21|
|G911000482|
|Date|of|
|Authorisation|24-05-2021|
|Issued:|.|
|Office|of Issue;|||Office of the|Additional|Director|General|of Foreign Trade, Hyderabad|
|0990002110|
|GLAND|PHARMA|LIMITED|Te|i|)|
|PIN:|[(502307]|Part of|Plot No.11 & 87, Sy No.119 to 140, 258, 275 to 280,,HY DERABAD,502307.|
|Type|of License:|||[Advance]|[Licence]|[with][ AU]|[Condition]|—|
|Application|Export|Order|
|Basis:|
|Status|Merchant|Cum|Manufacturer|Exporter|
|ofExporter:|
|Exporter Type:||Public|Limited|
|E|Chemical|and Allied Products|
|Group:|
|CIF Value|of|[the]|[684298411]|
|License:|
|cirrcc:[9is4a93|
|FOB|FCC:|10544793|
|Decision:|The|Committee|considered|the|request|of the|firm|and|it|was|decided|to|ratify|adhoc|norms|under|Para|
|4.07|of HBP|vol.|I|as per|details|given|below|or|as|applied|by the|firm,|whichever|is|less:|
----- End of picture text -----<br>
==> picture [425 x 137] intentionally omitted <==
----- Start of picture text -----<br> INo. No.<br>1 Low Molecular Weight Heaprin Enoxaparin | 4118180 Numbers<br>Sodium Injection USP, 40mg in 0.4ml Pre-<br>filled Syringe(Composition per - syringe,<br>Enoxaparin Sodium USP 40mg, Water for<br>Injection USP q.s. to 0.4ml) 5 Preventis Needle Net to Net<br>Shielding System<br>2 Low Molecular Weight Heaprin Enoxaparin | 1455841 Numbers<br>Sodium Injection USP 60mg in 0.6ml Pre-<br>filled Syringe(Composition per syringe,<br>Enoxaparin Sodium USP 60mg, Water for<br>Injection USP q.s. to 0.6ml} 5 Preventis Needle Net to Net<br>Shielding System<br>----- End of picture text -----<br>
JRA concerned may take further necessary action as per above decision of NC.
.
.
:
155
,
|
|
==> picture [431 x 329] intentionally omitted <==
----- Start of picture text -----<br>
||||||||
|---|---|---|---|---|---|---|
|License|Number: 0311008034|
|Authorisation|24-05-2021|
|Issued:|
|nn|_———SSOSCSCSCSCSCSCSCSCSCS“SCS~‘“SsS~“~SsS~S~S~S~SCSS|
|Basis:|
|ofExporter:|
|for|in this|Advance|Authorization|by|the|firm.|
----- End of picture text -----<br>
156
:
| recefem<br>Authorisation<br>Issued: | fem<br>{24-05-2021 |
|---|---|
| Basis: | |
| ofExporter: | |
| farece.[soss—SSCSCSOSSSSSSCSSCSCSCCCCCSCS |
157
,
| Authorisation | {24-05-2021 |
|---|---|
| Issued: | |
| Basis: | |
| ofExporter:. |
158
a
oo
==> picture [459 x 319] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|,|
|Authorisation|25-05-2021|
|Issued:|
|(East),|MUMBAI,400022.|
|Basis:|
|ofExporter:|
|Decision:|The|Committee|considered|the|case|as|per|agenda|and|it|was|decided|to|call|for|following|information|
|from the|firm:|
----- End of picture text -----<br>
,
159
| pmfe<br>Authorisation<br>25-05-2021<br>Issued: | pmfe<br>Authorisation<br>25-05-2021<br>Issued: |
|---|---|
| Names | [UPLUIMIMED——SSSOSCSCSCSCCSSCSCS |
| Basis: | |
| ofExporter; | |
| FoRVas | [335769500<br>—S—SS—SCSCSCSSCSCOCCCOCSCSCSCSCSTT |
| Decision:<br>fromthefirm: | The Committee considered the case as per agenda and it was decided to call for following information |
160
_ :
==> picture [449 x 342] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Authorisation|25-05-2021|
|Issued:|
|llee|
|(East),|MUMBAI,400022.|
|Basis:|
|ofExporter:|
|CS|
|Decision:|The|Committee|considered|the|case|as|per|agenda|and|it|was|decided|to|call|for|following|information||
|from|the|firm:|
|@|Production|Consumption|data|duly|certified|by GST.|:|
----- End of picture text -----<br>
161
==> picture [447 x 292] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Authorisation|25-05-2021|
|Issued:|
|Basis:|
|ofExporter:|
|Decision:|The|Committee|considered|the|case|as|per|agenda|and|it|was|decided|to|call|for|following|information|
|from the|firm:|
----- End of picture text -----<br>
162
— :
|
==> picture [448 x 318] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Authorisation|25-05-2021|
|Issued:|
|oe|em|
|(East),|MUMBAI,400022.|
|Basis:|
|ofExporter:|
|Decision:|The|Committee|considered|the|case|as|per|agenda|and|it|was|decided|to|call|for|following|information|
|from the|firm:|
----- End of picture text -----<br>
163
,
|fefee<br>Authorisation<br>25-05-2021<br>Issued:|fefee<br>Authorisation<br>25-05-2021<br>Issued:|
|---|---|
||(East), MUMBAI,400022.|
|Basis:||
|ofExporter:||
|Decision:|The Committee considered the case as per agenda and itwas decided to call for following information||
|fromthefirm:||
164
==> picture [416 x 20] intentionally omitted <==
----- Start of picture text -----<br> Meeting No: . Case No:<br>NC/3/MEET/Jun/202122/2 Date: 02/07/2021 158/NC/3/MEET/Tun/202122/2<br>----- End of picture text -----<br>
HQ File Number:| HORNORMAPPLY00099364AM22 RA File Number: ]34AA04001425AM22 Date of Authorisation 25-05-2021 —__[pssued:] Office of Issue: |Office of the Joint Director General of Foreign Trade, Vadodara 1399008365 Best Value Chem Private Limited 706,707,708 Atlantis Heights,, VADODARA,390023. 500005 Type of License: {|[Advance][Licence][with][ AU][Condition] Application Export Order Basis: Status Manufacturer Exporter ofExporter: Exporter Type: | Private Limited Export Product Chemical and Allied Products Group: CIF Value of the 170504750 License: ; FOB Value: 215497500 FOB FCC: 2950000 Decision: |= The Committee considered the case as per agenda and taking cue from earlier decision for same export product in Meeting No. 10/AM18 dt. 20.03.2018 against advance authorization No. 3410040114 dated 23.05.2014 and 3410040841 dated 29.12.2014, it was decided to ratify norms under Para 4.07 of HBP Vol. las pe details given below or as applied by the firm, whichever is less: No. MELONAL((2,6-dimethylhept-5- enal)) ike Methyl Heptenone 1.125 kg 2 Methyl Mono Chloro 1.201 kg | Acetate Sodium Methoxide 0.562 kg
RA may take appropriate action as per the decision of Norms Committee.
165
|
|
: ,
|
| a<br>Authorisation,<br>— [25-05-2021<br>Issued: | a<br>Authorisation,<br>— [25-05-2021<br>Issued: |
|---|---|
| PIN | PBBSSCS |
| Basis: | |
| ofExporter: | |
| Decision:<br>fromthefirm: | TheCommittee considered the case as peragenda and it was decided to call for following information |
166
_
_.
;
==> picture [100 x 24] intentionally omitted <==
----- Start of picture text -----<br> Meeting No:<br>NC/3/MEET/Jun/202122/2<br>----- End of picture text -----<br>
==> picture [266 x 24] intentionally omitted <==
----- Start of picture text -----<br> Case No:<br>Date: 02/07/2021 160/NC/3/MEET/Jun/202122/2<br>----- End of picture text -----<br>
||HQ FileNumber:| HQRNORMAPPLY00099750AM22|
|---|---|
||RA File Number: ]344A04001815AM22|
||Date of|
||Authorisation<br>25-05-2021|
|_____[Issued:<br>OfficeofIssue: |Office ofthe Joint Director GeneralofForeignTrade, Vadodara<br>mc;<br>[099008365<br>|<br>Best Value Chem Private Limited||
|Px|706,707,708 Atlantis Heights,, VADODARA,390023.<br>pees<br>OSOSOSOCSOSOSCSCSC“CSC‘“SN™SCNSCNOCS<br>Type ofLicense: |Advance Licence with AU Condition|
||Application<br>Export Order|
||Basis:|
||Status<br>Manufacturer Exporter|
||ofExporter:|
||Chemical andAlliedProducts<br>Group:|
||CIFValue ofthe 101809500<br>License:|
||CIF FCC:<br>1362000|
||FOB Value:<br>208192500|
||FOB FCC:<br>2850000<br>-|
||Decision:<br>|The Committee considered the case as per agenda and taking cue from earlier decision for same export|
||product in Meeting No, 2/82-ALC4/2020 dt. 10.07.2020 against advance authorization No. 3410044991 dated<br>22.03.2019,<br>itwas decided to ratifynorms under Para4.07 of HBP Vol. I as per details givenbelow or as appliedb|
||thefirm,whicheverisless:|
|||||||||No,|||
|---|---|---|---|---|---|---|---|---|---|---|
|Undecavertol <br>5-ol))|(Kakdinol)|((4-|<br>,|Methyl-3-decen-|||i|kg|2|Methyl Heptenone<br>1-Pentanol<br>/N<br>Alcohol|0.842kg<br>Amy]| 0.639kg|
RA may take appropriate action as per the decision of Norms Committee,
167
.
:
,
|
|ec<br>Authorisation<br>26-05-2021<br>‘<br>Issued:|ec<br>Authorisation<br>26-05-2021<br>‘<br>Issued:|ec<br>Authorisation<br>26-05-2021<br>‘<br>Issued:|
|---|---|---|
|Basis:|||
|ofExporter:|||
|fiom|||
|Decision:|The Committee considered|the case as per agenda and it was decided to call for following information||
|fromthefirm:|||
168
;
oo
2
Authorisation 26-05-2021 Issued: ove fem Basis: ofExporter: (cirrcG__|6sis00 55335375 ) Decision: |The Committee considered the request of the firm and it was decided to ratify adhoc norms under Para 4.07 ofHBP vol. J as per details given below or as applied by the firm, whichever is less:[265][ kg] nn neNo. i RA concerned may take further necessary action as per above decision of NC.
:
169
.
| Authorisation | 27-05-2021 |
|---|---|
| Issued: | |
| pm | I<br>SOSCSOSOSCSCSCSCSST |
| Basis: | |
| ofExporter: | |
| CS |
170
|
|
Authorisation 27-05-2021 Issued: ee fre Basis: ofExporter: jarrca_pis——SOSCS—~—~—SCSCSSSC‘“‘“‘SSSS FOR Vales _pprieamt FOBFCG:_pmmas)SSSC—C—C—SCSCSCSCSCSCSCSSSS Decision: The Committee considered the case as per agenda and it was decided to call for following information from the firm: (i) Complete technical details as per Appendix 4E.
171
,
||eeee<br>Authorisation<br>27-05-2021<br>Issued:|eeee<br>Authorisation<br>27-05-2021<br>Issued:|eeee<br>Authorisation<br>27-05-2021<br>Issued:|
|---|---|---|---|
||Basis:|||
||ofExporter:|||
|,||||
||Decision:|The Committee considered the case as per agenda and it was decided to call for following information|||
||fromthefirm:|||
172
:
.
|al<br>Authorisation<br>___|Issued:|27-05-2021| |---|---|
Basis: ofExporter:
==> picture [1 x 2] intentionally omitted <==
----- Start of picture text -----<br> |<br>----- End of picture text -----<br>
Decision: |The Committee considered the request of the firm and it was decided to ratify adhoc norms under Para 4.07 of HBP vol. J as per details given below or as applied by the firm, whichever is less:
No. 5 DICHLORO BENZO PHENONE
173
.
|
|
==> picture [447 x 304] intentionally omitted <==
----- Start of picture text -----<br>
||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Authorisation|27-05-2021|
|Issued:|
|(East),|MUMBAL400022.|
|Basis:|
|ofExporter:|
|Decision:|The|Committee|considered|the|case|as|per agenda and|it was|decided to|call|for following|information|
|from the|firm:|
----- End of picture text -----<br>
174
,
:
==> picture [505 x 316] intentionally omitted <==
----- Start of picture text -----<br>
|||||
|---|---|---|---|
|Meeting|No:|Case|No:|
|Authorisation|27-05-2021|
|Ue|—___pe|[fssued:]|.|
|aBasis:|
|ofExporter:|
|Group:|
|CIF|Value|of the|
----- End of picture text -----<br>
;
==> picture [447 x 190] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Decision:|| The Committee|considered|the|request|of the|firm and|it was|decided|to|ratify|adhoc norms|under|Paral|
|4.07|of|HBP|vol.|J|as per details|given below|or as|applied by|the|firm,|whichever|is|less:|
|No.|No.|;|
|©|[[hsterssecrasters]|21|CARPROFEN CHEWABLE|[tows100000||!l|[SmeeCARPROFEN|ORAL|GRADEPET ||2.55 kg|
|°"2|[[rasters-muecasters)]|43|[asters[tastersCARPROFENCARPROFENCARPROFEN ssmgcasuersovecrascersy CHEWABLECHEWABLECHEWABLE|[toe[Toi[toe 676007500050000||!|!|!|[[mn][[gues]|111|| SnoCARPROFENCARPROFENCARPROFEN ORAL GRADEORALORALOME ONDEGRADEGRADE||S2.5863.8253.825 kgkgkg|
|*|[[-rascerecoongcrap.ers)]|5|CARPROFEN CEWABLE|[tose73000||!1|| AmenCARPROFEN|ORALOMESMDEGRADE|[TM7.65|kg|
----- End of picture text -----<br>
175
:
,
,
| a<br>Authorisation<br>Issued: | a<br>Authorisation<br>Issued: | 28-05-2021<br>. | |
|---|---|---|---|
| Nene | [ATULLIMITED | ||
| Basis: | |||
| ofExporter: |
176
a .
| fiefem<br>Authorisation<br>Issued: | fem<br>30-05-2021 |
|---|---|
| Basis: | |
| ofExporter: |
|
|
177
,
7
| ne<br>Authorisation<br>31-05-2021<br>Issued; |
|---|
| Basis: |
| ofExporter: |
| erro fiom SSCS |
| Foprce;_fiomeaaSSS<br>Decision:<br>.<br>The Committee considered the case as per agenda and it was decided to call for following information<br>fromthefirm: |
178
Meeting No: . Case No: NC/3/MEET/Jun/202122/2 Date: 02/07/2021 172/NC/3/MBET/Jun/202122/2 HQ File Number:| HQRNORMAPPLY00103712AM22 RA File Number: ]09AA04002159AM22 0911000574
Date of Authorisation 31-05-2021 |[Issued:] Office of Issue: |Office of the Additional Director General of Foreign Trade, Hyderabad HONOUR LAB LIMITED H.NO.8-3-166/7/1, HETERO HOUSE,,HYDERABAD,500018. 500018 Type of License: |[Advance][Licence][with][ AU][Condition] Application Export Order Basis: Status Merchant Cum Manufacturer Exporter ofExporter: Exporter Type: |Public Limited Export Product |chemical and Allied Products Group: CIF Value of[the][334768000] License: CIF FCC: 4396165 FOB Value: 435198400
. ee .
Decision: | The Committee considered the request of the firm and it was decided to ratify adhoc norms under Para 4.07 of HBP vol. I as per details given below or as applied by the firm, whichever is less:
No. (1R,28,5R)-2-Isopropyl-5200000 kg N,N-Dimethyl formamide 56,000 kg methylcyclohexyl- (2R,5S)-5-(4-aminoHexamethy] disilazane 1,41,600 kg 2-__oxopyrimidin-1(2H)-yl)-1,386,800 kg oxathiolane-2carboxylate. 4 Triphosgene 1,00,000 kg ((1R,28,5R)-2-Isopropyl-5methylcyclohexyl- (2R,5S)-5-(4-amino2oxopyrimidin-1(2H)-yl)-1,3oxathiolane-2carboxylate. (OR) Cyclohexyl Ester (PE) (OR)Cyclohexyl , Ester HN)
;
179
:
==> picture [451 x 306] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Authorisation|31-05-2021|
|Issued:|
|ena|
|Basis:|
|ofExporter:|
|SSSSSSSSSSSSSSSSSSSSSSC‘C~*”r|
|ronrcc:|_psaso0|
|Decision:|The|Committee|considered|the|case|as|per|agenda|and|it|was|decided|to|call|for|following|information|
|from the|firm:|,|
----- End of picture text -----<br>
.
180
oe
Authorisation 31-05-2021 Issued: . Basis: ofExporter:
,
,
Decision: |The Committee considered the case as per agenda and taking cue from earlier decision for same expor product in Meeting No. NC/3/MEET/Jan/202021/4 dt. 12.02.201 against advance authorization No. 3410046153 dated 15.06.2020, it was decided to ratify norms under Para 4.07 of HBP Vol. ] as per details given below or as applied by the firm, whichever is less:
No. RA may take appropriate action as per the decision of Norms Committee.
181
|
,
|
,
Authorisation {31-05-2021 Issued: epeepm Basis: ofExporter:
Decision: The Committee considered the case as per agenda and taking cue from earlier decision for same export product in Meeting No. NC/3/MEET/Jan/202021/4 dt. 12.02.201 against advance authorization No. 0310836830 dated 23.06.2020, it was decided to ratify norms under Para 4.07 of HBP Vol. I as per details given below or as applied by the firm, whichever is less: :
No,
RA may take appropriate action as per the decision of Norms Committee,
182
a
,
.
|
==> picture [451 x 306] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Authorisation|01-06-2021|
|||[Issued:]|
|pecme|fm|
|Basis:|
|ofExporter:|
|Decision:|The|Committee|considered|the|case|as|per|agenda|and|it|was|decided|to|call|for|following|information|
|from the|firm:|;|
----- End of picture text -----<br>
183
,
i
==> picture [530 x 306] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Authorisation|01-06-2021|
|Issued:|
|Officeee of Issue:|| Officea of the Additional Director|General of Foreign Trade,|Bengaluru|
|Basis:|
|ofExporter:|
|SSCS|
|Exporter Typer_[Pivaeimed|
|Decision:|The|Committee|considered|the|case|as|per|agenda|and|it|was|decided|to|call|for|following|information|
|from the|firm:|
----- End of picture text -----<br>
184
|ee<br>Authorisation<br>01-06-2021<br>Issued:|
|---|
|Basis:<br>.|
|ofExporter:|
|Decision;<br>The Committee considered the request ofthe firm and it was decided to ratify adhoc norms under Para|
|4.07 ofHBP vol. I as per details givenbelow or as appliedby the firm, whichever is less:|
|No.<br>;<br>Seen<br>5MG/ML<br>10ML |Numbers<br>AMPOULE(MIDAZOLAM<br>INJECTIONBP SMG/ML 1OML|
RA concerned may take further necessary action as per above decision of NC,
185
| Authorisation | 01-06-2021 |
|---|---|
| Issued: | |
| Basis: | |
| ofExporter: |
:
186
Meeting No:
Case No:
Date of Issued:
Basis:
ofExporter:
Group:
- .
Decision; |The Committee considered the request of the firm and it was decided to ratify adhoc norms under Para 4.07 of HBP vol. I as per details given below or as applied by the firm, whichever is less: No. - 4-AMINO-2- OXO PYRIMIDINYL 200000 kg : OXATHIOLANE- 2- CARBOXYLIC PERCENT ACID ISO PROPYL METHYL CYCLO DISILAZANE [8 | DIMETHYL FORMAMIDE | 56000kg | =] =
187
|
;
==> picture [220 x 327] intentionally omitted <==
----- Start of picture text -----<br> Meeting No:<br>Date of<br>Issued:<br>COLLEGE,, AHMEDABAD,380058.<br>Basis:<br>ofExporter:<br>Group:<br>License:<br>----- End of picture text -----<br>
Case No:
|
|
Decision: | The Committee considered the request of the firm and it was decided to ratify adhoc norms under Paral 4.07 of HBP vol, I as per details given below or as applied by the firm, whichever is less:
==> picture [428 x 142] intentionally omitted <==
----- Start of picture text -----<br> No. ‘ No.<br>1 Metamizaole Magnesium 300 mg and Pargeverine | 32500 1 Metamizole 51.875 kg<br>Hydrochloride 6mg Oral Drop((Considering the Numbers Magnesium<br>loss on drying @14.50 PERCENT of Bulkdrug for<br>300MG we need to poor 350.88 Mg. So net<br>content of the raw material is :- 32500 Bottles X 5<br>2 Metamizaole Magnesium 300 mg and Pargeverine | 1074880 1 Metamizole 5078.80 kg<br>Hydrochloride 6mg Oral Drop((Considering the | Numbers Magnesium<br>loss on drying @14.50 PERCENT of Bulkdrug for<br>300MG we need to poor 350.88 Mg. So net<br>content of the raw material is :- 1074880 Bottles X<br>----- End of picture text -----<br>
188
- ,
==> picture [474 x 305] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Authorisation|01-06-2021|
|,|aIssued:|
|Basis:|;|
|‘||ofExporter:|
|Decision:|The|Committee|considered|the|case|as|per|agenda|and|it|was|decided|to|call|for|following|information|
|from the|firm:|
----- End of picture text -----<br>
|
189
:
==> picture [451 x 263] intentionally omitted <==
----- Start of picture text -----<br>
|||
|---|---|
|Authorisation|01-06-2021|
|)|Issued:|
|pee Pm|
|[a 5|
|Basis:|
|ofExporter:|
|CSS|
----- End of picture text -----<br>
==> picture [447 x 127] intentionally omitted <==
----- Start of picture text -----<br>
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Decision:|| The|Committee|considered|the|request|of the|firm|and|it|was|decided|to|ratify|adhoc norms|under|Para|
|4.07|of|HBP|vol.|I|as per|details|given below|or|as|applied|by|the firm,|whichever|is|less:|
|;|No.|;|
|L|MENTHYL|GLYOXYLATE|||100000kg|
|HYDRATE(L-|MENTHYL|2|CYCLOHEXANE|1,41,000 kg|
|GLYOXYLATE HYDRATE|
|Eger||S|
|RA|concerned|may|take|further necessary|action|as|per|above|decision|of|NC.|
----- End of picture text -----<br>
|
190
a
7
|
|
==> picture [449 x 363] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Ticense|Number|[0311002735|
|Authorisation|01-06-2021|
|Issued:|
|alSCS|
|(East),|MUMBAI,400022.|
|Basis:|
|ofExporter:|
|SSSCSCSCSCSSCSCSCSS|
|crroc.|passe|
|Decision:|The|Committee|considered|the|case|as|per|agenda|and|it|was|decided|to|call|for|following|information|
|from the|firm:|
|(i|Complete|technical|details|as|per Appendix|4E.|:|
----- End of picture text -----<br>
191
,
,
|Authorisation<br>Issued:|fem<br>01-06-2021|
|---|---|
|Basis:||
|ofExporter:||
|Decision:|The Committee considered the case as per agenda and it was decided to call for following information||
|fromthefirm:||
!
192
el
|
,
|
==> picture [447 x 292] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Authorisation|01-06-2021|
|Issued:|
|Basis:|
|ofExporter:|
|Decision:|The|Committee|considered|the|case|as|per|agenda|and|it|was|decided|to|call|for|following|information|
|from the|firm:|
----- End of picture text -----<br>
|
193
.
|
|feces<br>Authorisation<br>Issued:|feces<br>Authorisation<br>Issued:|01-06-2021||
|---|---|---|---|
|Basis:||||
|ofExporter:||||
|Decision:|The|Committee considered the case as per agenda and it was decided to call for following information||
|fromthe firm:||.||
||||||
:
194
,
|
|
==> picture [452 x 342] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Authorisation|02-06-2021|
|Issued:|oo|::|
|ee|
|Basis:|
|ofExporter:|
|Decision:|The|Committee|considered|the|case|as|per|agenda|and|it|was|decided|to|call|for|following|information||
|from the|firm:|
|||
|;|(iid)|Master Batch|Formula.|
----- End of picture text -----<br>
195
,
| rea<br>Authorisation<br>02-06-2021<br>Issued: | rea<br>Authorisation<br>02-06-2021<br>Issued: |
|---|---|
| Basis: | |
| ofExporter: |
:
;
196
,
==> picture [448 x 306] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Authorisation|03-06-2021|
|Issued:|
|pce|mm|
|Basis:|
|ofExporter:|
|Decision:|The|Committee|considered|the|case|as|per|agenda|and|it|was|decided|to|call|for|following|information|
|from the|firm:|,|
----- End of picture text -----<br>
197
|
| fermepoem<br>Authorisation<br>Issued: | poem<br>03-06-2021<br>; | |
|---|---|---|
| Basis: | , | |
| ofExporter: |
:
198
__
7
| ee<br>Authorisation<br>03-06-2021<br>Issued: | ee<br>Authorisation<br>03-06-2021<br>Issued: |
|---|---|
| (East), MUMBAI,400022. | |
| Basis: | |
| ofExporter: | |
| Decision: | The Committee considered the case as per agenda and it was decided to call for following information |
| fromthefirm: |
199
,
7
2
|
==> picture [449 x 317] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Authorisation|03-06-2021|
|Issued:|
|a|
|(East)|MUMBAI,400022.|
|Basis:|
|ofExporter:|
|Decision:|The|Committee|considered|the|case|as|per|agenda|and|it|was|decided|to|call|for|following|information|
|from the|firm:|
----- End of picture text -----<br>
200
|
,
| ,
,
==> picture [448 x 305] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|04-06-2021|
|AuthorisationIssued:|pe|
|Basis:|
|ofExporter:|||
|Decision:|The|Committee|considered|the|case|as|per|agenda|and|it|was|decided|to|call|for|following|informatio:|
|from the|firm:|
----- End of picture text -----<br>
;
201
:
,
| eea<br>Authorisation<br>04-06-2021<br>Issued: | eea<br>Authorisation<br>04-06-2021<br>Issued: |
|---|---|
| Basis: | |
| ofExporter: |
202
_
==> picture [449 x 341] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Authorisation|04-06-2021|
|Issued:|
|epee few|
|Basis:|
|ofExporter:|
|Decision:|The|Committee|considered|the|case|as|per|agenda|and|it|was|decided|to|call|for|following|information|
|from the|firm:|
|(ii)|Master Batch|Formula.|;|
----- End of picture text -----<br>
203
==> picture [513 x 331] intentionally omitted <==
----- Start of picture text -----<br>
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|,|
|Authorisation|04-06-2021|
|Issued:|;|
|soe|fer|
|,|
|(East),|MUMBAI,400022.|
|Basis:|
|ofExporter:|;|
|,|
|Decision:|The|Committee|considered|the|case|as|per|agenda and|it|was|decided|to|call|for|following|information||
|from|the firm:|
----- End of picture text -----<br>
204
ee
,
, :
| Authorisation | 04-06-2021 |
|---|---|
| Issued: | |
| Basis: | |
| ofExporter: | |
| Decision: | The Committee considered the case as per agenda and it was decided to call for following information |
| fromthefirm: |
205
a
7
==> picture [1 x 1] intentionally omitted <==
----- Start of picture text -----<br> .<br>----- End of picture text -----<br>
==> picture [102 x 23] intentionally omitted <==
----- Start of picture text -----<br> Meeting No:<br>NC/3/MEET/Sun/202122/2<br>----- End of picture text -----<br>
Case No: Date: 02/07/2021 199/NC/3/MBET/Tun/202122/2
HQ File Number:| HQRNORMAPPLY00106948AM22
RA File Number: /09AA04003410AM22 0911001007
Date of Authorisation 04-06-2021 Issued: Office of Issue: |Office of the Additional Director General of Foreign Trade, Hyderabad gp97003006
_
HETERO LABS LIMITED HETERO CORPORATE, NO. 7-2-A2,,HYDERABAD,500018. 500018 Type of License: ][Advance][Licence][with][ AU][Condition] Application | [Export Order Basis: Status Merchant Cum Manufacturer Exporter ofExporter: , Exporter Type: |Public Limited Export Product Chemical and Allied Products Group: CIF Value ofthe 58814400 License: CIF FCC: 793716 FOB Value: 76458720 |FOB FCC: 1056789
Decision: The Committee considered the request of the firm and it was decided to ratify adhoc norms under Para 4.07 of HBP vol. I as per details given below or as applied by the firm, whichever is less:
==> picture [429 x 99] intentionally omitted <==
----- Start of picture text -----<br> No. ;<br>( R)-9-[2-Phosphonomethoxy) propy!] | 6000 kg ADENINE 6138 ke<br>Adenine N,N-DIMETHYLFORMAMIDE | 12720kg<br>3 (R)- 1, 2+ PROPYLENE] 5880kg<br>CARBONATE<br>N-METHYL- PYRROLIDONE [| 1260kg<br>RA concerned may take further necessary action as per above decision of NC.<br>----- End of picture text -----<br>
206
oo
,
,
,
||el<br>Authorisation<br>Issued:<br>-|04-06-2021|
|---|---|---|
||Basis:||
|:|ofExporter:||
||Decision:<br>The|Committee considered the case as per agenda and it was decided to call for following information||
||fromthefirm:||
:
207
|
| rea<br>Authorisation<br>[04-06-2021<br>Issued: | rea<br>Authorisation<br>[04-06-2021<br>Issued: |
|---|---|
| Basis: | |
| ofExporter: |
|
208
,
|femPm<br>Authorisation<br>05-06-2021<br>Issued:|femPm<br>Authorisation<br>05-06-2021<br>Issued:|
|---|---|
|Basis:||
|ofExporter:||
|Decision:|The Committee considered the case as per agenda and it was decided to call for following information||
|fromthe firm:||
||(ii)<br>Detailedworking.|
209
:
7
==> picture [451 x 310] intentionally omitted <==
----- Start of picture text -----<br>
||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Authorisation|06-06-2021|
|Issued:|
|Sea|
|OSOSCSOSOSOSCOCSCSCS|
|PIN|paseo|
|Basis:|
|ofExporter:|
|SSCS|
|Exponer|type_[Parmenhip|
|CC|
|Decision:|| The Committee|considered|the|case|as per agenda and|it|was|decided to|ratify|adhoc norms|as|applied|
|for in this|Advance|Authorization by|the|firm.|
----- End of picture text -----<br>
210
‘
—
|iae|ae<br>'|ae<br> |Authorisation<br>07-06-2021<br>Issued:|ae<br> |Authorisation<br>07-06-2021<br>Issued:|
|---|---|---|---|
|||pe|eo<br>SSCSCSCSSCSCSCSC‘“SC*~C*‘“‘C;SC*d<br>Advance Licence with AU Condition|
||||Export Order|
|||Basis:||
|||ofExporter:||
|||FOBVene|[ong<br>SSCSCSCSOSSCSSCSCSCSSSSOSCCCSC—S|
211
Authorisation 07-06-2021 Issued: fe fe , Basis: ofExporter: Decision: The Committee considered the case as per agenda and it was decided to call for following information from the firm:
212
a ,
|
==> picture [483 x 331] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Authorisation|_||07-06-2021|
|Issued:|
|om pom|
|PN|souseSSCSCSC‘“CS*SC~‘“S~S~S~S~SC~SCS|
|Basis:|
|ofExporter:|
|crrroc|274505|
|lroprocfsasusi_——SCSCSCSCSCSCSSSSSSSSSSSSSSSSSSSSSSSSSSSCC‘dTC!|
|Decision:|The|Committee|considered|the|case|as|per|agenda|and|it|was|decided|to|call|for|following|information|
|from the|firm:|
|(i)|Complete technical|details|as|per Appendix|4E.|
----- End of picture text -----<br>
,
213
,
,
| sie <br>Authorisation<br>Issued: | mm<br>08-06-2021 |
|---|---|
| Basis: | |
| ofExporter: |
,
214
:
_.
| Meeting<br>N | Case | N' |
|---|---|---|
| Ee<br>Authorisation<br>Issued: | 08-06-2021 | |
| PN | poms<br>SSSSOCOSCSCSCSCSCSCSCSCSC‘*dS | |
| Basis: | ||
| ofExporter: |
|
215
.
| eea<br>Authorisation<br>08-06-2021<br>Issued: | eea<br>Authorisation<br>08-06-2021<br>Issued: |
|---|---|
| DISTRICT,500101. | |
| Basis: | |
| ofExporter: | |
| Decision: | The Committee considered the case as per agenda and it was decided to call for following information |
| from thefirm: | . |
| (ii)<br>MasterBatchFormula. |
216
|
_
|
| fepee | pee<br>Authorisation<br>08-06-2021<br>Issued: |
|---|---|
| Basis: | |
| ofExporter: |
|
217
:
|
|
==> picture [497 x 340] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Authorisation|08-06-2021|
|Issued:|
|Se|fe|
|Basis:|
|ofExporter:|
|CS|CE|
|Decision:|The|Committee|considered|the|case|as|per|agenda|and|it|was|decided|to|call|for|following|information||
|from the|firm:|
|(ii)|Master Batch|Formula.|:|‘|
----- End of picture text -----<br>
218
2
,
|
|
—
==> picture [449 x 316] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Authorisation|09-06-2021|
|Issued:|
|__faaccxssn’—SSCSCSCS~—SSCSCSCSC“C‘“‘“‘“‘<CST|
|isc|
|OSCSCSCSCSCSSSSCSCSSCSCSCSCSCSCSC*|
|PN|pi|
|Basis:|
|ofExporter:|
|areca|[sa996 SSS|
|SSOS—SOSSSSSSCCCOSCCOSCCC—CSYT|
|fRopece,|foray|
|Decision:|The|Committee|considered|the|case|as|per|agenda|and|it|was|decided|to|call|for|following|information|
|from the|firm:|
|(i)|Complete|technical|details|as|per Appendix|4E,|
----- End of picture text -----<br>
|
219
|
,
,
==> picture [471 x 327] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||
|---|---|---|---|---|---|---|---|
|Authorisation|10-06-2021|
|Issued:|
|PaneMAHARASHTR4,421103.|OCSCSOSOSSSSCSCSCSC‘Csi‘CSSCSC*d|
|Basis:|
|ofExporter:|
|for|in|this|Advance Authorization|by the|firm.|
|RA|concerned may take further|necessary|action|as per above decision|of|NC.|:|
----- End of picture text -----<br>
220
|BO|[I|scefom<br>Authorisation<br>ssued:<br>[Office ofIssue:|fom<br>10-06-2021<br> |Officeofthe Joint Director Generalof Foreign Trade,Pune<br>sd<br>ofthe Joint Director General ofForeign Trade, Pune|
|---|---|---|---|
|||Basis:||
|||ofExporter:||
221
| [LicenseNamberpnni000397_———SSSOSCSCSCSCSSSSCCCCSCSCSCSCS<br>sein fom<br>Authorisation<br>10-06-2021<br>Issued: | [LicenseNamberpnni000397_———SSSOSCSCSCSCSSSSCCCCSCSCSCSCS<br>sein fom<br>Authorisation<br>10-06-2021<br>Issued: |
|---|---|
| Basis: | |
| ofExporter: |
:
|
222
_ ;
:
||Meeting No:<br>.<br>NC/3/MEBT/Jun/202122/2<br>Date: 02/07/2021|Meeting No:<br>.<br>NC/3/MEBT/Jun/202122/2<br>Date: 02/07/2021|CaseNo:<br>216/NC/3/MEBT/Jun/202122/2|
|---|---|---|---|
||HQ FileNumber:| HQRNORMAPPLY00111396AM22|||
||RA File Number: }03AA04013894AM22|||
|||0311004496||
||Date of|||
||Authorisation|10-06-2021||
|||Issued:||;|
||Office ofIssue:|{Office ofthe Additional Director General ofForeign Trade, Mumbai||
|||0388069969||
|||JB CHEMICALS & PHARMACEUTICALS LTD||
|||NEELAM CENTRE, B WING,MUMBAL,400030.||
|||200080||
||Type ofLicense: |Advance Licence with AU Condition|||
||Application|Export Order|-|
||Basis:|||
||Status|Manufacturer Exporter||
||ofExporter:|||
||Exporter Type:||Public Limited||
||ExportProduct <br>Group:||chemical andAlliedProducts||
||CIFValueofthe 157579307<br>License:|||
||CIF FCC:|2126576||
||FOB Value:|333666586||
||FOBFCC:|{4611839||
||Decision:<br>|The Committee considered the case as per agenda and taking cue from earlier decision for same export|||
||product in Meeting No. NC/3MEET/Jan/202021/4 dated 12.02.2021 against advance authorizationNo. 0310836099|||
||dt. 05.05.2020, it was decided to ratify norms under Para4.07 ofHBP Vol, I as per details given below or as applied|||
||bythefirm,whicheverisless:|||
-
Sl. Export Product No. 1 GLIPIZIDE EXTENDED RELEASE TABLETS 10 MG. Each tablet contains (i) | 1 Number Glipizide USP- 10 mg((ii) Eastman (TM Cellulose Acetate (CA 398- LONF/EP)- 29.70 mg (iii) Sentry Polyox WSR N80 FP NF- 178.10 mg (iv) Sentry Polyox WSR 303 NF- 100 mg, Net content (i) 459.46 Kgs (ii) 1364.59 Kgs (iii) 8182.96 Kgs (iv) 4594.59 Kgs.)
-
2 GLIPIZIDE EXTENDED RELEASE TABLETS 5 MG. Each tablet contains (i) Glipizide | 1 Number USP- 5 mg((ii) Eastman (TM Cellulose Acetate (CA 398- LONF/EP)- 20.40 mg (iit) Sentry Polyox WSR N80 FP NF- 89.05 mg (iv) Sentry Polyox WSR 303 NF- 50 mg. Net content (i) 182.43 Kgs (ii) 744.32 Kgs (iii) 3249.12 Kgs (iv) 1824.33 Kgs.)
-
3 GLIPIZIDE EXTENDED RELEASE TABLETS 2.5 MG. Each tablet contains (i) lipizide | 1 Number USP- 2.5 mg((ii) Eastman (TM Cellulose Acetate (CA 398- LONF/EP)- 20.40 mg (iii) Sentry Polyox WSR N80 FP NF- 89.05 mg (iv) Sentry Polyox WSR 303 NF- 50 mg. Net content (i) 33.78 Kgs (ii) 275.68 Kgs (iii) 1203.38 Kgs (iv) 675.68 Kgs.)
223
;
==> picture [378 x 68] intentionally omitted <==
----- Start of picture text -----<br>
||||||||||
|---|---|---|---|---|---|---|---|---|
|No.|GLIPIZIDE USP|10.20 mg|
|2|EASTMAN (TM)|CELLULOSE ACETATE|20.40 mg ||20.40 mg ||29.70 mg|
|(CA|398-10NF/EP)|
|SENTRY POLYOX WSR N80 FP NF|89.05|mg|||89.05|mg|||178.10|mg|
|SENTRY POLYOX WSR 303 NF|50.00 mg|| 50.00 mg|||100,00 mg|
----- End of picture text -----<br>
RA may take appropriate action as per the decision of Norms Committee.
224
e
,
|
==> picture [447 x 173] intentionally omitted <==
----- Start of picture text -----<br>
|||
|---|---|
|Authorisation|10-06-2021|
|feeIssued:|
|Basis:|
|ofExporter:|
----- End of picture text -----<br>
,
|
225
|
==> picture [475 x 342] intentionally omitted <==
----- Start of picture text -----<br>
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Authorisation|10-06-2021|
|Issued:|
|ee|
|Basis:|;|
|ofExporter:|
|FOR Value|[awneaia|
|SSSOSOSCSCSCSSSSSSSSSSOOCO—CSYSC|
|Fosroc.|pasarSSCS|
|Decision:|The|Committee|considered|the|case|as|per|agenda|and|it|was|decided|to|call|for following|information|
|from|the|firm:|
|(i)|DML.|
|(ii)|COA of import|item|from foreign|supplier.|
----- End of picture text -----<br>
;
226
_.
:
|pssfem<br>Authorisation<br>__|Issued:|fem<br>10-06-2021|:|
|---|---|---|
|Basis:|||
|ofExporter:|||
,
227
|
| .
| elcee<br>Authorisation<br>11-06-2021<br>Issued: | elcee<br>Authorisation<br>11-06-2021<br>Issued: |
|---|---|
| PIN, | fois<br>SSOSCSCSCSCSCSCCC‘éS |
| Basis: | |
| ofExporter: | |
| roprec: | _[lisea0—SCSCSSCSCSCSSCSCTTCCOCOCOCOCSCSCS |
228
|
,
.
||a<br>Authorisation<br>Issued:|11-06-2021|
|---|---|
|,||
|Basis:||
|ofExporter:||
|,||
|Decision:|The Committee considered the case as per agenda and it was decided to call for following information||
|fromthefirm:||
229
|
,
|
:
==> picture [447 x 319] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Authorisation|11-06-2021|
|Issued:|
|ecm|fe|
|(East),|MUMBAI,400022.|
|Basis:|
|ofExporter:|
|Decision:|The|Committee|considered|the|case|as|per|agenda|and|it|was|decided|to|call|for|following|information|
|from the|firm:|
----- End of picture text -----<br>
230
,
:
Authorisation 11-06-2021 f e perIssued: Basis: ofExporter:
,
Decision: |The Committee considered the request of the firm and it was decided to ratify adhoc norms under Para 4.07 of HBP vol. I as per details given below or as applied by the firm, whichever is less: peo450+50mg (9:1)) asTablets eellNo. | - RA concerned may take further necessary action as per above decision of NC.
231
|
,
| |
==> picture [448 x 306] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Authorisation|12-06-2021|
|Issued:|
|fca|
|Basis:|
|ofExporter:|
|Decision:|The|Committee|considered|the|case|as|per|agenda|and|it|was|decided|to|call|for|following|information||
|from the|firm:|
----- End of picture text -----<br>
232
—~
,
|
|fiefom<br>Authorisation<br>12-06-2021<br>Issued:|fiefom<br>Authorisation<br>12-06-2021<br>Issued:|fiefom<br>Authorisation<br>12-06-2021<br>Issued:|
|---|---|---|
|Basis:|||
|ofExporter:|||
|Decision:|The Committee considered the case as per agenda and itwas decided to call for following information|||
|from the firm:|||
||(ii)<br>MasterBatchFormula.|;|
233
| a<br>Authorisation<br>Issued: | 12-06-2021 | 12-06-2021 | : | |
|---|---|---|---|---|
| Basis: | ||||
| ofExporter: | ||||
| Decision: | The Committee considered the case as | per | agenda and it was decided to call for following information | |
| fromthe firm: | ||||
| (ii) | MasterBatchFormula. | © |
234
; ,
==> picture [447 x 306] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|Authorisation|13-06-2021|
|Issued:|
|soe|fm|
|Basis:|
|ofExporter:|
|Decision:|The|Committee|considered|the|case|as|per|agenda|and|it|was|decided|to|call|for|following|information||
|from the|firm:|
----- End of picture text -----<br>
235
,
| [BQ FileNumber]HORNORMAPPLYOOIS@TANDA | SSCS |
|---|---|
| fee pee<br>Authorisation<br>14-06-2021<br>Issued: | |
| Basis: | |
| ofExporter: |
|
)
236
. me :
cee ae
;
:
MANUAL CASES
enhancement in the quantity of import item of adhoc norms fixed by NC-3 against Advance Authorization No. “ ; 0310817246-dated-23.11.2017--- ~~. - es
submitted its Advance Authorization in RLA, Mumbai for redemption.
In view of above, the Committee decided to withdraw the case.
M.No. NC/3/MEET/Jun/202122/2 F.No. 01/82/50/01769/AM16/DES-IEI Date 02.07.2021 RLA F.No, 08/24/040/00137/AM16 Advance Licence No 0810136085 Dated 22.09.2015 CALCIUM” under para 4.7 of against adv. Lic. No. 0810136085 Dated:22.09.2015 of M/s CadilaHealthcare Limited. Decision: The Committee considered the request of the firm and it was decided to enhance the quantity of import item - (4R-cis)-1,1-dimethylethyl-6-[2-[2-4-fluorophenyl)-3-phenyl [-4(phenylamino)carbonyl]-1-H-pyrrol-1-ylJethy!]-2,2-dimethy!-1,3-dioxane-4-acetate from 0.708 kg to 1.11 kg.
,
Rest of the earlier Minutes would remain unchanged.
enhancement in the quantity of Import Item No. 2 in the adhoc norms fixed by NC-3 against Advance Authorization No. 0310817118 dated 16.11.2017
237
. : .
“~
==> picture [473 x 300] intentionally omitted <==
----- Start of picture text -----<br> _Case No. A-O4<br>|Meeting No. NC/3/MEET/Jun/202122/2<br>Date| 02/07/2021<br>Firm’s Name M/s Shiva Pharmachem Limited,aVadodara<br>HQ F. No. 01/82/050/00926/AM15/ /DES-HI<br>01/82/050/00529/AM 16/ /DES-ILI<br>01/82/050/01116/AM15/DES-II]<br>7 _ 01/82/050/00105/AM16/DES-Ifl<br>RLA F. No. 34/24/040/00100/AM15<br>34/24/040/0013 1/AM15<br>34/24/040/00200/AM15<br>ee 34/24/040/00010/AM16<br>Advance Authorization No. and Date 34100404893410040395 dateddated 27.08.201423.07.2014 __ __ .<br>3410040669 dated 07.11.2014<br>fo. . : : 3410041157 dated 22.04.2015<br>Subject Request of M/s Shiva Pharmachem Limited, Vadodara for<br>enhancement in the quantity of import item in respect of adhoc<br>norms fixed by NC -3 against Advance Authorization Nos.<br>3410040395 dated 23.07.2014, 3410040489 dated 27.08.2014,<br>Decision: 3410040669 dated 07.11.2014 and 3410041157 dated 22.04.2015|<br>information fromThetheCommitteefirm: considered the request of the firm and it was decided to call for following<br>@ Production Consumption data for the relevant licensing year duly certified by<br>GST. ,<br>----- End of picture text -----<br>
;
238
os,
;
==> picture [444 x 498] intentionally omitted <==
----- Start of picture text -----<br> | [Meeting][ No.] NC/3/MEET/Jun/202122/2<br>Date 02/07/2021<br>|Firm’s Name | ee<br>-HQF.No. 0.1/82/050/01M/s Reckitt Benckiser142/AM15/DES-IIIHealthcare India Limited, New Delhi<br>|Advance_RLA F.No.Authorization ; No. and; Date | 051039164505/24/040/00325/AM15dated 20.10.2014<br>Subject Request of M/s Reckitt Benckiser Healthcare India Pvt.<br>Ltd., New Delhi for enhancement in the quantity of import<br>items in respect of adhoc norms fixed against Advance<br> Authorization No, 0510391645 dated 20.10.2014<br>Decision: The Committee considered the request of the firm and it was decided to revise the norms as<br>under:<br>MucinexExport Product Fast-Max Severe Congestion and Cough Liquid ooQty. eg ——<br>Qty. recommended<br>{NoRa Import items ~~ |<br>i | (per bottle of 180 ml)<br>Sorbitol Solution (70%) USP(D-Sorbital/Sorbitol 70%) 24.545 gm<br>2 __| Propylene Glycol, USP 49.091 gin<br>3__Glycerin USP 32.727 gm —<br>47 |_Xantham<br>5 | AnhydrousGumCitricPHAcid Eur, US US P ,(Citric JH Acid) . 0. 2918 0 gm -<br>6 .<br>| 7 | PropyiSodium Gallate,Benzoate USNF NF _ a 0.360O327 gm _<br>9 | Magnasweet 110 ° . | 1.244 gm<br>10 | Red Fruits 0.147 gm<br>I] EDTA Disodium USP 0.082 gm<br>12 FD&C Blue #1 0.005 gm<br>13 FD&C Red # 40 {9.001 gm<br>Ws14 Venus24 MM (Plastic Closure) Relevant, as per<br> “Square M/Wash O/C Blue HT (Plastic Closures) ; packing policy<br>16 Mucinex -4P Multipage Severe Cough Paper Labels<br>Note: I. Above revised norms are as per Master Batch Formuta with nil wastage,<br>2. Above norms are for the export of 180 ml bottle. The firm will declare to<br>RA, the number of bottles exported / to be exported against the total<br>... .. --£Xport obligation in the present Advance Authorization,<br>RA concerned may take further necessary action as per above decision of NC,<br>----- End of picture text -----<br>
,
239
.
.
. ,
==> picture [449 x 510] intentionally omitted <==
----- Start of picture text -----<br> Case No. _ 7 A-06 /<br>Meeting Now| NEP IMEET/Su/202022/2<br>(| Date T2020<br>Firm’s Name M/s Reckitt Benckiser Healthcare india Limited, New Dethi<br>HQF.No sf 01 /82/050/0114.1/AM 15/DES-LI1 ee<br>CRLAF.No.+ «05/2.4/040/00330/AM15<br>|Advance Authorization No. and Date<br>Subject ; _ Request0510391644of M/sdated 20.10.2014Reckitt Benckiser Healthcare India Pvt.<br>Ltd., New Delhi for enhancement in the quantity of import<br>items in respect of adhoc norms fixed against Advance<br>necesDecision: Authorization 0510391644No. dated 20.10.2014<br>| The Committee considered the request of the firm and it was decided to revise the norms as<br>under:<br>~MucinexExport ProductFast-Max Cold & Sinus Liquid Qty.117800.000kg—©<br>SL. Importitems _ Qty. Recommended<br>No. | (per bottle of 180 m))<br>] Xantham Gum (0207499) PH, Eur, USP, JH (O.180gm<br>“12 Propyt Gallate, USNF 0.3273gm<br>3 |Magnasweet 110 1.2436 gm<br>4 | Red Fruits<br>_ O.1473gm<br>5 FD&C Blue # | a 0.0046 gm _<br>6 | FD&C Red #40 — 0.0009 gm<br>7 Sorbitol Solution (70%)USP<br>8 Propylene Glycol USP ee<br>9 ; 49.0910 gm<br>10 | AnhydrousGlycerin USPCitric Acid USP — ; 0.207832.7274gm gm<br>2 Sucralose NF _ (0.3273gm<br>13 EDTA Disodium USP 0.0818<br>rn)1614 _Mucinex| SquareVenus 24M/Wash—MM6P Multipage(PlasticO/C BlueClosure) ColdHT(Plastic &_Sinus Closures) (Paper Labels) Relevant,packing; policy as per<br>Note: 9. Above revised norms are as per Master Batch Formula with nil wastage.<br>2, .., Above norms are for the export of 180 ml bottle. The firm will declare to<br>| RA, the number of bottles exported / to be exported against the total<br>export obligation in the present Advance Authorization.<br>RA concerned may take further necessary action as per above decision of NC, _ ; _|<br>----- End of picture text -----<br>
.
240
,
:
,
==> picture [442 x 563] intentionally omitted <==
----- Start of picture text -----<br> “Case No. 4-07<br>|Meeting No. . NC/3/MEET/Jun/202122/2<br>Date oe 02/07/2021 7<br>Firm’sName M/s Reckitt Benckiser Healthcare India Limited, New Delhi<br>-RLAF.No.HQ F. No. 01/82/050/00290/AM15/DES-III<br>Advance 05/24/040/00480/AM14—__ <br>Subject Authorization No. and Date Request0510382032of datedM/s Reckitt18.03.2014Benckiser Healthcare india Pvt.<br>Ltd., New Dethi for fixation of adhoc norms in respect of<br>/ Advance Authorization No. 0510382032 dated 18.03.2014<br>Decision: The Committee considered the request of the firm and it was observed that the Advance<br>Authorization was taken for the export product Mucinex Fast — Max Cold & Sinus Liquid, however the<br>norms were wrongly ratified for export product — Mucinax Fast-Max Severe Congestion & Cough Liquid.<br>Accordingly, the Committee decided to revise the norms as under:<br>Mucinex Fast-Max Severe Congestion and Cough Liquid | 64470.000 kg<br>‘ise(7,02,72,300 Milileter (ML) Qty. <br>Export product: Mucinex Fast-Max Cold & Sinus Liquid (OTC product)<br>Sh Import items : Qty. Recommended<br>No |<br>1 _ (per bottle of 180m!)<br>2 Xantham Gum (0207499) PH, Eur, USP, TH | 9.180gm ee<br>3 _ | PropylGallate, USNF _ (03273¢m<br>|<br>4 - Magnasweet 110 — 1.2436 em a<br>5 Red Fruits - _ _ | 0.1473 gm<br>(6 | FD&C Blue # 1 0.00046gm<br>7 |FD&CRed #40 0.0009 gm<br>8 | Sorbitol Solution (70%) USP 24,5455gm<br>9 | Propylene Glycol USP __ __ 49.0910 gm<br>10 Glycerin USP - 32.7274 gm <br>| Anhydrous Citric Acid USP 0.2078 gm<br>l1| Sodium Benzoate NF<br>12_| Sucralose NF _ _ 0.36000.3273 gmgm<br>13 | EDTA Disodium USP ___|<br>14 0.0818<br>15 Venus 24 MM (Plastic Closure) Relevant, as per<br>Square M/Wash O/C Blue HT (Plastic Closures) |<br>“16 packing policy<br>Note: _Mucinex — 6P Multipage Cold & Sinus (Paper Labels)<br>i. Above revised norms are as per Master Batch Formuia with nil wastage.<br>2. > Above norms are for the export of 180 ml bottle. The firm will declare to<br>| _ _. exportRA, theobligationnumber inofthebottlespresentexportedAdvance/ toAuthorization.be exported against the _total<br>concernedmaymay take further necessary necessary action as per above decision above decision decision ofNC,NC, __ _.<br>----- End of picture text -----<br>
==> picture [313 x 17] intentionally omitted <==
----- Start of picture text -----<br> RA concernedmaymay take further necessary necessary action as per above decision above decision decision ofNC,NC,<br>----- End of picture text -----<br>
241
|
:
. rr
,
==> picture [440 x 532] intentionally omitted <==
----- Start of picture text -----<br> [MectingNo. | NC//MEET/Jun/202122/2<br>Date 020772020—<br>(earlier known as M/s Ranbaxy Labs Ltd,, New Delhi<br>Advance 0510337284 dt. 16.10.2012 0510325945 dt. 25.05.2012<br>aand Date<br>, M/s Ranbaxy Labs Ltd., New Delhi) for fixation of the input output norms against<br>Advance Authorization Nos. 0510337284 dated 16.10.2012 and 0510325945 dated<br>23.05.2012<br>“Decision: - The-Committee considered the request of the firm and it was decided to ratify adhoc norms under<br>Para 4.07 of HBP vol. I as per details given below or as applied by the firm, whichever is less:<br>No.<br>ACETYLTHIOSULFAMIDE (ATS) (4- Lkg<br>Nitrobenzyl (2S, 48)-4-acetylthio-2-<br>(N-sulfamoyl-tert-butoxycarboxamidomethy]) CARBON<br>pyrrolidine-1-carboxylate) ( Bulk Drug /<br>Pharmacopeal Grade) ISOCYANATE<br>FORMAMIDE<br>AZODICARBOXYLA<br>TE<br>eaeCHLORIDE<br>leneCHLOROFORMATE<br>, THIOACETATE<br>BOROHYDRIDE(pow<br>der)<br>BUTANOL<br>14 TRIPHENYL 0.64 kg<br>MS [etossme [SS<br>15 | TRANS-4- 0.44 kg<br>eePROLINE<br>----- End of picture text -----<br>
RA concerned may take further necessary action as per above decision ofNC.
242
,
;
==> picture [431 x 541] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|known|as|M/s DSM|Sinochem|Pharmaceuticals|India|Pvt.|Ltd.),|
|Chandigarh|
|Limited|(formerly|known|as|M/s|DSM|_|Sinochem|
|Pharmaceuticals|India|Pvt.|Ltd.),|Chandigarh|for|revision|of|
|adhoc|norms|fixed|against|Advance|Authorization|No.|
|2210015511|dated|23.06.2016|
|Decision:||The|Committee|considered|the request|of the|firm and|it|was|decided|to|revise|the norms|as under:|
|No.|
|ROSUVASTATIN|The|
|CALCIUM|
|———=SCSCSC*dt*(N allowed|
|6_[|Sodium Carbonate|
|[s_[Acetadeiyde9.|| Sodium|Bicarbonaie|SCS|
|Not|allowed|
|,|Not|allowed|
|Fluorophenyl)-6-Isopropyl-2-[(N-Methy]|
|Sulfonyljamino]pyrimidinyl-5-yl-fomy]]|
|DLR|
|2M|solution|
|,|Not allowed|
----- End of picture text -----<br>
The firm is only importing 10 import items out of 29. Hence, the norms are not ratified for other 19 import items.
243
. -
| : .
|
==> picture [443 x 58] intentionally omitted <==
----- Start of picture text -----<br> Subject Request of M/s Neogen Chemicals Ltd., Mumbai for<br>enhancement in the quantity of Import Items in respect of adhoc<br>0310822930 dated 08.08.2018 ,<br>See<br>Decision: The Committee considered the request of the firm and it was observed that the firm has not provided<br>----- End of picture text -----<br>
Case No. A-11 NC/3/MEET/Jun/202122/2 _ 02/07/2021 Subject Request of M/s Global Calcium Pvt, Ltd., Bangalore for revision of adhoc norms fixed against Advance Authorization No. ee Decision: The Committee considered the case as per online agenda in the presence of technical experts and it was noted that the firm still has not furnished the following information asked for by NC-3 in its Meeting No. 07/AM21 dated 24.12.2020, followed by Reminder on 29.06.2021:
(i) Production / Consumption data for last two years for each export product: duly certified by Superintendent, GST.
:
(ii) Receipt of payment of Rs. 5000/~ composition fee deposited in concerned RA in terms of Para 4.17 of HBP Vol. I.
In view of above, the Committee decided to issue Final Reminder to firm to furnish its reply, failing which the case will be rejected.
244
_.
[CaseNo. [AZ
Authorization No, and Date SsSubject Request19.09.2008, of M/s 0710084171Organicadated Aromatics, 23.11.2011Bangaloreand _ 0710062745for enhancementdated 04.02.2009in the quantity of import .....} Decision: The.Committee considered the request of the firm and it was observed that the reply furnished by the firm is not proper, since the Excise Certificate does not have total quantity produced / total raw material consumed for the specific period of licence (2009-09, 2009-10, 2010-11) and also no date is mentioned on the Certificate.
In view of above, it was decided to again call for following information from the firm:
(i) Central Excise Data for specific Production (in kg) and specific Consumption (in kg) for the specific year 2008-09, 2009-10 and 2010-11.
~ in the quantity of import items in respect of adhoc norms fixed by NC-3 against. Advance Authorization No. 0310812544 dated 18.04.2017 Decision: The Committee considered the request of the firm and it was decided to call for following
information from the firm:
(i) Technical literature in support of yields. (ii) Production-Consumption data duly certified by GST. (iii) Copy of amended licence. (iv) Receipt of payment of Rs. 5000/- composition fee deposited in concerned RA in terms of Para 4.17 of HBP Vol. I.
|
245
|
: oo
”
,
Case No. A-14 M/s. Eurolife Healthcare Pvt. Ltd. M.No. NC/3/MEET/Jun/202122/2 ’ | F,No.01/82/050/00323/AM13/DES-III Date 02/07/2021 F.No. 01/82/050/00571/AM16/DES-III RLA File No: 08/24/040/00981/AM13 Adv.Auth. No. 0310728713 Dated 19.03.2013 RLA File No: 08/24/040/01086/AM15 Adv.Auth. No. 0310794964 Dated:27.03.2015
==> picture [446 x 471] intentionally omitted <==
----- Start of picture text -----<br> Subject: Request for fixation of I/O norms for the export product “METRONIDAZOLE INTRAVEOUS<br>INFUSION 100ml METRONIDAZOLE 500mg” unnder para 4.7 of against adv. Lic. No. 0310728713<br>dated 19.03.2013 and ady.Lic. No. 0310794964 dated 27.03.2015 of M/s. Eurolife Healthcare Pvt. Ltd.<br>Decision: The Committee considered the request of the firm and it was observed that the reply given by the<br>firm was not as per the DL issued earlier, Further, the import items include large quantity of LDPE Graules,<br>Craft Paper and other packing material.<br>~ In view of above, the Committee decided to call for clarification from the firm, © ~~ "77 oT<br>[CaseNow CAS<br>NC/3/MEET/Jun/202122/2<br>[HQF.No.—S—~—SSSSSS M/s Inchem Laboratories Private Limited., Hyderabad<br>| 09/24/040/00413/AM12<br>LRLAF.No. 01 8.2/050/01275/AM12/DES-IT<br>Advance Authorization No, and Date 0910050238 dated 15.12.2011<br>Subject Request of M/s Inchem Laboratories Pyt. Ltd., Hyderabad for<br>fixation of adhoc norms against Advance Authorization No.<br>0910050238 dated 15.12.2011<br>Decision: | The Committee considered the request of the firm and it was decided to ratify adhoc norms under<br>Para 4.07 of HBP vol. I as per details given below or as applied by the firm, whichever is less:<br>RACTOPAMINE No.<br>HCL lkg | 1 CAS(RS) 4-(2amino-1-hydroxyNo 770-05-8 ethyl) phenol HCL- | 0.446 kg<br>2 4(4-HYDROXY PHENYL )-2-BUTANONE - | 0.70 kg<br>CAS 5471-51-2<br>Raney Nickel Grade, -CAS No KALCAT 1961 | Either not<br>4 4-Hydroxy benzal Dehide -CAS No 123-08-0 required in<br>Or 4- Hydroxy AcetoPhenone ITC HS Code the process<br>- | 29145000 or shown<br>fo [ACETONESodium Boro Hydride -CAS No+d 16940-66-2 indigenousAppendix in<br>|8 IPA (ISO PROPYLE ALCOHOL) 4E.<br>|9 | PETROLIUM ETHAR<br>}10 | MDC (METHYLENE CHLORIDE)<br>11 [METHONOL Cid<br>| NITRO METHANE or Hydroxyl Amino<br>Sulphate ITC HS No 28251040<br>----- End of picture text -----<br>
.
RA concerned may take further necessary action as per above decision ofNC.
246
CaseNo.A DateTOD FirmsName | Mis Inchem Laboratories Pvt, Ltd, Hyderabad HOF.No. on O1/82/050/01493/AMI2/DES-T PRLAF.No. OT O9RAOAOOOSTSVAMI2 Subject : Request of M/s Inchem Laboratories Pvt Ltd., Hyderabad for 0910051360 dated 21.02.2012 eeDecision: The Committee considered theeee request of the firm and it was decided to ratify adhoc norms under Para 4.07 of HBP vol. las per details given below or as applied by the firm, whichever is less: RACTOPAMINE 1kg (RS) 4-(2Amino-1-Hydroxy Ethyl) Phenol HCL USAGE (CAS 5471-51-2 )
Case No. Ad? C [MeetingNo.*dCNCSIMIRETSun20202272 DateOTN a THOF.No. SC 01/82/050/00910/AM14/DES-IIL PRLAF.No. | 09/24/040/00287/AMA fixation of adhoc norms against Advance Authorization No. 0910057785 dated 01.10.2013 Decision: The Committee considered the request of the firm and it was decided to ratify adhoc norms under Para 4.07 of HBP vol. I as per details given'below or as applied by the firm, whichever is less: No. SODIUM
247
,
. ,
|
.
==> picture [477 x 520] intentionally omitted <==
----- Start of picture text -----<br> Meeting No. NC/3/MEET/Jun/202122/2<br>Firm’s Name M/s Clean Science and Technology Private Limited, Pune<br>HQ F. No. : 01/82/050/00108/AM18/DES-I]<br>Advance Authorization No. and Date 3110066636 dated 21.03.2017<br>Subject Request of M/s CLEAN SCIENCE AND TECHNOLOGY PVT.<br>LTD., Pune for enhancement in the quantity of import items of<br>norms in respect of adhoc norms fixed against Advance<br>Authorization No. 3110066630 dated 21.03.2017<br>Decision: The Committee considered the request of the firm and it was decided to call for following<br>information from the firm:<br>(D Production Consumption data for the licensing year duly certified by GST.<br>Case No. PATO<br>_Meeting No. NC/B/MEET/Sun/202022/72<br>| Date O20T/2028<br>Firm’sName | «M/s Clean Science and Technology Private Limited, Pune _<br>HIQPNo | 99/AMIS/DESUEF/B 2/05 0/005<br>RLA F. No, 31/83/040/00074/AM 18 __ <br>Advance Authorization No. and Date 3110066858 dated 02.09.2017<br>Subject Request of M/s CLEAN SCIENCE AND TECHNOLOGY PVT.<br>LTD., Pune for enhancement in the quantity of import items of<br>: norms in respect of adhoc norms fixed against Advance<br>Decision: The Committee considered Authorizationthe case as perNo.agenda3110066858and it wasdatedobserved02.09.2017that the case can be<br>approved as the firm has requested for marginal increase in quantity of all raw materials and also in later case of | ~<br>same export product in Meeting No. 9/82-ALC4/2018 dated 15.01.2018 against advance authorization No.<br>3116066966 dt. 15.01.2018 same norms were approved on the basis of proper technical details furnished by the<br>firm. Hence, it was decided to revise the norms as under:<br>Export product Qty. Import items Qty.<br>No.<br>Acetyl Anisole lkg | 1 | Phenol! 0,906 kg<br>2| Dimethyl Sulphate sf0.693 keg<br>3 Caustic Lye PURITY 40% AND ABOVE| 0.437 kg<br>ee 4 Acetic(100% AnhydrideBasis) PURITY 99% 0.755 ke|<br>Note: RA may close the case in respect of above advance authorization after the receipt of payment<br>of Rs. 5060/- composition fee in termsof Para 4.17 of HBP Vol.<br>----- End of picture text -----<br>
,
248
. .
Case No.———-aeA-20 |Meeting No. — | NC/3/MEET/Jun/202122/2 Date | 02/07/2021 _ Firm’s Name M/s Clean Science and Technology Private Limited, Pune -HQF.No. 01/82/050/00149/AM18/DES-Il] ee RLA F.No. 3 1/83/040/00012/AM 18 Advance Authorization No. and Date 3110066716 dated 02.05.2017 _ Subject Request of M/s CLEAN SCIENCE AND TECHNOLOGY PVT. LTD., Pune for enhancement in the quantity of import items of norms in respect of adhoe norms fixed against Advance fo - Authorization No. 3110066716 dated 02.05.2017 Decision: The Committee considered the request of the firm and it was decided to call for following information from the firm: (i Quantity and Commercial value of by-Product Guaiacol. ai Production Consumption data for the licensing year duly certified by GST. (iii) Receipt of payment of Rs. 5000/- composition fee deposited in concerned RA in _ terms of Para 4.17 of HBP Vol. 1. _ CaseNow - A-24 , . Meeting No. NC/3/MEET/Jun/202122/2 | Date 02/07/2021 |[Pirm’s][ Name] M/s Clean Science and Technology Private Limited, Pune HQF.No. 01/82/050/01742/AM16/DES-HI RLAF.No ; |.31/83/040/00147/AM16 _ Advance Authorization No. and Date 3110065899 dated 01.02.2016 Subject Request of M/s CLEAN SCIENCE AND TECHNOLOGY PVT. LYD., Pune for enhancement in the quantity of import items of norms in respect of adhoc norms fixed against Advance Authorization No. 3110065899 dated 01.02.2016 Decision:7 . The Committee considered the request of the firm and it was observed that this case can be approved since theortically on the basis of purity required should be 1.069 kg taking wastage of 3% requested should be 1.10 kg / kg as requested and also approved earlier. Accordingly, it was decided[to][revise][the] quantity of import item - Anisole Purity 93% Max from 1.065 kg to 1.10 kg. Rest of the earlier Minutes would remain unchanged, Note: RARAmay concernedclose the maycase takein furtherrespectnecessaryof aboveactionadvanceas perauthorization above decisionafterof NC,the receipt of payment of| Rs, 5000/- composition fee in terms of Para 4.17 of HBP Voi. |CaseNo, MeetingNo. |NEB/MEET/Sun/2020220 Date 02/07/2021 ‘FirmsName | «Mis Clean Science and Technology Private Limited, Fume __ HQF.No. 01/82/05 0/009 16/AMID/DES-U RLAF.No 31/83/040/00034/AMI9 Advance AuthorizationNo. and Date| 3110067081 dated 15.06.2018 Subject Request of M/s CLEAN SCIENCE AND TECHNOLOGY PVT. LTD., Pune for enhancement in the quantity of import items of norms in respect of adhoc norms fixed against Advance Authorization No. 3110067081 dated 15.06.2018 7 Fe Decision: Fhe Committee considered the request of the firm and it was decided to call for following information from the firm: (i) Quantity and Commercial value of by-Product Acetic. (iD Production Consumption data for the licensing year duly certified by GST. Gid Receipt of payment of Rs. 5000/- composition fee deposited in concerned RA in terms of Para 4.17 of HBP Vol bh __
,
249
.
:
:
|Case No.|||||||A-23||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|| Meeting No. _|||||||NC/3/MEET/Jun/202122/2||||||
|Date|||||||02/07/2021|||:|coe||
|Firm’s Name|||||||M/s Clean Science and Technology||Private Limited,|||Pune|
|HQ F. No.|||||||01/82/050/00597/AM18/DES-III||||||
||||||||01/82/050/00723/AM 18/DES-Ii]||||||
||||||||01/82/050/00996/AM1<br>8/DES-III||||||
||||||||01/82/050/00090/AM 19/DES-III||||||
|“|||||||01/82/050/00522/AM19/DES-II1||||||
||||||||01/82/050/00525/AM19/DES-Il||||||
||||||||01/82/050/01188/AM19/DES-HI||||||
||||||||01/82/050/01211/AM19/DES-II]||||||
|:|||°||||01/82/050/01236/AM19/DES-III||||||
|Z||ee|||||01/82/050/01357/AM19/DES-HI|||__||_|
|RLA F.No.|||||||3 1/83/040/00035/AMI8||||||
||||||||31/83/040/00082/AM18||||||
||||||||3 1/83/040/00124/AM18||||i||
||||||||31/83/040/00150/AM18||||||
||||||||31/83/040/00048/AM19||||||
||||||||31/83/040/00048/AM{9||||||
||||||||31/83/040/00049/AM19||||||
||||||||31/83/040/00085/AM19||||||
||||||||31/83/040/00113/AM19||||||
|_|||||_||3 1/83/040/00128/AM19/||||_||
|Advance Authorization||||No.|and|Date|3110066777 dated 09.06.2017,|3110066885|||dated|03.10.2017,|
||||||||3110066937 dated<br>19.12.2017,|3110066984|||dated|15.02.2018,|
||||||||3110067104<br>dated<br>03.07.2018,|3110067113|||dated|13.07.2018,|
||||||||3110067165<br>dated<br>28.08.2018,|3110067223|||dated|31.10.2018,|
|| 3110067227 dated 06.11.2018& 3110067240 dated 22.11.2018,|<br>Subject<br>Request ofM/s CLEAN SCIENCE ANDTECHNOLOGY PVT.|||||||||||||
||||||||LTD., Pune for enhancement in the quantity||||ofimport items of||
||||||||norms<br>in<br>respect<br>of adhoe|norms||fixed|against Advance||
||||||||Authorization No. 3110066777 dated|||09.06.2017,||3110066885|
||||||||dated 03.10.2017, 3110066937|dated||19.12.2017,||3110066984|
||||||||dated<br>15.02.2018, 3110067104|dated||03.07.2018,||3110067113|
||||||||dated<br>13.07.2018, 3110067165|dated||28.08.2018,||3110067223|
||||||||dated 31.10.2018, 3110067227 dated 06.11.2018 &|||||3110067240|
|_|||||||dated22.11.2018||_.|||||
|Decision:|The||Committee|||considered<br>the<br>request ofthe firm and it||was|decided to call for following||||
|information from||the.firm:|||||||||||
||rey}|||Production Consumption data for the licensingyear||||year duly certified byGST.|||||
||(i)|||Receipt of payment of Rs. 5000/- composition fee deposited in|||||||concerned RA in||
|a||||termsofPara4.17 ofHBP Vol.E|||||||.||
250
, ,
:
. :
==> picture [481 x 691] intentionally omitted <==
----- Start of picture text -----<br> Case No. A-24<br>Meeting No. NC/3/MEET/Jun/202122/2<br>‘Date . _| 02/07/2021 _<br>_Firm’s Name : M/s Satyadeva Pharmaceuticals Pvt. Ltd, Hyderabad<br>“HQF.No. _ 01/82/050/01070/AM18/DES-UI<br>_RLA F. No. 09/24/040/00337/AM 18 a<br>Advance Authorization No. and Date 0910065537 dated 05.10.2017<br>Subject Request of M/s Satyadeva Pharmaceuticals Pvt. Ltd, Hyderabad<br>for fixation of adhoc norms against Advance Authorization No.<br>0910065537 dated 05.10.2017<br><br>Decision: The Committee considered the case as per online agenda in the presence of technical experts and it<br>was noted that the firm still has not furnished the following information asked for by NC-3 in its Meeting No.<br>3/AM21 dated 24.07.2020, followed by Reminder on 28.10.2020:<br>(i) import items and quantities actually imported against these exports.<br>Gi) Complete technical details including chemistry, yields, material balance for each stage.<br>in view of above, the Committee decided to issue Final Reminder to firm to furnish its reply, failing which the<br>CaseNo. [AB __<br>Meeting No. ___ | NC3/MEET/Jun/202122/2 : <br> Date 02/07/2021<br>Firm’s Name M/s. SRINI PHARMACEUTICALS PRIVATE LIMITED,<br>Hyderabad . _<br>a a<br>HQ F. No. 01/82/050/00217/AM 19/DES-10J<br>oeRLA F. No. a 01/82/050/01317/AM17/DES-Il__09/24/040/00430/AM 18 <br>09/24/040/00348/AM17<br>Advance. Authorization No. and Date 0910065723 dated 07.12.2017<br>ee 0910064196 dated 28.09.2016 _ a<br>Subject Request of M/s SRINT PHARMACEUTICALS PRIVATE<br>LIMITED, Hyderabad for enhancement in the quantity of<br>import items in respect of norms fixed against Advance<br>Authorization Nos. 0910064196 dt. 28.09.2016 and 0910065723<br>ee ___| dt, 07.42.2017, . ee<br>Decision: The Committee considered the request of the firm and it was observed that the firm has not provided<br>any technical data in support of its request and the norms were given on the basis of comparative data from the<br> industry. Hence, itwas decided to reject the case maintaining the status quo. <br>‘GaseNo AR<br>“MeetingNo NCIS / MEE Yidun/202122/2<br>Date 2/07 OAA<br>Firm’s Name M/s SRINt PHARMACEUTICALS PRIVATE LIMITED,<br>Hyderabad<br>a<br><br>HQ F.No. 0)1/82/050/01074/AM [1][ 8/DES-IIL]<br>-RLAF.No. __ 09/24/040/ 00309/AM18<br>Advance Authorization No. and Date 0910065528 dated 29.09.2017 : _<br>Subject Request of M/s SRINI PHARMACEUTICALS PRIVATE<br>LIMITED, Hyderabad for enhancement in the quantity of<br>import items in respect of adhoc norms fixed against Advance<br>ee _ ___ | Authorization No. 0910065528 dt. 29.09.2017. _<br>Decision: The Committee considered the request of the firm and it was observed that the firm has not provided<br>any technical data in support of its request and the norms were given on the basis of comparative data from the<br>_industry. Hence, it was decided to reject the case maintaining the status quo.<br>----- End of picture text -----<br>
, |
251
oe | - 3 : :
==> picture [536 x 360] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
||TT CaseNo|
|| MeetingNo.||NCS/MEET/Jun/2021222——S—‘“—*~s*~*s*~s~—*~s~—‘—~s~sSCS|
||DateTRO|
|eeFirm’s Name|M/siitertngSRINI|PHARMACEUTICALSARMSCECTICATS|PRIVATEPRIVAT|LIMITED,NITED,|
||RLAF.No.|||O9/24/0A000459/AMI8|ss|CSC—“—~S*~s~s~s~SS|
|Subject|Request|of|M/s|SRINI|PHARMACEUTICALS|PRIVATE|
|LIMITED,|Hyderabad|for|enhancement|in|the|quantity|of|
|import|items|in|respect|of|norms|fixed|against|Advance|
|.|ns|.|.|
|Decision:||The|Committee|considered|the|request|of the|firm and|it|was|observed|that|the|firm has not provided|
|any|technical|data|in|support|of|its|request|and|the|norms|were|given|on|the|basis|of comparative|data|from|the|
||CaseNow|AB|—OC—~—CS*T|
|||MeetingNo.|TT|
|DateTONNCB/MEETIun2021222—s—C—“‘“‘*S*~*~*|
|Firm’s|iC|C—*”|
|_Litnapaa_ARMACEUTICATS” Name|_|| M/s|SRINI|PHARMACEUTICALS|PRIVATE|LIMITED,|
|JHQF.No.||2/050/0T170/AMIO/DESISC—“—~s*s~SCS01/8|PRIVATE” HIMTTED,|
|||Subject|Request|of|M/s|SRINI|PHARMACEUTICALS|PRIVATE|
|LIMITED,|Hyderabad|for|enhancement|in|the|quantity|of|
|import|items|in|respect|of|norms|fixed|against|Advance.|
|Decision:|The Committee|considered|the request|of the|firm|and|it|was observed|that the|firm has not provided|
|any|technical|data|in|support|of|its|request|and|the|norms|were|given|on|the|basis|of comparative|data|from|the|
----- End of picture text -----<br>
==> picture [2 x 2] intentionally omitted <==
----- Start of picture text -----<br> °<br>----- End of picture text -----<br>
==> picture [447 x 114] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||
|---|---|---|---|---|---|---|---|---|---|
||AR CaseNow|
|Meeting No.|NC/3/MEET/Jun/202122/2|
|Date|02/07/2021|
|JHQF.No.|01783/050/00503/AMI7DES|
|Subject|Request|of|M/s|Techno|Drugs|&|Intermediates,|Mumbai|for|
|fixation|of|adhoc|norms|against|Advance|Authorization|No.|
|0310392619|dated|02.08.2006|
----- End of picture text -----<br>
==> picture [4 x 5] intentionally omitted <==
----- Start of picture text -----<br> i<br>----- End of picture text -----<br>
252
. .
[MeetingNo.[CaseNo.—™——C—CSABS DateC—~—™—SCOOTIONN—SSSS~S™~S™SCSCSC* (NBME /Jun/20202272 THQF.No. SSCS182/0SO/OOOISVAMITDES-INE Subject Request of M/s Wanbury Ltd, Mumbai for enhancement in the Advance Authorization No. 0310803062 dated 04.03.2016 Ne Decision: The Committee considered the request of the firm and it was observed that the firm has not provided Authorization as per SION A-290. Hence, it was decided to reject the case maintaining the status quo.
[CascNo C—O [MeetingNo. SSS™SCSCSC~S:CNCVB MMT Jun/202022/2— a 71077) 5 HQ F. No. Subject Request of M/s Sterile India Pvt Ltd, CLA, New Delhi for fixation of adhoc norms against Advance Authorization No. 0510364653 dated 05.09.2013 Decision: The Committee considered the request of the firm and it was observed that as per 4.07 application of Advance Authorization, the description of export product is Amoxycilline Sterile BP, however as per DML furnished by the firm, the description of export product is Amoxycilline Sodium Sterile.
In view of above, it was decided to ask firm as to whether Amoxycilline Sterile BP and Amoxycilline Sodium Sterile are one and the same item alongwith copy of technical literature.
(GaseNo.C—O | MeetingNo. SSCS MME /um/20212272 0 91777) 7 Subject Request of M/s Rumit Life Care, Mumbai for enhancement in the Advance Authorization No. 0310824914 dated 05.11.2018 EN ee ee provided any technical data in support of its request and the norms were given on the basis of comparative data from the industry. Hence, it was decided to reject the case maintaining the status quo.
|
253
.
,
Case No. _ A-33 Meeting No. _ NC/3/MEET/Jun/202122/2 Date 02/07/2021 _ |. Firm’s Name M/s Privi Organics Limited, Mumbai -HQFP.No _ 01/82/050/00387/AM19/DES-U] _ |[RLA][F.] No. 03/95/040/00981/AM18 __ Advance Authorization No. and Date 0310819238 dated 19.02.2018 . _ Subject Request of M/s Privi Organics India Ltd, Mumbai for enhancement in the quantity of import item in respect of adhoc norms fixed against Advance Authorization No. 0310819238 —Decision: eeThe Committee considered____| datedthe 19.02.2018.request of the firm and it was decided to call for following_ information from the firm: G) Quantity and Commercial value of By-Product obtained. (i) Production Consumption data for the licensing year duly certified by GST. _Meeting No. NC/3/MEET/Jun/202122/2 _ Date _ __| 02/07/2021 ee Tt -Firm’s Name ___| M/s Synnat Pharma Pvt. Ltd., Kolkata ee HQE.No. __ 01/82/050/00749/AM[|][ 8/DES-III] RLAF.No. 02/24/040/00108/AM18 _ | Advance AuthorizationNo. and Date __| 0210207903 dated 24.10.2017 Subject Request of M/s Synnat Pharma Pvt. Ltd, Kolkata for enhancement in the quantity of import item in respect of adhoc norms fixed against Advance Authorization No, 0210207903 oe dated 24.10.2017 _ __| Decision: The Committee considered the request of the firm and it was observed that the firm has not provided any tecnnical data in support of its request and the norms were given on the basis of comparative data | from the industry. Hence,itwas decided to reject the case maintaining the status quo. ee
254
JGaseNow AS _ Meeting No. NC/3/MEET/Jun/202122/2 | Firm’sDate __ Name . ; 02/07/2021M/s UPL Ltd., Mumbai HQ F. No, 0.1/82/050/0070 1/AM19/DES-II _RLA F. No. _ 03/95/040/00239/AM19 _Advance Authorization No. and Date 0310822448 dated 19.07.2018 Subject Request of M/s UPL Ltd, Mumbai for enhancement in the quantity of import items in respect of adhoc norms fixed against Advance Authorization No. 0310822448 dated 19.07.2018
Decision: — The Committee considered the case as per agenda and it was decided to ratify adhoc norms as applied for in this Advance Authorization by the firm as under:
No. Tris Tri Decyl Phosphite | 250000,000 kg Iso Tri Decyl Alcohol 232750,000 ke 2 Yellow Phosphorus 16750.000 kg [ Note: RA may close the case in respect of above advance authorization after the receipt of payment S Rs. 5000/- composition fee in terms of Para 4.17 of HBP Vel.
|CaseNo. __<br>ZZ<br>A-36|
|---|
|.<br>|<br>_Meeting No.<br>|<br>_<br>___|NC/3/MEET/Jun/202122/2°<br>__.<br>Date<br>02/07/2021|
|.<br>_<br>Firm’s<br>Name<br>;<br>M/sRumitLifeCare,Mumbai<br>_<br>__.<br>HQ F. No.<br>.<br>F. No. 01/82/050/01655/AM19/DES-TiI<br>_<br>RLA F.No.<br>03/95/040/00737/AM1 9<br>;<br>_<br>_<br>|Advance Authorization No. and Date_<br>0310824932dated06.11.2018<br>_<br>_<br>4<br>Subject<br>Request of M/s Rumit Life Care, Mumbai for enhancement in|
|.<br>the quantity of import item in respect of adhoc norms fixed|
|_<br>_ againstAdvanceAuthorization No.0310824932 dated 06.11.2018<br>Decision:<br>The Committee considered the request ofthe firm and it was observed that the firm has not provided<br>any technical data in support of its request and the norms were given on the basis ofcomparative data from the<br>industry. Hence, itwas decided to rejeet the case maintaining the status quo.<br>_<br>_|
:
255
. -
==> picture [476 x 618] intentionally omitted <==
----- Start of picture text -----<br> -| Case No. __| A-37 ee<br>Meeting No. _ NC/3/MEET/Jun/202122/2 _<br>Date _. 02/07/2021 _ _ ee<br>|Firm's Name M/s Global Calcium Pvt. Litd., Bangalore<br>|HQ [F.] No. _ 01/82/050/00508/AM20/DES-II1<br>RLAF.No. 07/24/040/00095/AM20 |<br>Advance Authorization No. and Date 0710115189 dated 19.07.2019<br>Subject Request of M/s Global Calcium Pvt. Ltd., Bangalore for<br>correction / revision in the description of import item in respect<br>of Advance Authorization No. 0710115189 dated 19.07.2019<br>Decision: The Committee considered the request of the firm and it was decided to revise the description of<br>import item fron: CALCIUM GLUCONATE to CALCIUM GLUCONATE ORAL GRADE. Accordingly,<br>the norms are revised as wader:<br>Export Product Sl. import items Qty.<br>No,<br>CALCIUM GLUCONATE (EP FOR lke | 1.09 kg<br>INJECTION/JP/USP) ORAL GRADE<br>| CALCIUM BOROGLUCONATE | 0.946 kg<br>ORAL GRADE<br>CALCIUM GLUBIONATE(FOR ike CALCIUM GLUCONATE<br>Note: RA may close the case in respect of above advance authorization after the receipt of<br>payment of Rs. 5000/- composition fee in terms of Para 4.17 ofHBP Vol. _<br>RA concerned may take further necessary action as per above decision ofNC. __ ee<br>“CaseNo. _. A-38 _ <br>MeetingNo. NC/S/MEET/Sun/202122/2<br>Date 02/07/2021 ee<br>Rirm’sName | Mis Cipla Ltd., Mua<br>HQ F. No. F, No, 01/82/050/00972/AM17/DES-III<br>F, No. 01/82/050/00285/AM 18/DES-HI<br>F. No. 01/82/050/00610/AM 18/DES-ITI<br> es _ F. No. 01/82/050/00127/AM19/DES-HT<br>RLAF.No 03/94/040/00617/AM17—<br>03/94/040/01181/AM17<br>03/94/040/00295/AM18<br>: — _ _03/94/040/00822/AM 18 _ _ ee<br>Advance Authorization No. and Date 0310808312 dated 06.10.2016<br>0310812323 dated 03.04.2017<br>0310814908 dated 31.07.2017<br>: Subject _ 0310818765Request of M/sdatedCipla30.01.2018Ltd, Mumbai for fixation__of adhoc norms<br>against Advance Authorization Nos. 0310808312 dated<br>06.10.2016, 0310812323 dated 03.04.2017, 0310814908 dated<br>ee 31.07.2017 and 0310818765 dated 30.01.2018<br>Decision: Deferred for comments of TE. _ .<br>----- End of picture text -----<br>
,
256
==> picture [459 x 130] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||
|---|---|---|---|---|---|---|---|---|---|
|||[Case]|[No.]|.|A-39|“|
||Meeting|No.|NC/3/MEET/Jun/202122/2|;|
|||[Date]|02/07/2021|_|
|Firm’s Name|M/s|Cipla|Ltd.,|Mumbai|
||RLAF. No.|03/94/040/00038/AM19|
|Advance|Authorization|No.|and|Date|0310820626|dated|25.04.2018|
|Subject|Request|of M/s|Cipla|Ltd.,|Mumbai|for|fixation|of adhoc|norms|
|against|Advance|Authorization|No.|0310820626|dated|
|25.04.2018|
|Decision:|Deferred|for|comments|of TE.|
----- End of picture text -----<br>
==> picture [464 x 195] intentionally omitted <==
----- Start of picture text -----<br>
|||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|CasoNo|
|_Meeting No.|NC/3/MEET/Jun/202122/2|
|Date||82/07/2021|ee|
|Firm’sName|M/s|Global|Caleium|Pyt.|Ltd., Bangalore|
|FHQFLNo.|01/82/050/003 l4/AM16/DES-I]|
|RLAF.No|O7/24/040/040/00393/AMI5|
|_Advance|Authorization No.|and|Date|0710108142|dated|01.05.2015|
|Subject|Request|of|M/s|Global|Calcium|Pvt.|Ltd.,|Bangalore|for|
|revision|of|adhoc|norms|fixed|against|Advance|Authorization|
|No.|0710108142|dated|01.05.2015|
|Decision:|The|Committee|considered|the|request|of the|firm|and|it|was|decided|to|call|for|following|
|information|from|the|firm:|
|(i)|Complete|set|of 4.07|application|alongwith|all|technical|detaiis.|
|(ii)|Receipt|of|payment|of|Rs.|5000/-|composition|fee|deposited|in|concerned|RA|in|
|terms|of|Para|4.17|of HBP|Vol.|f.|
----- End of picture text -----<br>
257
,
Dee
ven
7 : : a
Para - 4.06 Cases
==> picture [448 x 105] intentionally omitted <==
----- Start of picture text -----<br> [CaseNow AM<br>| MeetingNo. |NC/B/MEET/Jun/2021222——s—‘“C~s~SCC<br>| Date<br>Firm’s Name<br>.<br>Subject Request of M/s Tenshi Kaizen Private Limited, Bangalore for<br>fixation of norms of the export product Loperamide RDT<br>----- End of picture text -----<br>
-~ | Decision: - The Committee considered the request of the firm-and:it was decided to call for following information from the firm:
;
(i) Export description does not match with DML. Please clarify it. (ii) Justification for requirement of Cold Form Laminate with the export quantity. (iii) Specification of Laminates alongwith catalogue may be furnished alongwith {mport quantity in numbers of Cold Form Laminates. Similar details may be furnished for Peelable Lid Foil.
,
.
| CaseNow 02/07/2021 M/s Fine Organic Industries Limited, Mumbai 01/82/MISC/Para 4.06/3/AM2 1/DES-III 03/AA/040/32850/AM21 Subject Request of M/s Fine Organic Industries Limited, Mumbai for fixation of adhoc norms of export product - Moniglyceride (GMS) (ITC HS "ieeeDecision: The Committee considered the request of the firm and it was decidedsarerrncmto ratify adhoc norms res) under Para 4.06 of HBP vol. I as per details given below: No. Monoglyceride — PS 0.872 ke
.
258
! ! ; | ; ; .
==> picture [446 x 199] intentionally omitted <==
----- Start of picture text -----<br> [GaeNo. CSR<br>[MeetingNo.——SSSSCS*wSN@BMMETVSu2020292—<br>DateS™—™~—~—SS—~dOTIODN<br>M/s Fine Organic Industries Limited, Mumbai<br>HQF.No. 01/82/MISC/Para 4.06/2/AM2 1/DES-I<br>RLA F. No. 03/AA/040/21337/AM21 .<br>Advance Authorization No. and Date<br>Subject Request of M/s Fine Organic Industries Limited, Mumbai for fixation<br>of adhoc norms of export product ~ Moniglyceride (GMS) (ITC HS<br>Code — 29157030) under Para 4.06 of HBP Vol. I (2015-20<br>Decision: The Committee considered the request of the firm and it was decided to ratify adhoc norms under Para<br>4.06 of HBP vol. I as per details given below:<br>No.<br>Monoglyceride - PS 1 kg Hydrogenated Palm Stearin (HPS) 0.872 kg<br>f2 |0.22Glycerine eg<br>----- End of picture text -----<br>
==> picture [446 x 217] intentionally omitted <==
----- Start of picture text -----<br> RA concerned may take further necessary action as per above decision of NC.<br>[MeetingNo.CaseNoS——C—~SRA<br>Dae SCS™~™~CSS~SSSCS TDN MEET/Su/20212272—<br>M/s Fine Organic Industries Limited, Mumbai<br>01/82/MISC/Para 4.06/4/AM21/DES-III<br>RLA F. No. 03/AA/040/32803/AM21<br>Advance Authorization No. andDate [Notissued yet<br>Subject Request of M/s Fine Organic Industries Limited, Mumbai for fixation<br>. of adhoc norms of export product - Moniglyceride (GMS) (TC HS<br>Code — 29157030) under Para 4.06 of HBP Vol. I (2015-20)<br>Decision: The Committee considered the request of the firm and it was decided to ratify adhoc norms under Para<br>4.06 of HBP vol. I as per details given below: .<br>No,<br>Monoglyceride - PS Lkg Hydrogenated Palm Stearin (HPS) 0.872 kg<br>[2 |(0.222 Glycerine Kg<br>----- End of picture text -----<br>
259
ae ia
; , . -
;
:
Formerly known as M/s Rhodia Specialty Chemicals India Subject Request of M/s Solvey Specialities India Pvt. Ltd., Mumbai (Formerly known as M/s Rhodia Specialty Chemicals India) for Authorization No, 0310819042 dated 08.02.2018 __ eRe Decision: The Committee considered the request of the firm and it was decided to call for following information from the firm: (i) Complete chemistry, chemical reaction with molecular weight and yield. Gi) Stoichiometric balance.
Case No. TTTAdvance Authorization No. andNT Date ——————— Subject , Request of M/s Hubergroup India Private Limited for fixation of P| 29159099)normstata for theunder Para export product4.06 of HBP- VegetableSetteVol. I Oil(2015-20) based Fatty Bu t yl! Estere Decision: The Committee considered the request of the firm and it was decided to call for following information from the firm: i) Total chemistry involved. (ii) Chemistry with molecular weight of imports and export (iii) % yield of reaction. (iv) Justification for 7.4% total wastage.
Meeting ended with thanks to Chair and participants ae Me oft
|
|
Verbatim extracted text (OCR/PDF). Older scans and tables may show extraction artifacts — verify against the original for anything you act on.
No analysis has been generated for this document yet.